Processing 00000000.tx.1: Endosomal Proteolysis of Glucagon at Neutral pH Generates the Bioactive Degradation Product Miniglucagon-(1929) Franois Authier, Pamela H. 

Phrase: "Endosomal Proteolysis of Glucagon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0597304:Proteolysis [Molecular Function]

Phrase: "at Neutral pH"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:Neutral pH [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "Generates"

Phrase: "the Bioactive Degradation Product Miniglucagon-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0082712:miniglucagon [Amino Acid, Peptide, or Protein]

Phrase: "(1929"

Phrase: ")"

Phrase: "Franois Authier,"

Phrase: "Pamela H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.2: Cameron, Clmence Merlen, Mostafa Kouach and Gilbert Briand Institut National de la Sant et de la Recherche Mdicale Unit 510 (F.A., C.M.), Facult de Pharmacie Paris XI, 92296 Chtenay-Malabry, France; 

Phrase: "Cameron,"

Phrase: "Clmence Merlen,"

Phrase: "Mostafa Kouach"

Phrase: "and"

Phrase: "Gilbert Briand Institut National de la Sant et de la Recherche Mdicale Unit 510"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   786   C0011198:DE [Geographic Area]
   786   C0017480:DE [Geographic Area]
   786   C0023031:La [Element, Ion, or Isotope]
   786   C0439148:Unit [Quantitative Concept]
   786   C1519795:Unit [Quantitative Concept]
   786   C1551090:Gilbert [Quantitative Concept]
   786   C1704753:Unit [Manufactured Object]
   786   C1880519:Unit [Quantitative Concept]
   786   C3245503:national [Intellectual Product]
   786   C3541240:DE [Idea or Concept]

Phrase: "(F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "A.,"

Phrase: "C."

Phrase: "M."

Phrase: ")"

Phrase: ","

Phrase: "Facult de Pharmacie Paris XI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1720296:Xi [Intellectual Product]

Phrase: "92296 Chtenay-Malabry,"

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: ";"
Processing 00000000.tx.3: Department of Anatomy and Cell Biology (P.H.C.), McGill University, Montral, Qubec, Canada H3A 2B2; 

Phrase: "Department of Anatomy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Cell Biology"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0010819:Cell Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "(P.H.C."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "McGill University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Montral,"

Phrase: "Qubec,"

Phrase: "Canada H3A 2B2"

Phrase: ";"
Processing 00000000.tx.4: and Laboratoire de Spectromtrie de Masse (M.K., G.B.), Facult de Mdecine, 59000 Lille, France Address all correspondence and requests for reprints to: Franois Authier, Institut National de la Sant et de la Recherche Mdicale Unit 510, Facult de Pharmacie Paris XI, 5 rue Jean-Baptiste Clment, 92296 Chtenay-Malabry, France. 

Phrase: "and"

Phrase: "Laboratoire de Spectromtrie de Masse"

Phrase: "("

Phrase: "M."

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "G.B."

Phrase: ")"

Phrase: ","

Phrase: "Facult de Mdecine,"

Phrase: "59000 Lille,"

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: "Address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "all correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "and"

Phrase: "requests for reprints"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   882   C0686900:Request for [Functional Concept]
           request
   790   C1272683:Request [Functional Concept]
   790   C1522634:Request [Intellectual Product]
   756   C3273171:Reprint [Intellectual Product]

Phrase: "to"

Phrase: ":"

Phrase: "Franois Authier,"

Phrase: "Institut National de la Sant et de la Recherche Mdicale Unit 510,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   787   C0011198:DE [Geographic Area]
   787   C0017480:DE [Geographic Area]
   787   C0023031:La [Element, Ion, or Isotope]
   787   C0439148:Unit [Quantitative Concept]
   787   C1519795:Unit [Quantitative Concept]
   787   C1704753:Unit [Manufactured Object]
   787   C1880519:Unit [Quantitative Concept]
   787   C3245503:national [Intellectual Product]
   787   C3541240:DE [Idea or Concept]

Phrase: "Facult de Pharmacie Paris XI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1720296:Xi [Intellectual Product]

Phrase: "5 rue Jean-Baptiste Clment,"

Phrase: "92296 Chtenay-Malabry,"

Phrase: "France."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]
Processing 00000000.tx.5: E-mail: francois.authier{at}cep.u-psud.fr .  Abstract Top Abstract Introduction Materials and Methods Results Discussion References  We have investigated the proteolytic mechanisms of glucagon degradation within hepatic endosomes at neutral pH before lumen acidification. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "francois.authier{at}cep.u-psud.fr .  Abstract Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   787   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "We"

Phrase: "have"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "the proteolytic mechanisms of glucagon degradation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0441712:Mechanisms [Functional Concept]
   719 E C1706376:Mechanism [Manufactured Object]

Phrase: "within hepatic endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034850:Endosomes [Cell Component]

Phrase: "at neutral pH"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:Neutral pH [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "before lumen acidification."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1522821:acidification [Cell Function]
   861   C2987513:Acidification [Phenomenon or Process]
Processing 00000000.tx.6: Hepatic endosomes incubated at neutral pH rapidly degraded native glucagon into 13 intermediate products, one of which corresponded to the bioactive fragment glucagon-(1929) (miniglucagon). 

Phrase: "Hepatic endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034850:Endosomes [Cell Component]

Phrase: "incubated at neutral pH rapidly"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C1882074:Neutral pH [Qualitative Concept]
           Neutral
   760   C0020283:[pH] [Quantitative Concept]
   760   C0450407:ph+ [Finding]
   760   C0450408:ph++ [Finding]
   760   C0450409:ph+++ [Finding]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1637379:Rapidly [Qualitative Concept]
   760   C2825492:Neutral [Phenomenon or Process]

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "native glucagon into 13 intermediate products,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0017687:Glucagon product [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
           Glucagon
   753   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "one of which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205447:One [Quantitative Concept]

Phrase: "corresponded to the bioactive fragment glucagon-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   753   C0332255:fragment [Functional Concept]
   753   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1708096:Fragment [Qualitative Concept]

Phrase: "(1929"

Phrase: ")"

Phrase: "(miniglucagon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0082712:miniglucagon [Amino Acid, Peptide, or Protein]

Phrase: ")."
Processing 00000000.tx.7: The serine protease inhibitor phenylmethylsulfonyl fluoride as well as the nonspecific protease inhibitor bacitracin inhibited the endosomal degradation of glucagon at pH 7. 

Phrase: "The serine protease inhibitor phenylmethylsulfonyl fluoride"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   804   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]
   717   C0036733:Serine protease inhibitor [Biologically Active Substance,Pharmacologic Substance]

Phrase: "as well as"

Phrase: "the nonspecific protease inhibitor bacitracin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   756 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the endosomal degradation of glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "at pH 7."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:pH 7 [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]
Processing 00000000.tx.8: In purified endosomal fractions, miniglucagon endopeptidase was undetectable as evaluated by immunoblotting, and immunoprecipitation with antibodies to insulin-degrading enzyme, cathepsins B and D, or furin failed to remove the endosomal neutral glucagonase activity. 

Phrase: "In purified endosomal fractions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "miniglucagon endopeptidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "was"

Phrase: "undetectable"

Phrase: "as"

Phrase: "evaluated by immunoblotting,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0220825:Evaluated [Functional Concept]

Phrase: "and"

Phrase: "immunoprecipitation with antibodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "to insulin-degrading enzyme,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "cathepsins B"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0699919:Cathepsins B [Amino Acid, Peptide, or Protein,Enzyme]
   983 E C1332804:CATHEPSIN B [Gene or Genome]

Phrase: "and"

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "or"

Phrase: "furin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0919550:FURIN [Gene or Genome]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "the endosomal neutral glucagonase activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.9: Incubation of endosomal fractions and [125I]iodoglucagon with the zero-length bifunctional cross-linker 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide resulted in specific labeling of a 170-kDa polypeptide. 

Phrase: "Incubation of endosomal fractions"

Phrase: "and ["

Phrase: "125I"

Phrase: "]iodoglucagon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0063780:iodoglucagon [Amino Acid, Peptide, or Protein]

Phrase: "with the zero-length bifunctional cross-linker 1-ethyl-3-"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   793   C0919414:Zero [Quantitative Concept]
   793   C1444754:Length [Quantitative Concept]
   793   C1706316:LENGTH [Research Activity]
   793   C2828360:Cross [Conceptual Entity]
   721 E C0205166:Long [Qualitative Concept]
   721 E C1522425:Longest [Qualitative Concept]
   721 E C1706317:Long [Qualitative Concept]

Phrase: "(3-dimethylaminopropyl"

Phrase: ")"

Phrase: "carbodiimide"

Phrase: "resulted in specific labeling of a 170-kDa polypeptide."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   742   C0205369:Specific [Qualitative Concept]
   742   C1167624:Labeling [Mental Process]
   742   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]
   742   C1532717:kDa [Quantitative Concept]
   742   C1552740:specific [Intellectual Product]
   742   C1947902:Labeling [Manufactured Object]
   742   C2827499:Labeling [Governmental or Regulatory Activity]
   708   C1274040:Result [Functional Concept]
   708   C1546471:Result [Idea or Concept]
   708   C2825142:Result [Finding]
Processing 00000000.tx.10: The labeling was completely inhibited by unlabeled glucagon (IC50 value, 5 x 10-7 M) and bacitracin (IC50 value, 1 g/ml), suggesting that it may correspond to a bacitracin-sensitive glucagon-degrading enzyme. 

Phrase: "The labeling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1167624:Labeling [Mental Process]
  1000   C1947902:Labeling [Manufactured Object]
  1000   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "was"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "inhibited by unlabeled glucagon"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   770   C0311403:Inhibited [Qualitative Concept]
   770   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(IC50 value,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1522609:Value [Quantitative Concept]

Phrase: "5 x 10-7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439084:>5 [Quantitative Concept]
   812   C0728893:+5 [Quantitative Concept]

Phrase: "M)"

Phrase: "and"

Phrase: "bacitracin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   944 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "(IC50 value,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1522609:Value [Quantitative Concept]

Phrase: "1 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C1300565:g/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "it"

Phrase: "may"

Phrase: "correspond to a bacitracin-sensitive glucagon-degrading enzyme."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   800   C0298190:glucagon-degrading enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   767   C0332324:Sensitive to [Functional Concept]
           Sensitive
   744   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
   744   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   744   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1550474:sensitive [Idea or Concept]
Processing 00000000.tx.11: Treatment of the 125I-labeled 170-kDa cross-linked polypeptide with N-glycanase demonstrated that the cross-linked complex contained approximately 30 kDa of N-linked oligosaccharides. 

Phrase: "Treatment of the 125I-"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "170-kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "cross-linked"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178576:Cross Linked [Natural Phenomenon or Process]
  1000   C0332220:cross linked [Functional Concept]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "polypeptide with N-glycanase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the"

Phrase: "cross-linked"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178576:Cross Linked [Natural Phenomenon or Process]
  1000   C0332220:cross linked [Functional Concept]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "approximately 30 kDa of N-linked oligosaccharides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1532717:kDa [Quantitative Concept]
Processing 00000000.tx.12: Specific cross-linking of the 170-kDa polypeptide was also observed using [125I]Tyr12-miniglucagon as the radioligand. 

Phrase: "Specific"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205369:Specific [Qualitative Concept]
  1000   C1552740:specific [Intellectual Product]

Phrase: "cross-linking of the 170-kDa polypeptide"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   778   C0332220:Cross-linking [Functional Concept]
   762 E C0178576:Cross link [Natural Phenomenon or Process]
   748   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]
   748   C1532717:kDa [Quantitative Concept]
   748   C2828360:Cross [Conceptual Entity]
   714   C1517892:Link [Intellectual Product]
   714   C1704666:Link [Intellectual Product]

Phrase: "was"

Phrase: "also"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "[125I"

Phrase: "]Tyr12-miniglucagon as the radioligand."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0082712:miniglucagon [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.13: Together, these data suggest that the 170-kDa glycoprotein represents a novel glucagon-degrading activity that could mediate glucagon proteolysis within endosomes before the acidification step and generate the bioactive (1929) miniglucagon peptide.  

Phrase: "Together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the 170-kDa glycoprotein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017968:Glycoprotein [Amino Acid, Peptide, or Protein,Carbohydrate]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a novel glucagon-degrading activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "that"

Phrase: "could"

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "glucagon proteolysis within endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0597304:Proteolysis [Molecular Function]

Phrase: "before the acidification step"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1261552:Step [Conceptual Entity]
   861   C1704379:Step [Functional Concept]
   861   C1705117:Step [Quantitative Concept]
   861   C2825408:Step [Manufactured Object]

Phrase: "and"

Phrase: "generate"

Phrase: "the bioactive"

Phrase: "(1929"

Phrase: ")"

Phrase: "miniglucagon peptide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.14: Introduction Top Abstract Introduction Materials and Methods Results Discussion References  GLUCAGON IS A 29-amino acid peptide hormone secreted by the -cells of the pancreatic islets. 

Phrase: "Introduction Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "GLUCAGON"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "IS"

Phrase: "A 29-amino acid peptide hormone"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   840   C0597192:peptide hormone [Amino Acid, Peptide, or Protein,Hormone]
   840   C1149477:peptide hormone [Molecular Function]
   804   C0019932:Hormone [Hormone]
   733 E C0458083:Hormonal [Qualitative Concept]

Phrase: "secreted by the -cells of the pancreatic islets."
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   770   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
           cells islets
   760   C0734999:Pancreatic islet cell [Cell]
   744   C0007634:Cells [Cell]
   744   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   744   C1327616:Secreted [Cell Function]
   744   C3282337:Cells [Cell]
   734 E C1522529:Islet Cell [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.15: Initially, the binding of glucagon to its cell surface receptor (1) triggers the G protein-mediated activation of adenylyl cyclase. 

Phrase: "Initially,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "the binding of glucagon"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0243122:binding [Functional Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]

Phrase: "to its cell surface receptor"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0034800:Cell Surface Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C0699040:Cell surface [Cell Component]
   827   C0007634:Cell [Cell]
   827   C0205148:Surface [Spatial Concept]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "triggers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "the G protein-mediated activation of adenylyl cyclase."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1155418:adenylyl cyclase activation [Molecular Function]
   767   C0599177:protein activation [Genetic Function]
   744   C1879547:Activation [Activity]
Processing 00000000.tx.16: This leads to an increase in intracellular cAMP followed by the activation of protein kinase A and, ultimately, an increase in glycogenolysis and a reduction in glycogen synthase activity in the liver (2). 

Phrase: "This"

Phrase: "leads to an increase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0181586:leads [Medical Device]
   770   C0442805:Increase [Functional Concept]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in intracellular cAMP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0050063:c-AMP [Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "followed by the activation of protein kinase A"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   822   C2247782:protein kinase A activation [Cell Function]
   800   C0010531:Protein Kinase A [Amino Acid, Peptide, or Protein,Enzyme]
   793   C1819041:protein kinase activation [Cell Function]
   770   C0033640:PROTEIN KINASE [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0332283:Followed by [Temporal Concept]
           followed
   767   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   767   C0599177:protein activation [Genetic Function]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1879547:Activation [Activity]
   711 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: ","

Phrase: "ultimately,"

Phrase: "an increase in glycogenolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:Increase [Functional Concept]

Phrase: "and"

Phrase: "a reduction in glycogen synthase activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C2267000:Reduction Activity [Molecular Function]
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "in the liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.17: Over a period of 2030 min, the agonist-receptor complex is internalized to a low-density endocytic compartment, physically separable from lysosomes and Golgi elements (3, 4, 5, 6). 

Phrase: "Over a period"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0439531:/period [Temporal Concept]
  1000   C1948053:Period [Temporal Concept]
   928 E C0332182:Periodic [Temporal Concept]
   928 E C1706381:PERIODIC [Intellectual Product]
   900 E C0031084:Periodicities [Temporal Concept]

Phrase: "of 2030 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "the agonist-receptor complex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1523873:receptor complex [Cell Component]
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "is"

Phrase: "internalized to a low-density endocytic compartment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0178587:density [Quantitative Concept]
   748   C0205251:low [Qualitative Concept]
   748   C1185625:Compartment [Body Space or Junction]
   748   C1299352:Low [Qualitative Concept]
   748   C1550472:low [Idea or Concept]
   748   C2986730:Compartment [Spatial Concept]

Phrase: "physically separable from lysosomes"

Phrase: "and"

Phrase: "Golgi elements"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0013879:Elements [Element, Ion, or Isotope]
   827 E C1705248:Element [Conceptual Entity]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4,"

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6"

Phrase: ")."
Processing 00000000.tx.18: Finally, hepatic subcellular fractionation studies identified the endosomal compartment as a major site of degradation of internalized glucagon (5). 

Phrase: "Finally,"

Phrase: "hepatic subcellular fractionation studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0947630:studies [Laboratory Procedure]
   779 E C0557651:Study [Manufactured Object]
   779 E C2603343:Study [Research Activity]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "the endosomal compartment as a major site of degradation of internalized glucagon"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C2336292:Compartment of endosome [Body Space or Junction]
   736   C1185625:Compartment [Body Space or Junction]
   736   C2986730:Compartment [Spatial Concept]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.19: Glucagon degradation within hepatic endosomes was optimal at acidic pH and functionally linked to ATP-dependent endosomal acidification (7). 

Phrase: "Glucagon degradation within hepatic endosomes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "optimal at acidic pH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2698651:Optimal [Qualitative Concept]

Phrase: "and"

Phrase: "functionally"

Phrase: "linked to ATP-dependent endosomal acidification"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0851827:Dependent [Qualitative Concept]
   753   C1522821:acidification [Cell Function]
   753   C1701901:Dependent [Qualitative Concept]
   753   C2987513:Acidification [Phenomenon or Process]
   753   C3244310:dependent [Functional Concept]
   719   C1517892:Link [Intellectual Product]
   719   C1704666:Link [Intellectual Product]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.20: Recently, glucagon degradation has been attributed to membrane-bound forms of cathepsins B and D (8). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "glucagon degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "has"

Phrase: "been"

Phrase: "attributed to membrane-bound forms of cathepsins B"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   770   C0699919:Cathepsins B [Amino Acid, Peptide, or Protein,Enzyme]
   754 E C1332804:CATHEPSIN B [Gene or Genome]
   744   C0007428:Cathepsins [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0025255:Membrane [Tissue]
   744   C0332297:bound [Spatial Concept]
   744   C0348078:forms [Qualitative Concept]
   744   C0376315:Forms [Manufactured Object]
   744   C0596901:Membrane [Cell Component]
   744   C1145667:Bound [Activity]
   744   C1167622:Bound [Molecular Function]
   744   C1689898:% bound [Quantitative Concept]
   744   C1706182:Membrane [Manufactured Object]
   744   C2349209:Bound [Conceptual Entity]
   711   C0449234:Attribute [Idea or Concept]
   711 E C1522492:Form [Functional Concept]
   711   C1704772:Attribute [Conceptual Entity]
   711   C1882133:Attribute [Qualitative Concept]

Phrase: "and"

Phrase: "D ("

Phrase: "8"

Phrase: ")."
Processing 00000000.tx.21: In addition, another hepatic endosomal protease, insulin-degrading enzyme (IDE), has also been proposed to participate in endosomal clearance of glucagon at neutral pH (9, 10). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "another hepatic endosomal protease,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C1947941:Protease [Enzyme]

Phrase: "insulin-degrading enzyme (IDE),"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "participate in endosomal clearance of glucagon"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   753   C0449297:Clearance [Qualitative Concept]
   753   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1382187:Clearance [Clinical Attribute]
   753   C2825073:Clearance [Natural Phenomenon or Process]

Phrase: "at neutral pH (9,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C1882074:Neutral pH [Qualitative Concept]
           Neutral
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
   827   C2825492:Neutral [Phenomenon or Process]

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.22: A large number of studies have proposed the plasma membrane as another physiological locus for glucagon degradation (reviewed in Ref. 11). 

Phrase: "A large number of studies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "have"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "the plasma membrane as another physiological locus"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0007603:Plasma membrane [Cell Component]
   748   C0025255:Membrane [Tissue]
   748   C0032105:Plasma [Body Substance]
   748   C0596901:Membrane [Cell Component]
   748   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   748   C1706182:Membrane [Manufactured Object]

Phrase: "for glucagon degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "("

Phrase: "reviewed in Ref. 11"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.23: At least four neutral proteolytic activities have been proposed to operate at the hepatic cell surface: 1) a tripeptidyl aminopeptidase that sequentially deletes three amino acids from the N terminus of glucagon (12); 

Phrase: "At least four neutral proteolytic activities"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   804   C0441655:Activities [Activity]
   804   C0597304:Proteolytic [Molecular Function]
   804   C1947941:proteolytic [Enzyme]
   771 E C0205177:Activity [Functional Concept]
   771 E C0439167:% activity [Quantitative Concept]
   771 E C1561536:*Activity [Idea or Concept]

Phrase: "have"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "operate at the hepatic cell surface"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0227525:Hepatic Cell [Cell]
   790   C0699040:Cell surface [Cell Component]
   783   C0458922:Hepatic surface [Body Location or Region]
   753   C0007634:Cell [Cell]
   753   C0205054:Hepatic [Body Location or Region]
   753   C0205148:Surface [Spatial Concept]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   753   C3242339:operate [Functional Concept]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "a tripeptidyl aminopeptidase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0077246:Tripeptidyl aminopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0661884:Tripeptidyl aminopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1429209:tripeptidyl aminopeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0002570:Aminopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "that sequentially"

Phrase: "deletes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880274:Delete [Activity]

Phrase: "three amino acids from the N terminus of glucagon"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   764   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0001128:Acids [Chemical]
   731 E C2917660:Amino Acid [Pharmacologic Substance]
   708 E C0202406:Acid [Laboratory Procedure]

Phrase: "(12"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.24: 2) a glucagon receptor-linked serine protease that cleaves at the internal peptide bond Tyr13-Leu14 (13); 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "a glucagon receptor-linked serine protease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0036734:serine protease [Amino Acid, Peptide, or Protein,Enzyme]
   840   C2717971:Serine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   804   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   804   C1947941:Protease [Enzyme]

Phrase: "that"

Phrase: "cleaves at the internal peptide bond Tyr13-Leu14"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0678595:peptide bond [Natural Phenomenon or Process]
   744   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   744   C0205102:Internal [Spatial Concept]
   744   C1553872:Internal [Intellectual Product]
   744   C1619620:Internal [Intellectual Product]

Phrase: "(13"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.25: 3) dipeptidyl peptidase IV, a serine protease that releases dipeptides from the N terminus of glucagon and produces glucagon-(329) and glucagon-(529) (14); 

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "dipeptidyl peptidase IV,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0081937:Dipeptidyl-Peptidase IV [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
  1000   C1414141:DIPEPTIDYL PEPTIDASE IV [Gene or Genome]
   901   C0022709:dipeptidyl peptidase [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   827   C0030940:Peptidase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1947941:Peptidase [Enzyme]

Phrase: "a serine protease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0036734:serine protease [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C2717971:Serine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C1947941:Protease [Enzyme]

Phrase: "that releases dipeptides from the N terminus of glucagon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0012512:Dipeptides [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "produces"

Phrase: "glucagon-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(329"

Phrase: ")"

Phrase: "and"

Phrase: "glucagon-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(529"

Phrase: ")"

Phrase: "(14"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.26: and 4) a bacitracin-sensitive metalloprotease, miniglucagon endopeptidase (MGE), which processes glucagon to its bioactive fragment glucagon-(1929) (miniglucagon) (15, 16). 

Phrase: "and"

Phrase: "4"

Phrase: ")"

Phrase: "a bacitracin-sensitive metalloprotease,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0025543:METALLOPROTEASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "miniglucagon endopeptidase (MGE),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "which processes glucagon to its bioactive fragment glucagon-"

Phrase: "(1929"

Phrase: ")"

Phrase: "(miniglucagon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0082712:miniglucagon [Amino Acid, Peptide, or Protein]

Phrase: ")"

Phrase: "(15,"

Phrase: "16"

Phrase: ")."
Processing 00000000.tx.27: The miniglucagon fragment has its own biological activity and is a modulator of the action of glucagon, the mother molecule. 

Phrase: "The miniglucagon fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332255:fragment [Functional Concept]
   861   C1708096:Fragment [Qualitative Concept]

Phrase: "has"

Phrase: "its own biological activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0005532:Biological [Biomedical Occupation or Discipline]
   827   C0205177:Activity [Functional Concept]
   827   C0205460:biological [Qualitative Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "is"

Phrase: "a modulator of the action of glucagon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1709060:Modulator [Manufactured Object]

Phrase: "the mother molecule."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0567416:Molecule [Substance]
   789 E C1521991:Molecular [Qualitative Concept]
Processing 00000000.tx.28: At picomolar concentrations, it inhibits the hepatic plasma membrane Ca2+ pump without interfering with the adenylyl cyclase activity (17). 

Phrase: "At picomolar concentrations,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "it"

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the hepatic plasma membrane Ca2+ pump without"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0007603:Plasma membrane [Cell Component]
   774   C1563226:Hepatic pump [Therapeutic or Preventive Procedure]
   748   C0025255:Membrane [Tissue]
   748   C0032105:Plasma [Body Substance]
   748   C0182537:Pump [Medical Device]
   748   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0596901:Membrane [Cell Component]
   748   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   748   C1706182:Membrane [Manufactured Object]
   748   C1706421:Pump [Manufactured Object]

Phrase: "interfering with the adenylyl cyclase activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C1151015:adenylyl cyclase activity [Molecular Function]
   790   C0001492:Adenylyl Cyclase [Amino Acid, Peptide, or Protein,Enzyme]
   790   C1323396:cyclase activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C0521102:interfering [Qualitative Concept]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "(17"

Phrase: ")."
Processing 00000000.tx.29: At the same concentration, glucagon-(1929) displays a negative inotropic effect on myocyte contraction (18) and the ability to inhibit insulin release through a Ca2+ pathway (19). 

Phrase: "At the same concentration,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "glucagon-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(1929"

Phrase: ")"

Phrase: "displays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870432:displays [Functional Concept]
  1000   C1705417:Display [Manufactured Object]

Phrase: "a negative inotropic effect on myocyte contraction"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0205160:Negative [Qualitative Concept]
   748   C1280500:Effect [Qualitative Concept]
   748   C1513916:Negative [Finding]
   748   C2348382:Effect [Qualitative Concept]
   748   C2825415:Negative [Conceptual Entity]
   748   C2825491:Negative [Qualitative Concept]

Phrase: "(18"

Phrase: ")"

Phrase: "and"

Phrase: "the ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "insulin release through a Ca2+ pathway"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   783   C2984427:Insulin Pathway [Functional Concept]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0030685:Release [Health Care Activity]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1283071:Release [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
   753   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.30: The fragment appears to be produced either from the circulating glucagon at the surface of the target cells or inside the islets of Langerhans (15, 20). 

Phrase: "The fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "produced"

Phrase: "either from the circulating glucagon"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   760   C0175630:Circulating [Functional Concept]
   760   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "at the surface"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205148:Surface [Spatial Concept]

Phrase: "of the target cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0221284:Target cells [Cell]
  1000   C3272919:Target Cells [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C1521840:Target [Functional Concept]
   861   C2986546:TARGET [Diagnostic Procedure]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "or inside the islets of Langerhans"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0022131:Islets of Langerhans [Body Part, Organ, or Organ Component]
           Langerhans Islets

Phrase: "(15,"

Phrase: "20"

Phrase: ")."
Processing 00000000.tx.31: It has been suggested that miniglucagon might be produced from circulating glucagon after interaction with glucagon target tissues, such as the liver, via the cell surface MGE (15). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that miniglucagon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0082712:miniglucagon [Amino Acid, Peptide, or Protein]

Phrase: "might"

Phrase: "be"

Phrase: "produced from circulating glucagon"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   770   C0175630:Circulating [Functional Concept]
   770   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "after interaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704675:Interaction [Functional Concept]

Phrase: "with glucagon target tissues,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0040300:Tissues [Tissue]
   827   C1521840:Target [Functional Concept]
   827   C2986546:TARGET [Diagnostic Procedure]
   793 E C1547928:Tissue [Intellectual Product]

Phrase: "such as the liver,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "via the cell surface MGE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.32: Thus, miniglucagon-like immunoreactivity appeared in the cell supernatant upon incubation of glucagon with HepG2 hepatoma cells, which do not contain high-affinity glucagon receptors (15). 

Phrase: "Thus,"

Phrase: "miniglucagon-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0082712:miniglucagon [Amino Acid, Peptide, or Protein]

Phrase: "like immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597879:immunoreactivity [Molecular Function]

Phrase: "appeared in the cell supernatant"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0007634:Cell [Cell]
   760   C1269647:Cell [Cell]
   760   C1550101:Supernatant [Body Substance]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726   C0700364:APPEAR [Qualitative Concept]

Phrase: "upon incubation"

Phrase: "of glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "with HepG2 hepatoma cells,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   913   C2717940:HepG2 Cells [Cell]
   867   C0677626:hepatoma cell [Cell]
   827   C0007634:Cells [Cell]
   827   C0023903:Hepatoma [Neoplastic Process]
   827   C2239176:Hepatoma [Neoplastic Process]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "which"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "high-affinity glucagon receptors"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0061352:Receptors, Glucagon [Amino Acid, Peptide, or Protein,Receptor]
   827 E C1415011:GLUCAGON RECEPTOR [Gene or Genome]
   812   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   812   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   812   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.33: Purified from rat liver plasma membrane, the MGE activity, which was shown to be distinct from IDE, displayed a neutral pH optimum, a molecular mass of 100 kDa on SDS-PAGE, and a sensitivity to sulfhydryl-modifying reagents and chelating agents (16). 

Phrase: "Purified from rat liver plasma membrane,"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   790   C0007603:Plasma membrane [Cell Component]
   790   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   753   C0023884:Liver [Body Part, Organ, or Organ Component]
   753   C0025255:Membrane [Tissue]
   753   C0032105:Plasma [Body Substance]
   753   C0034693:Rat, NOS [Mammal]
   753   C0034721:Rat [Mammal]
   753   C0596901:Membrane [Cell Component]
   753   C0736268:LIVER [Body Part, Organ, or Organ Component]
   753   C1278929:Liver [Body Part, Organ, or Organ Component]
   753   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   753   C1706182:Membrane [Manufactured Object]
   753   C1998793:Purified [Functional Concept]
   753   C2346688:LIVER [Food]

Phrase: "the MGE activity,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1150171:endopeptidase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "which"

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "distinct from IDE,"

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "a neutral pH optimum,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2698651:Optimum [Qualitative Concept]
   734   C1882074:Neutral pH [Qualitative Concept]

Phrase: "a molecular mass of 100 kDa"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   783   C0577559:A mass [Finding]
           Mass
   753   C1306372:*Mass [Quantitative Concept]

Phrase: "on SDS-PAGE,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   861   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "a sensitivity to sulfhydryl-modifying reagents"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   754   C0332324:Sensitive to [Functional Concept]
   753   C0036667:Sensitivity [Quantitative Concept]
   753   C0312418:Sensitivity [Mental Process]
   753   C0427965:Sensitivity [Finding]
   753   C1511883:Sensitivity [Quantitative Concept]
   753   C1522640:Sensitivity [Qualitative Concept]
   753   C2346484:SENSITIVITY [Phenomenon or Process]
   753   C2349185:Sensitivity [Qualitative Concept]

Phrase: "and"

Phrase: "chelating agents"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0007974:Chelating Agents [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C3537131:Chelating [Molecular Function]
   827   C0450442:Agent [Chemical Viewed Functionally]
   827   C1254351:Agent [Pharmacologic Substance]
   827   C1521826:Agent [Intellectual Product]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.34: However, the role of the plasma membrane as the physiological locus of miniglucagon production remains controversial due to inconsistencies in the data obtained with the in vivo and in vitro experiments on miniglucagon production. 

Phrase: "However,"

Phrase: "the role of the plasma membrane"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "as the physiological locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708726:Locus [Gene or Genome]

Phrase: "of miniglucagon production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "remains"

Phrase: "controversial due to inconsistencies"

Phrase: "in the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "obtained with the in vivo"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C1515655:In Vivo [Spatial Concept]
           vivo
   760   C1301820:Obtained [Functional Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "in vitro experiments on miniglucagon production."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0021135:In Vitro [Intellectual Product]
   790   C1533691:in vitro [Qualitative Concept]
           vitro
   790   C2827718:In Vitro [Functional Concept]
   753   C0681814:Experiments [Research Activity]
   719 E C1706386:Experiment [Conceptual Entity]
Processing 00000000.tx.35: Thus, the absence of detectable amounts of native glucagon-(1929) in rat plasma (15), and the very low peptide level generated upon incubation of glucagon with plasma membrane [1% of glucagon being converted into glucagon-(1929) even in the presence of protease inhibitors (15)] make the involvement of the cell surface membrane in the generation of miniglucagon questionable. 

Phrase: "Thus,"

Phrase: "the absence of detectable amounts of native glucagon-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0332197:absence [Quantitative Concept]
   744   C1689985:Absence [Anatomical Abnormality]

Phrase: "(1929"

Phrase: ")"

Phrase: "in rat plasma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032105:Plasma [Body Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "(15"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the very low peptide level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0441889:Level [Qualitative Concept]
   812   C0456079:Level [Classification]
   812   C1547707:Level [Geographic Area]
   812   C2946261:Level [Pharmacologic Substance]

Phrase: "generated upon incubation of glucagon"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   760   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C3146294:Generated [Activity]

Phrase: "with plasma membrane"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "[1% of glucagon"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   790   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C2827734:1+ [Quantitative Concept]
   790   C2981698:1+ [Classification]

Phrase: "being"

Phrase: "converted into glucagon-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   790   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(1929"

Phrase: ")"

Phrase: "even in the presence of protease inhibitors"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   778   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   748   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C0243077:inhibitors [Chemical Viewed Functionally]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C1947941:Protease [Enzyme]
   745 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   714 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "(15"

Phrase: ")"

Phrase: "]"

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "the involvement of the cell surface membrane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1314939:Involvement [Functional Concept]

Phrase: "in the generation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0079411:Generation [Temporal Concept]
  1000   C3146294:Generation [Activity]
   907 E C1414672:Genesis [Gene or Genome]
   907 E C2984892:Genesis [Gene or Genome]

Phrase: "of miniglucagon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0082712:miniglucagon [Amino Acid, Peptide, or Protein]

Phrase: "questionable."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332241:Questionable [Qualitative Concept]
Processing 00000000.tx.36: Moreover, the MGE enzyme has been shown to be competitively inhibited by insulin (which does not contain any dibasic sites) with an affinity higher than that for glucagon (16), indicating that it is not specific for the glucagon pathway. 

Phrase: "Moreover,"

Phrase: "the MGE enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "competitively"

Phrase: "inhibited by insulin"
Meta Candidates (Total=10; Excluded=6; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C0311403:Inhibited [Qualitative Concept]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "("

Phrase: "which"

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "any dibasic sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]

Phrase: ")"

Phrase: "with an affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "higher than that"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   756   C0205250:High [Qualitative Concept]
   756   C1299351:High [Qualitative Concept]
   756   C2700149:HIGH [Intellectual Product]
   706 E C0489786:Height [Organism Attribute]

Phrase: "for glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(16"

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "that"

Phrase: "it"

Phrase: "is"

Phrase: "not specific for the glucagon pathway."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205369:Specific [Qualitative Concept]
   753   C1552740:specific [Intellectual Product]
Processing 00000000.tx.37: Pancreatic production of miniglucagon has been observed, in which the bioactive peptide is present in a stored form at molar concentrations in the range of 34% that of glucagon, and then released concomitant to glucagon secretion (20). 

Phrase: "Pancreatic production of miniglucagon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033268:production [Occupational Activity]

Phrase: "has"

Phrase: "been"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "in which"

Phrase: "the bioactive peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "present in a stored form"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "at molar concentrations"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0026367:Molar [Body Part, Organ, or Organ Component]
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "in the range"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1514721:Range [Quantitative Concept]
  1000   C2348147:Range [Quantitative Concept]
  1000   C3542016:Range [Intellectual Product]

Phrase: "of 34%"

Phrase: "that of glucagon,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   790   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "released"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0391871:Released [Functional Concept]
  1000   C1283071:Released [Functional Concept]
   966 E C0030685:Release [Health Care Activity]
   966 E C0439180:% release [Quantitative Concept]
   966 E C0680255:release [Health Care Activity]
   966 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "concomitant to glucagon secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0521115:Concomitant [Temporal Concept]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.38: Consequently, the present study has attempted to evaluate the physiological relevance of the endosomal compartment to the generation of miniglucagon from internalized glucagon. 

Phrase: "Consequently,"

Phrase: "the present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "has"

Phrase: "attempted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1516084:Attempt [Event]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "the physiological relevance of the endosomal compartment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2347946:Relevance [Qualitative Concept]

Phrase: "to the generation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0079411:Generation [Temporal Concept]
  1000   C3146294:Generation [Activity]
   907 E C1414672:Genesis [Gene or Genome]
   907 E C2984892:Genesis [Gene or Genome]

Phrase: "of miniglucagon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0082712:miniglucagon [Amino Acid, Peptide, or Protein]

Phrase: "from internalized glucagon."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   861   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.39: We report here that hepatic endosomes contain a membrane serine endopeptidase activity that yields at neutral pH the glucagon-(1929) peptide. 

Phrase: "We"

Phrase: "report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "here"

Phrase: "that hepatic endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034850:Endosomes [Cell Component]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a membrane serine endopeptidase activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   902   C0596897:membrane activity [Cell Function]
   861   C1150171:endopeptidase activity [Molecular Function]
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "that yields at neutral pH"

Phrase: "the glucagon-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(1929"

Phrase: ")"

Phrase: "peptide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptide [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.40: Using immunological criteria, the data presented here demonstrate that the endosomal glucagon-(1929)-generating enzyme is not related to the MGE activity previously suggested to be at the cell surface (15, 16), to IDE previously reported to be a candidate endosomal glucagon-degrading enzyme (10), nor to endosomal cathepsins B and D (8). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "immunological criteria,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0243161:criteria [Intellectual Product]

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "here"

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the endosomal glucagon-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   861   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(1929"

Phrase: ")-"

Phrase: "generating enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "related to the MGE activity previously"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   778   C1150171:endopeptidase activity [Molecular Function]
   748   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C0082712:miniglucagon [Amino Acid, Peptide, or Protein]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0439849:Related [Qualitative Concept]
   748   C0441655:Activity [Activity]
   748   C0445223:Related [Finding]
   748   C1561536:*Activity [Idea or Concept]
   714 E C0163712:Relate [Organic Chemical]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be at the cell surface"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0699040:Cell surface [Cell Component]
   760   C0007634:Cell [Cell]
   760   C0205148:Surface [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C2987476:Be [Conceptual Entity]

Phrase: "(15,"

Phrase: "16"

Phrase: ")"

Phrase: ","

Phrase: "to IDE previously"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "a candidate endosomal glucagon-degrading enzyme"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   884   C0298190:glucagon-degrading enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0014442:Enzyme [Enzyme,Organic Chemical]
   721 E C0014445:enzymes [Functional Concept]

Phrase: "(10"

Phrase: ")"

Phrase: ","

Phrase: "nor to endosomal cathepsins B"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0699919:Cathepsins B [Amino Acid, Peptide, or Protein,Enzyme]
   790 E C1332804:CATHEPSIN B [Gene or Genome]
   760   C0007428:Cathepsins [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0028423:NOR [Geographic Area]
   760   C0028609:NOR [Cell Component]
   760   C1513854:NOR [Mammal]

Phrase: "and"

Phrase: "D ("

Phrase: "8"

Phrase: ")."
Processing 00000000.tx.41: Finally, affinity-labeling experiments using the zero-length bifunctional cross-linker 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) demonstrate the specific binding of [125I]iodoglucagon and [125I]Tyr12-miniglucagon to a 170-kDa endosomal membrane glycoprotein that fulfills the criteria expected for an endosomal-neutral glucagonase in terms of affinity and specificity toward the glucagon molecule, and sensitivity to the protease inhibitor bacitracin.  

Phrase: "Finally,"

Phrase: "affinity-labeling experiments"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]
   734   C0178463:affinity labeling [Laboratory or Test Result]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the zero-length bifunctional cross-linker 1-ethyl-3-"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   793   C0919414:Zero [Quantitative Concept]
   793   C1444754:Length [Quantitative Concept]
   793   C1706316:LENGTH [Research Activity]
   793   C2828360:Cross [Conceptual Entity]
   721 E C0205166:Long [Qualitative Concept]
   721 E C1522425:Longest [Qualitative Concept]
   721 E C1706317:Long [Qualitative Concept]

Phrase: "(3-dimethylaminopropyl"

Phrase: ")"

Phrase: "carbodiimide"

Phrase: "(EDC)"

Phrase: "demonstrate"

Phrase: "the specific binding of [125I"

Phrase: "]iodoglucagon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0063780:iodoglucagon [Amino Acid, Peptide, or Protein]

Phrase: "and ["

Phrase: "125I"

Phrase: "]Tyr12-miniglucagon to a 170-kDa endosomal membrane glycoprotein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0082712:miniglucagon [Amino Acid, Peptide, or Protein]

Phrase: "that"

Phrase: "fulfills"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550543:Fulfill [Idea or Concept]

Phrase: "the criteria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243161:criteria [Intellectual Product]

Phrase: "expected for an endosomal-neutral glucagonase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1517001:Expected [Idea or Concept]
   753   C1882074:Neutral [Qualitative Concept]
   753   C2825492:Neutral [Phenomenon or Process]

Phrase: "in terms of affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "specificity toward the glucagon molecule,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037791:Specificity [Quantitative Concept]
   760   C1511884:Specificity [Quantitative Concept]

Phrase: "and"

Phrase: "sensitivity to the protease inhibitor bacitracin."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   754   C0332324:Sensitive to [Functional Concept]
   753   C0036667:Sensitivity [Quantitative Concept]
   753   C0312418:Sensitivity [Mental Process]
   753   C0427965:Sensitivity [Finding]
   753   C1511883:Sensitivity [Quantitative Concept]
   753   C1522640:Sensitivity [Qualitative Concept]
   753   C2346484:SENSITIVITY [Phenomenon or Process]
   753   C2349185:Sensitivity [Qualitative Concept]
Processing 00000000.tx.42: Materials and Methods Top Abstract Introduction Materials and Methods Results Discussion References  Peptides, antibodies, protein determination, peptide synthesis, antibody preparation, and materials Porcine glucagon and recombinant human furin extracted from Sf-9 cells (2000 U/ml) were purchased from Sigma-Aldrich (St. Louis, MO). 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Peptides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "antibodies,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "protein determination,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1148554:determination [Laboratory Procedure]

Phrase: "peptide synthesis,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1327133:peptide synthesis [Molecular Function]
  1000   C1518961:Peptide Synthesis [Research Activity]
  1000   C2945683:Peptide synthesis [Molecular Function]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "antibody preparation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0455052:Preparation [Health Care Activity]
   861   C1521827:Preparation [Functional Concept]

Phrase: "and"

Phrase: "materials Porcine glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   827   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "recombinant human furin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0919550:FURIN [Gene or Genome]

Phrase: "extracted from Sf-9 cells"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   760   C0007634:Cells [Cell]
   760   C0185115:Extracted [Therapeutic or Preventive Procedure]
   760   C3282337:Cells [Cell]
   760   C3541890:EXTRACTED [Finding]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
   726 E C2828366:Extract [Substance]

Phrase: "(2000 U/ml)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0439340:U/ml [Quantitative Concept]
   901   C1880521:U/mL [Quantitative Concept]
   901   C2945590:U/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "were"

Phrase: "purchased from Sigma-Aldrich"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0869011:purchased [Activity]
   770   C1719918:Sigma [Intellectual Product]

Phrase: "(St. Louis,"

Phrase: "MO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.43: Rabbit antimouse cathepsin D R291 (8, 21) and antirat cathepsin B 7183 (8, 22) were obtained from Dr. 

Phrase: "Rabbit antimouse cathepsin D R291"

Phrase: "(8,"

Phrase: "21"

Phrase: ")"

Phrase: "and"

Phrase: "antirat cathepsin B 7183"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0699919:Cathepsin B [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1332804:CATHEPSIN B [Gene or Genome]
   812   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(8,"

Phrase: "22"

Phrase: ")"

Phrase: "were"

Phrase: "obtained from Dr."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   790   C0031831:DR [Professional or Occupational Group]
   790   C1301820:Obtained [Functional Concept]
   790   C1707664:DR [Biomedical or Dental Material]
   790   C2348314:Dr. [Conceptual Entity]
   790   C3540849:DR [Idea or Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]
Processing 00000000.tx.44: J. 

Phrase: "J."
Processing 00000000.tx.45: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.46: Mort (Shriners Hospital for Crippled Children, Montral, Qubec, Canada) and used to immune deplete samples of native mature enzymes as described previously (8, 21, 22). 

Phrase: "Mort (Shriners Hospital for Crippled Children,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0020017:Children's hospital [Health Care Related Organization]
   753   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   753   C1510665:Hospital [Qualitative Concept]

Phrase: "Montral,"

Phrase: "Qubec,"

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "used to immune"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0439662:Immune [Functional Concept]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "deplete"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   944   C1550032:Unload [Idea or Concept]
   944   C1880497:Empty [Qualitative Concept]
   944   C1996907:Emptying [Activity]
   916 E C0333668:Depleted [Functional Concept]

Phrase: "samples of native mature enzymes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0370003:Sample [Substance]
   726   C2347026:Sample [Conceptual Entity]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(8,"

Phrase: "21,"

Phrase: "22"

Phrase: ")."
Processing 00000000.tx.47: Mouse monoclonal antibody 9B12 directed against the human IDE (23) was a gift from Dr. 

Phrase: "Mouse monoclonal antibody 9B12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "directed against the human IDE"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   814   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   814   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   778   C0795635:Human insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0086418:Human [Human]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
   714   C0439851:Direct [Qualitative Concept]
   714   C1947931:Direct [Qualitative Concept]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "a gift from Dr."
Processing 00000000.tx.48: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.49: A. 

Phrase: "A."
Processing 00000000.tx.50: Roth (Stanford University, Stanford, CA). 

Phrase: "Roth"

Phrase: "(Stanford University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Stanford,"

Phrase: "CA)."
Processing 00000000.tx.51: Rabbit polyclonal antiserum against rat liver 3-ketoacyl-coenzyme A (CoA) thiolase (thiolase) was a gift from Dr. 

Phrase: "Rabbit polyclonal antiserum against rat liver 3-ketoacyl-coenzyme A (CoA) thiolase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(thiolase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001019:Thiolase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "was"

Phrase: "a gift from Dr."
Processing 00000000.tx.52: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.53: A. 

Phrase: "A."
Processing 00000000.tx.54: Rachubinski (University of Alberta, Edmonton, Alberta, Canada). 

Phrase: "Rachubinski"

Phrase: "(University of Alberta,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0001914:Alberta [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]
   827   C1030330:Alberta [Plant]

Phrase: "Edmonton,"

Phrase: "Alberta,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0001914:Alberta [Geographic Area]
  1000   C1030330:Alberta [Plant]

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: ")."
Processing 00000000.tx.55: Rabbit polyclonal IgG H-220 raised against the C-terminal region of recombinant human furin (amino acids 575794) and affinity-purified goat polyclonal IgG raised against human Hsp-60 were purchased from Santa Cruz Biotechnology, Inc. 

Phrase: "Rabbit polyclonal IgG H-220"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0033727:H+ [Element, Ion, or Isotope]
   804   C0034493:Rabbit [Mammal]
   804   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0441932:H+ [Classification]
   804   C0564385:/h [Quantitative Concept]

Phrase: "raised against the C-terminal region of recombinant human furin"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   760   C1707271:C-Terminal [Amino Acid Sequence]
   739   C0017446:Region [Geographic Area]
   739   C0086418:Human [Human]
   739   C0205088:Terminal [Temporal Concept]
   739   C0205147:Region [Spatial Concept]
   739   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0442818:Raised [Quantitative Concept]
   739   C0919550:FURIN [Gene or Genome]
   739   C1514798:recombinant [Organism]
   739   C1705314:Terminal [Manufactured Object]
   739   C1705315:Terminal [Spatial Concept]

Phrase: "(amino acids 575794"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   901   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   867 E C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "and"

Phrase: "affinity-purified goat polyclonal IgG"

Phrase: "raised against human Hsp-60"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C3538704:HSP-60 [Gene or Genome]
   806   C3539602:HSP-60 [Amino Acid, Peptide, or Protein]
   760   C0086418:Human [Human]
   760   C0442818:Raised [Quantitative Concept]

Phrase: "were"

Phrase: "purchased from Santa Cruz Biotechnology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0005574:Biotechnology [Biomedical Occupation or Discipline]
   760   C0869011:purchased [Activity]

Phrase: "Inc."
Processing 00000000.tx.56: (Santa Cruz, CA). 

Phrase: "(Santa Cruz,"

Phrase: "CA)."
Processing 00000000.tx.57: Horseradish peroxidase-conjugated goat antirabbit IgG was from Bio-Rad (Hercules, CA). 

Phrase: "Horseradish peroxidase-conjugated goat antirabbit IgG"

Phrase: "was from Bio-Rad (Hercules,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0043194:WAS [Disease or Syndrome]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1421478:WAS [Gene or Genome]

Phrase: "CA)."
Processing 00000000.tx.58: The protein content of isolated fractions was determined by the method of Lowry et al. 

Phrase: "The protein content of isolated fractions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0423896:Content [Mental Process]
   753   C0456205:Content [Conceptual Entity]

Phrase: "was"

Phrase: "determined by the method of Lowry et al."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0025663:Method [Intellectual Product]
   744   C0449851:Method [Functional Concept]
   744   C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.59: (24). 

Phrase: "(24"

Phrase: ")."
Processing 00000000.tx.60: A peptide of 12 amino acids (AQDFVQWLMNTY) corresponding to the C-terminal region of human glucagon was synthesized with a tyrosine at the C terminus using a solid-phase procedure. 

Phrase: "A peptide of 12 amino acids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "(AQDFVQWLMNTY"

Phrase: ")"

Phrase: "corresponding to the C-terminal region of human glucagon"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C1707271:C-Terminal [Amino Acid Sequence]
   742   C0017446:Region [Geographic Area]
   742   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   742   C0086418:Human [Human]
   742   C0205088:Terminal [Temporal Concept]
   742   C0205147:Region [Spatial Concept]
   742   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1705314:Terminal [Manufactured Object]
   742   C1705315:Terminal [Spatial Concept]

Phrase: "was"

Phrase: "synthesized with a tyrosine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C1883254:Synthesized [Activity]

Phrase: "at the C terminus"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a solid-phase procedure."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C1948041:Procedure [Therapeutic or Preventive Procedure]
   827   C2700391:Procedure [Activity]
   827   C3274430:PROCEDURE [Health Care Activity]
   827   C3538935:Procedure [Idea or Concept]
   827   C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.61: The C-terminal tyrosine permitted radioiodination of the synthetic peptide. 

Phrase: "The C-terminal tyrosine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C1707271:C-Terminal [Amino Acid Sequence]

Phrase: "permitted"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0329040:permitted [Fish]
   966 E C0023636:Permit [Regulation or Law]

Phrase: "radioiodination of the synthetic peptide."
Processing 00000000.tx.62: A peptide of 8 amino acids corresponding to the N-terminal residues (CREARPTTE) of rat MGE (16) was synthesized with a cysteine at the N terminus using a solid-phase procedure. 

Phrase: "A peptide of 8 amino acids"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "corresponding to the N-terminal residues (CREARPTTE) of rat MGE"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   739   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   739   C0034693:Rat, NOS [Mammal]
   739   C0034721:Rat [Mammal]
   739   C0082712:miniglucagon [Amino Acid, Peptide, or Protein]
   739   C0205088:Terminal [Temporal Concept]
   739   C0521447:Nuclear [Spatial Concept]
   739   C1705314:Terminal [Manufactured Object]
   739   C1705315:Terminal [Spatial Concept]
   706   C1709915:Residue [Conceptual Entity]
   706   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "(16"

Phrase: ")"

Phrase: "was"

Phrase: "synthesized with a cysteine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1883254:Synthesized [Activity]

Phrase: "at the N terminus"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a solid-phase procedure."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C1948041:Procedure [Therapeutic or Preventive Procedure]
   827   C2700391:Procedure [Activity]
   827   C3274430:PROCEDURE [Health Care Activity]
   827   C3538935:Procedure [Idea or Concept]
   827   C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.63: The identity and purity of the synthetic peptides were confirmed by HPLC, amino acid, and mass spectrometry analyses. 

Phrase: "The identity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0424215:Identity [Mental Process]
  1000   C2003939:Identity [Finding]

Phrase: "and"

Phrase: "purity of the synthetic peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882508:Purity [Quantitative Concept]

Phrase: "were"

Phrase: "confirmed by HPLC,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C0008562:HPLC [Laboratory Procedure]
   790   C0750484:Confirmed [Idea or Concept]
   756 E C1456348:Confirm [Qualitative Concept]

Phrase: "amino acid,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "mass spectrometry analyses."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]
   734   C0037813:Mass Spectrometry [Laboratory Procedure]
Processing 00000000.tx.64: For antibody production, the CREARPTTE peptide was conjugated to BSA and injected into female New Zealand white rabbits. 

Phrase: "For antibody production,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003261:Antibody Production [Biologic Function]
   861   C0033268:production [Occupational Activity]

Phrase: "the CREARPTTE peptide"

Phrase: "was"

Phrase: "conjugated to BSA"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0522529:Conjugated [Spatial Concept]
   756 E C0301869:Conjugate [Immunologic Factor]

Phrase: "and"

Phrase: "injected into female New Zealand white rabbits."
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   853   C0324547:New Zealand White Rabbits [Mammal]
           New Zealand White
           New Zealand Rabbits
   778   C0027978:New Zealand [Geographic Area]
   748   C0007457:White [Population Group]
   748   C0015780:Female [Finding]
   748   C0034493:Rabbit [Mammal]
   748   C0043157:White [Population Group]
   748   C0043210:female [Population Group]
   748   C0086287:female [Population Group]
   748   C0205314:New [Temporal Concept]
   748   C0220938:White [Qualitative Concept]
   748   C1705497:Female [Qualitative Concept]
   748   C1705498:Female [Qualitative Concept]
   714   C1720154:Inject [Functional Concept]
Processing 00000000.tx.65: Nitrocellulose membranes and enhanced chemiluminescence detection kit were from Amersham (Arlington Heights, IL). 

Phrase: "Nitrocellulose membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0025255:Membranes [Tissue]
   827 E C0596901:Membrane [Cell Component]
   827 E C1706182:Membrane [Manufactured Object]
   777 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "enhanced chemiluminescence detection kit"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0812225:KIT [Medical Device]
   812   C1150635:KIT [Molecular Function]
   812   C1705212:Kit [Medical Device]
   812   C1705213:KIT [Medical Device]
   812   C3273202:Kit [Manufactured Object]

Phrase: "were from Amersham"

Phrase: "(Arlington Heights,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0489786:heights [Organism Attribute]
   777 E C0205250:High [Qualitative Concept]
   777 E C1299351:High [Qualitative Concept]
   777 E C1522410:Highest [Qualitative Concept]
   777 E C2700149:HIGH [Intellectual Product]

Phrase: "IL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]

Phrase: ")."
Processing 00000000.tx.66: Protein G-Sepharose was from Pharmacia (Peapack, NJ). 

Phrase: "Protein G-Sepharose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0036681:Sepharose [Carbohydrate]

Phrase: "was from Pharmacia"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0331955:Pharmacia [Health Care Related Organization]
   790   C1421478:WAS [Gene or Genome]

Phrase: "(Peapack,"

Phrase: "NJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027971:NJ [Geographic Area]

Phrase: ")."
Processing 00000000.tx.67: Bacitracin, pepstatin-A, 1,10-phenanthroline, N-ethylmaleimide, p-hydroxymercuribenzoate, EDTA, EGTA, L-3-carboxy-2,3-trans-epoxypropionyl-leucylamido(4-guanidino)butane (E64), phenylmethylsulfonyl fluoride (PMSF), and benzamidine were from Sigma-Aldrich. 

Phrase: "Bacitracin,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   944 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "pepstatin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "A,"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "10-phenanthroline,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031370:phenanthroline [Organic Chemical]

Phrase: "N-ethylmaleimide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015101:Ethylmaleimide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "p-hydroxymercuribenzoate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0048363:p-hydroxymercuribenzoate [Organic Chemical,Pharmacologic Substance]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "L-3-carboxy-2,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0604267:L-3 [Carbohydrate]
   812   C0439394:l's [Quantitative Concept]
   812   C0596260:Carboxy [Organic Chemical]
   812   C1706495:L- [Intellectual Product]
   812   C3642217:/L [Quantitative Concept]

Phrase: "3-trans-epoxypropionyl-leucylamido"

Phrase: "(4-guanidino"

Phrase: ")"

Phrase: "butane"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006474:Butane [Organic Chemical,Pharmacologic Substance]
  1000   C0006476:butane [Organic Chemical]

Phrase: "(E64"

Phrase: ")"

Phrase: ","

Phrase: "phenylmethylsulfonyl fluoride (PMSF),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   861   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "benzamidine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0053140:benzamidine [Organic Chemical,Pharmacologic Substance]

Phrase: "were from Sigma-Aldrich."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1719918:Sigma [Intellectual Product]
Processing 00000000.tx.68: N-Glycanase and GTP were from Roche Molecular Biochemicals (Basel, Switzerland). 

Phrase: "N-Glycanase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0061534:glycanase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "GTP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were from Roche Molecular Biochemicals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0331965:Roche [Health Care Related Organization]
   760   C1521991:Molecular [Qualitative Concept]
   726   C0205474:Biochemical [Functional Concept]

Phrase: "(Basel,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331779:Basel [Health Care Related Organization]

Phrase: "Switzerland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039021:Switzerland [Geographic Area]

Phrase: ")."
Processing 00000000.tx.69: HPLC-grade acetonitrile and trifluoroacetic acid (TFA) were obtained from Baker Chemical Co. 

Phrase: "HPLC-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008562:HPLC [Laboratory Procedure]

Phrase: "grade"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441800:Grade [Classification]
  1000   C0919553:Grade [Classification]
  1000   C3244287:grade [Finding]

Phrase: "acetonitrile"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050456:acetonitrile [Organic Chemical]

Phrase: "and"

Phrase: "trifluoroacetic acid (TFA)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040982:Trifluoroacetic Acid [Organic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "were"

Phrase: "obtained from Baker Chemical Co."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0220806:Chemical [Chemical]
   760   C0238749:Baker [Professional or Occupational Group]
   760   C1301820:Obtained [Functional Concept]
   760   C3272558:Chemical [Intellectual Product]
   726 E C1706701:Obtain [Activity]
Processing 00000000.tx.70: (Phillipsburg, NJ). 

Phrase: "(Phillipsburg,"

Phrase: "NJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027971:NJ [Geographic Area]

Phrase: ")."
Processing 00000000.tx.71: All other chemicals were obtained from commercial sources and were of reagent grade. 

Phrase: "All"

Phrase: "other chemicals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0220806:Chemicals [Chemical]
   966 E C3272558:Chemical [Intellectual Product]

Phrase: "were"

Phrase: "obtained from commercial sources"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C1516719:Commercial Sources [Classification]
   770   C0449416:sources [Finding]
   770   C0680536:commercial [Intellectual Product]
   770   C1301820:Obtained [Functional Concept]
   770   C3272563:Commercial [Intellectual Product]
   737 E C1705919:Source [Idea or Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "were of reagent grade."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]
   770   C0441800:Grade [Classification]
   770   C0919553:Grade [Classification]
   770   C3244287:grade [Finding]
Processing 00000000.tx.72: Animals and injections In vivo procedures were approved by the institutional committee for use and care of experimental animals. 

Phrase: "Animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "and"

Phrase: "injections In vivo procedures"
Meta Candidates (Total=10; Excluded=6; Pruned=0; Remaining=4)
   886   C0021485:injection procedures [Therapeutic or Preventive Procedure]
   869 E C1533685:Injection procedure [Therapeutic or Preventive Procedure]
   869 E C1828121:Injection Procedure [Functional Concept]
   812   C0025664:procedures [Intellectual Product]
   812   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   812   C2700391:procedures [Activity]
   779 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   779 E C3274430:PROCEDURE [Health Care Activity]
   779 E C3538935:Procedure [Idea or Concept]
   779 E C3539779:Procedure [Intellectual Product]

Phrase: "were"

Phrase: "approved by the institutional committee"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205540:Approved [Qualitative Concept]
   760   C2699414:Committee [Group]

Phrase: "for use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "care of experimental animals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0178478:animals care [Occupation or Discipline]
   770   C1947933:Care [Activity]
Processing 00000000.tx.73: Male Sprague Dawley rats (body weight, 180200 g) were obtained from Charles River (St. Aubin Les Elbeufs, France) and were fasted for 18 h before being killed. 

Phrase: "Male Sprague Dawley rats"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   923   C0034715:Rats, Sprague-Dawley [Mammal]
   861   C2699239:Sprague-Dawley [Mammal]
   812   C0034693:rats [Mammal]
   812   C0034721:Rats [Mammal]

Phrase: "(body weight,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C0005910:Body Weight [Organism Attribute]
           weight
  1000   C1305866:body weight [Diagnostic Procedure]
           weight
   861   C0043100:Weight [Quantitative Concept]
   861   C0242821:body [Human]
   861   C0460148:Body [Anatomical Structure]
   861   C1268086:Body [Anatomical Structure]
   861   C1705104:Weight [Idea or Concept]
   777 E C1995017:Bodies [Cell Component]

Phrase: "180200 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "obtained from Charles River"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0337050:River [Natural Phenomenon or Process]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "(St. Aubin Les Elbeufs,"

Phrase: "France"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016674:France [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "were"

Phrase: "fasted for 18 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   737   C0015663:Fast [Finding]
   737   C0456962:Fast [Qualitative Concept]

Phrase: "before"

Phrase: "being"

Phrase: "killed."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0162388:killed [Social Behavior]
   966 E C0681205:Kill [Idea or Concept]
   966 E C1550555:kill [Functional Concept]
Processing 00000000.tx.74: Native glucagon (15 g/100 g body weight) in 0.4 ml of 0.15 M NaCl was injected within 5 sec into the penile vein under light anesthesia with ether. 

Phrase: "Native glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   861   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(15 g/100 g body weight"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   827   C0005910:Body Weight [Organism Attribute]
           weight
   827   C1305866:body weight [Diagnostic Procedure]
           weight
   799   C0043100:Weight [Quantitative Concept]
   799   C0242821:body [Human]
   799   C0460148:Body [Anatomical Structure]
   799   C1268086:Body [Anatomical Structure]
   799   C1705104:Weight [Idea or Concept]
   716 E C1995017:Bodies [Cell Component]

Phrase: ")"

Phrase: "in 0.4 ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439526:/mL [Quantitative Concept]

Phrase: "of 0.15 M NaCl"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C1959973:% NaCl [Quantitative Concept]

Phrase: "was"

Phrase: "injected within 5 sec"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1720154:Inject [Functional Concept]

Phrase: "into the penile vein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0226778:Penile vein [Body Part, Organ, or Organ Component]
  1000   C1281177:Penile vein [Body Part, Organ, or Organ Component]
   861   C0042449:Vein [Body Part, Organ, or Organ Component]
   861   C1278960:Vein [Body Part, Organ, or Organ Component]

Phrase: "under light anesthesia"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0475746:Light anaesthesia [Finding]
   861   C0002903:Anesthesia [Therapeutic or Preventive Procedure]
   861   C0002930:Anaesthesia [Biomedical Occupation or Discipline]
   745 E C0002932:Anaesthetic [Pharmacologic Substance]

Phrase: "with ether."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014994:Ether [Organic Chemical,Pharmacologic Substance]
  1000   C0014996:Ether, NOS [Organic Chemical,Pharmacologic Substance]
  1000   C1161324:ether [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.75: Isolation of subcellular fractions from rat liver Subcellular fractionation was performed using established procedures (5, 7, 8, 21, 22). 

Phrase: "Isolation of subcellular fractions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0204727:Isolation [Therapeutic or Preventive Procedure]
   770   C0205409:Isolation [Functional Concept]
   770   C0220862:isolation [Laboratory Procedure]

Phrase: "from rat liver Subcellular fractionation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1656251:subcellular fractionation [Laboratory Procedure]
   812   C0016640:fractionation [Laboratory Procedure]
   812   C0524811:fractionation [Therapeutic or Preventive Procedure]
   812   C3161031:Fractionation [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "established procedures"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0025664:procedures [Intellectual Product]
   861   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C2700391:procedures [Activity]
   827 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   827 E C3274430:PROCEDURE [Health Care Activity]
   827 E C3538935:Procedure [Idea or Concept]
   827 E C3539779:Procedure [Intellectual Product]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "7,"

Phrase: "8,"

Phrase: "21,"

Phrase: "22"

Phrase: ")."
Processing 00000000.tx.76: Following injection of human glucagon, animals were killed, and livers were rapidly removed and minced in isotonic ice-cold homogenization buffer as previously described (5, 7, 8, 21, 22). 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "injection of human glucagon,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021485:injection [Therapeutic or Preventive Procedure]
   770   C1272883:Injection [Biomedical or Dental Material]
   770   C1533685:Injection [Therapeutic or Preventive Procedure]
   770   C1828121:Injection [Functional Concept]

Phrase: "animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "killed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0162388:killed [Social Behavior]
   966 E C0681205:Kill [Idea or Concept]
   966 E C1550555:kill [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "livers"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0023884:Livers [Body Part, Organ, or Organ Component]
   966 E C0736268:LIVER [Body Part, Organ, or Organ Component]
   966 E C1278929:Liver [Body Part, Organ, or Organ Component]
   966 E C2346688:LIVER [Food]
   928 E C0205054:Hepatic [Body Location or Region]

Phrase: "were"

Phrase: "rapidly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1637379:Rapidly [Qualitative Concept]

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "minced in isotonic ice-cold homogenization buffer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0456963:Ice cold [Qualitative Concept]
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0009264:Cold [Natural Phenomenon or Process]
   748   C0009443:Cold [Disease or Syndrome]
   748   C0020746:Ice [Inorganic Chemical]
   748   C0234192:Cold [Physiologic Function]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "7,"

Phrase: "8,"

Phrase: "21,"

Phrase: "22"

Phrase: ")."
Processing 00000000.tx.77: Rat liver nuclear (N), large-granule (ML), microsomal (P), and cytosolic (S) fractions were isolated by differential centrifugation as previously described (5, 7, 25). 

Phrase: "Rat liver nuclear (N), large-granule"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0010837:Granule [Cell Component]
   804   C0993609:Granule [Biomedical or Dental Material]
   733 E C0205248:Granular [Qualitative Concept]

Phrase: "(ML"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0521450:Lysosomal [Body Location or Region]
   789 E C0024369:Lysosome [Cell Component]
   789 E C2984253:Lysosome [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "microsomal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1979928:Microsomal [Qualitative Concept]
   928 E C0026029:Microsome [Cell Component]

Phrase: "(P"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "cytosolic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosolic [Cell Component]

Phrase: "("

Phrase: "S)"

Phrase: "fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "isolated by differential centrifugation"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0007703:Centrifugation [Laboratory Procedure]
   770   C0205409:Isolated [Functional Concept]
   770   C0443199:Differential [Qualitative Concept]
   770   C1548221:Isolated [Idea or Concept]
   770   C1705242:Differential [Qualitative Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "7,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.78: The endosomal fraction (EN) was isolated by discontinuous sucrose gradient centrifugation and collected at the 0.251.0 M sucrose interface (5, 7, 8, 21, 22, 25). 

Phrase: "The endosomal fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "(EN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: ")"

Phrase: "was"

Phrase: "isolated by discontinuous sucrose gradient centrifugation"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   753   C0007703:Centrifugation [Laboratory Procedure]
   753   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0205409:Isolated [Functional Concept]
   753   C0439182:% gradient [Quantitative Concept]
   753   C0439599:Discontinuous [Temporal Concept]
   753   C0812409:Gradient [Quantitative Concept]
   753   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]
   753   C1444662:Discontinuous [Finding]
   753   C1548221:Isolated [Idea or Concept]
   719 E C0370215:Isolate [Substance]
   719 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "collected at the 0.251.0 M sucrose interface"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   742   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   742   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0441923:M+ [Intellectual Product]
   742   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]
   742   C1516695:Collected [Idea or Concept]
   742   C1516698:Collected [Functional Concept]
   742   C1708533:Interface [Manufactured Object]
   742   C2698172:Interface [Intellectual Product]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "7,"

Phrase: "8,"

Phrase: "21,"

Phrase: "22,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.79: Plasma membrane was prepared according to the method of Neville (26) as described by Authier et al. 

Phrase: "Plasma membrane"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "was"

Phrase: "prepared according to the method of Neville"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0025663:Method [Intellectual Product]
   748   C0449851:Method [Functional Concept]
   748   C0680240:according [Social Behavior]
   748   C0871511:METHOD [Intellectual Product]
   714   C1521827:Prepare [Functional Concept]

Phrase: "(26"

Phrase: ")"

Phrase: "as"

Phrase: "described by Authier et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.80: (5, 27). 

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "27"

Phrase: ")."
Processing 00000000.tx.81: Rough endoplasmic reticulum (ER) was prepared by the protocol of Walter and Blobel (28) as described previously (25) and used as described in Authier et al. 

Phrase: "Rough endoplasmic reticulum (ER)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0230779:Rough endoplasmic reticulum [Cell Component]
   901   C0014239:Endoplasmic Reticulum [Cell Component]
   827   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   755   C0598268:Endoplasm [Cell Component]

Phrase: "was"

Phrase: "prepared by the protocol of Walter"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0442711:Protocol [Intellectual Product]
   753   C1507394:Protocol [Intellectual Product]
   753   C1522729:Protocol [Intellectual Product]
   753   C2348563:Protocol [Intellectual Product]
   719   C1521827:Prepare [Functional Concept]

Phrase: "and"

Phrase: "Blobel"

Phrase: "(28"

Phrase: ")"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(25"

Phrase: ")"

Phrase: "and"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "as"

Phrase: "described in Authier et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.82: (25). 

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.83: Purified peroxisomes (Per) were obtained as described by Bodnar and Rachubinski (29) with an 18.6  0.5-fold cytochrome c oxidase enrichment and used as described in Authier et al. 

Phrase: "Purified peroxisomes (Per)"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0752063:Peroxisomes [Cell Component]
   827 E C2984308:Peroxisome [Functional Concept]
   777 E C3546463:peroxisomal [Cell Component]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "as"

Phrase: "described by Bodnar"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Rachubinski"

Phrase: "(29"

Phrase: ")"

Phrase: "with an 18.6  0.5-fold cytochrome c oxidase enrichment"

Phrase: "and"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "as"

Phrase: "described in Authier et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.84: (25). 

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.85: Lysosomes (L2 fraction) were prepared by isopycnic centrifugation of the light mitochondrial fraction in a discontinuous metrizamide gradient according to the method of Wattiaux et al. 

Phrase: "Lysosomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0024369:Lysosomes [Cell Component]
   966 E C2984253:Lysosome [Functional Concept]
   916 E C0521450:Lysosomal [Body Location or Region]

Phrase: "(L2 fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: "were"

Phrase: "prepared by isopycnic centrifugation of the light mitochondrial fraction"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   764   C0007705:Centrifugation, Isopycnic [Laboratory Procedure]
   762   C1264633:Fraction of [Quantitative Concept]
           Fraction
   742   C0007703:Centrifugation [Laboratory Procedure]
   742   C0023693:Light [Natural Phenomenon or Process]
   742   C0026237:Mitochondrial [Cell Component]
   742   C0521451:Mitochondrial [Functional Concept]
   742   C1306462:Light [Functional Concept]
   742   C1554103:Fraction [Idea or Concept]
   742   C1881376:Light [Qualitative Concept]
   708   C1521827:Prepare [Functional Concept]

Phrase: "in a discontinuous metrizamide gradient"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439182:% gradient [Quantitative Concept]
   827   C0812409:Gradient [Quantitative Concept]

Phrase: "according to the method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "of Wattiaux et al."
Processing 00000000.tx.86: (30) with a 53.2  4.1-fold N-acetyl--D-glucosaminidase enrichment (21). 

Phrase: "(30"

Phrase: ")"

Phrase: "with a 53.2  4.1-fold N-acetyl"

Phrase: "-"

Phrase: "-"

Phrase: "D-"

Phrase: "glucosaminidase enrichment"

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.87: Biochemical characterization Triton X-114 (Sigma-Aldrich) extraction was carried out by the method of Bordier (31). 

Phrase: "Biochemical characterization Triton X-114"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146953:Triton X-114 [Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]

Phrase: "(Sigma-Aldrich"

Phrase: ")"

Phrase: "extraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0185115:Extraction [Therapeutic or Preventive Procedure]
  1000   C0684295:extraction [Laboratory Procedure]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out by the method of Bordier"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0025663:Method [Intellectual Product]
   753   C0439787:Out [Spatial Concept]
   753   C0449851:Method [Functional Concept]
   753   C0849355:Out [Qualitative Concept]
   753   C0871511:METHOD [Intellectual Product]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.88: N-Glycanase treatment of the [125I]glucagon/gp-170 cross-linked complex (see Cross-linking studies) was carried out essentially as previously described for endoglycosidase digestion of [125I]glucagon/glucagon receptor cross-linked complex (27). 

Phrase: "N-Glycanase treatment of the [125I"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "]glucagon/gp-170"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   827   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "cross-linked"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178576:Cross Linked [Natural Phenomenon or Process]
  1000   C0332220:cross linked [Functional Concept]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: ")"

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out essentially"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439787:Out [Spatial Concept]
   861   C0849355:Out [Qualitative Concept]

Phrase: "as"

Phrase: "previously"

Phrase: "described for endoglycosidase digestion of [125I"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0012238:Digestion [Organism Function]
   753   C0014162:Endoglycosidase [Pharmacologic Substance]
   753   C1552738:described [Idea or Concept]
   753   C2349986:Digestion [Research Activity]

Phrase: "]glucagon/glucagon receptor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0061352:Glucagon Receptor [Amino Acid, Peptide, or Protein,Receptor]
   913   C1415011:GLUCAGON RECEPTOR [Gene or Genome]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "cross-linked"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178576:Cross Linked [Natural Phenomenon or Process]
  1000   C0332220:cross linked [Functional Concept]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.89: Cross-linked proteins (300 g protein) were incubated at 37 C under constant shaking with 1 U N-glycanase for various times in 30 mM sodium phosphate buffer (pH 7.6) containing 20 mM EDTA, 1% Nonidet P-40, 0.1% sodium dodecyl sulfate, and 0.5% 2-mercaptoethanol. 

Phrase: "Cross-linked"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178576:Cross Linked [Natural Phenomenon or Process]
  1000   C0332220:cross linked [Functional Concept]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(300 g protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "incubated at 37 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "under constant shaking"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040822:Shaking [Sign or Symptom]
   827 E C1883023:Shake [Activity]

Phrase: "with 1 U N-glycanase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0061534:glycanase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "for various times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "in 30 mM sodium phosphate buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C3256935:sodium phosphate buffer [Pharmacologic Substance]
   840   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(pH 7.6"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "20 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "1% Nonidet P-40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   812   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   812   C0439509:/40 [Temporal Concept]

Phrase: "0.1% sodium dodecyl sulfate,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   884   C0037506:Sodium Dodecyl Sulfate [Biomedical or Dental Material,Lipid,Pharmacologic Substance]
   853   C0074769:Sodium sulphate [Inorganic Chemical,Pharmacologic Substance]
   840   C0058632:dodecyl sulfate [Lipid,Pharmacologic Substance]
   804   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   804   C0038720:Sulfate [Inorganic Chemical]
   804   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   804   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   804   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "0.5% 2-mercaptoethanol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0025402:Mercaptoethanol [Organic Chemical]
Processing 00000000.tx.90: The digestion was stopped with Laemmli sample buffer (32), and the samples were subjected to electrophoresis in an 8% acrylamide resolving gel. 

Phrase: "The digestion"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0012238:Digestion [Organism Function]
  1000   C2349986:Digestion [Research Activity]
   944 E C0443277:Peptic [Functional Concept]

Phrase: "was"

Phrase: "stopped with Laemmli sample buffer"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   797   C0258024:Laemmli buffer [Organic Chemical]
   760   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0370003:Sample [Substance]
   760   C1272691:stopped [Qualitative Concept]
   760   C2347026:Sample [Conceptual Entity]
   726 E C1947925:Stop [Activity]
   726 E C2746065:Stop [Temporal Concept]

Phrase: "(32"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "subjected to electrophoresis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0013855:Electrophoresis [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "in an 8% acrylamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0050587:Acrylamide [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "resolving"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514893:resolving [Idea or Concept]
   966 E C2699488:Resolve [Conceptual Entity]

Phrase: "gel."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017243:Gel [Biomedical or Dental Material]
  1000   C1382104:Gel [Substance]
Processing 00000000.tx.91: Immunoblot analysis Electrophoresed samples were transferred to nitrocellulose membranes (0.45 x 10-6 m) for 60 min at 380 mA in transfer buffer containing 25 mM Tris base and 192 mM glycine. 

Phrase: "Immunoblot analysis Electrophoresed samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   858   C1303103:analysis sample [Laboratory Procedure]
   779   C0370003:Sample [Substance]
   779   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "to nitrocellulose membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0025255:Membranes [Tissue]
   793 E C0596901:Membrane [Cell Component]
   793 E C1706182:Membrane [Manufactured Object]
   743 E C0205287:Membranous [Qualitative Concept]

Phrase: "(0.45 x 10-6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0439187:/10^6 [Quantitative Concept]
   840   C1881839:10^6 [Quantitative Concept]

Phrase: "m) for 60 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]
   770   C0702093:/min [Temporal Concept]

Phrase: "at 380 mA"

Phrase: "in transfer buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "25 mM Tris base"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0041175:Tris-base [Organic Chemical,Pharmacologic Substance]
   812   C0002055:base [Inorganic Chemical]
   812   C0178499:Base [Chemical Viewed Functionally]
   812   C1880279:Base [Biomedical or Dental Material]
   741 E C0205112:Basal [Spatial Concept]
   729 E C0016617:Foundation [Organization]
   729 E C1626935:Bases [Quantitative Concept]

Phrase: "and"

Phrase: "192 mM glycine."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0522461:Glycine [Plant]
Processing 00000000.tx.92: The membranes were blocked by a 3-h incubation with 5% skim milk in 10 mM Tris-HCl (pH 7.5), 300 mM NaCl, and 0.05% Tween 20. 

Phrase: "The membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "blocked by a 3-h incubation"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   783   C0041119:h 3 [Element, Ion, or Isotope]
   753   C0028778:Blocked [Pathologic Function]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0332206:Blocked [Functional Concept]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   753   C2983591:BLOCKED [Research Activity]
   719 E C1533157:Block [Substance]
   719 E C1706084:Block [Geographic Area]
   719 E C2828370:Block [Quantitative Concept]

Phrase: "with 5% skim milk"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   901   C0349375:Skim milk [Food]
   827   C0026131:Milk [Body Substance]
   827   C0349374:Milk [Food]
   827   C0444318:Milk [Substance]
   827   C2825079:Milk [Food]
   771 E C0229890:Lacteal [Body Part, Organ, or Organ Component]
   771 E C1281353:Lacteal [Body Part, Organ, or Organ Component]
   755 E C0443260:Milky [Finding]

Phrase: "in 10 mM Tris-HCl (pH 7.5"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   818   C1882074:pH 7 [Qualitative Concept]
   795   C0020283:[pH] [Quantitative Concept]
   795   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   795   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   795   C0450407:ph+ [Finding]
   795   C0450408:ph++ [Finding]
   795   C0450409:ph+++ [Finding]
   795   C0814229:TRI [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "300 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "and"

Phrase: "0.05% Tween 20."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   833 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   812   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   756 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.93: The membranes were then incubated with primary antibody [rabbit polyclonal antisera against either mouse cathepsin D R291 (diluted 1:1500), rat MGE (diluted 1:200), rat liver 3-ketoacyl-CoA thiolase (diluted 1:300), affinity-purified goat polyclonal IgG against human Hsp-60 (diluted 1:500), or affinity-purified rabbit polyclonal IgG against human furin (diluted 1:500)] in the above buffer for 16 h at 4 C. 

Phrase: "The membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0025255:Membranes [Tissue]
   966 E C0596901:Membrane [Cell Component]
   966 E C1706182:Membrane [Manufactured Object]
   916 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated with primary antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0205225:Primary [Qualitative Concept]
   770   C0439631:Primary [Therapeutic or Preventive Procedure]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "[rabbit polyclonal antisera against either mouse cathepsin D R291"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "("

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1500"

Phrase: ")"

Phrase: ","

Phrase: "rat MGE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "("

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "200"

Phrase: ")"

Phrase: ","

Phrase: "rat liver 3-ketoacyl-CoA thiolase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0001019:Thiolase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "("

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "300"

Phrase: ")"

Phrase: ","

Phrase: "affinity-purified goat polyclonal IgG against human Hsp-60"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   762   C2702333:Human IgG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "("

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "500"

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "affinity-purified rabbit polyclonal IgG against human furin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   767   C2702333:Human IgG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "("

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "500"

Phrase: ")"

Phrase: "]"

Phrase: "in the above buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "for 16 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 4 C."
Processing 00000000.tx.94: The blots were then washed three times with 0.5% skim milk in 10 mM Tris-HCl (pH 7.5), 300 mM NaCl, and 0.05% Tween 20 over a period of 1 h at room temperature. 

Phrase: "The blots"

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "three times with 0.5% skim milk"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0040223:times [Temporal Concept]
   748   C1632851:Times [Quantitative Concept]
   714 E C3541383:Time [Temporal Concept]

Phrase: "in 10 mM Tris-HCl (pH 7.5"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   818   C1882074:pH 7 [Qualitative Concept]
   795   C0020283:[pH] [Quantitative Concept]
   795   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   795   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   795   C0450407:ph+ [Finding]
   795   C0450408:ph++ [Finding]
   795   C0450409:ph+++ [Finding]
   795   C0814229:TRI [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "300 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "and"

Phrase: "0.05% Tween 20 over a period of 1 h"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   760   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   757   C0700308:h 1 [Element, Ion, or Isotope]
   739   C0033727:H+ [Element, Ion, or Isotope]
   739   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   739   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0439531:/period [Temporal Concept]
   739   C0441932:H+ [Classification]
   739   C0564385:/h [Quantitative Concept]
   739   C1948053:Period [Temporal Concept]
   732 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.95: The bound Ig was detected using horseradish peroxidase-conjugated goat antirabbit IgG or rabbit anti-goat IgG. 

Phrase: "The bound Ig"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021027:Ig [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0305052:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0360506:IG [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C3541296:IG [Idea or Concept]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "horseradish peroxidase-conjugated goat antirabbit IgG"

Phrase: "or"

Phrase: "rabbit anti-goat IgG."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   875   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0018019:goat [Mammal]
   812   C0034493:Rabbit [Mammal]
   812   C1265549:goat [Mammal]
   812   C1510458:Goat [Mammal]
Processing 00000000.tx.96: In vitro proteolysis of native glucagon by hepatic endosomes and furin Hepatic endosomes (EN) (1 g) were incubated for varying lengths of time at 37 C with 1 M porcine glucagon in 200 l of 50 mM citrate-phosphate buffer (pH 74), in the presence or absence of protease inhibitors. 

Phrase: "In vitro proteolysis of native glucagon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0597304:Proteolysis [Molecular Function]

Phrase: "by hepatic endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034850:Endosomes [Cell Component]

Phrase: "and"

Phrase: "furin Hepatic endosomes (EN)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034850:Endosomes [Cell Component]

Phrase: "(1 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "were"

Phrase: "incubated for varying lengths of time"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0040223:Time [Temporal Concept]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1444754:Lengths [Quantitative Concept]
   753   C3541383:Time [Temporal Concept]
   719 E C1706316:LENGTH [Research Activity]

Phrase: "at 37 C"

Phrase: "with 1 M porcine glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   812   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in 200 l"

Phrase: "of 50 mM citrate-phosphate buffer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C3256468:citrate buffer [Pharmacologic Substance]
   840   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   804   C0031701:phosphate [Organophosphorus Compound]
   804   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "(pH 74"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of protease inhibitors."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]
Processing 00000000.tx.97: The samples were then acidified with acetic acid (15%) and immediately loaded onto a reversed phase-HPLC (RP-HPLC) column. 

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "acidified with acetic acid"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   833   C0000985:Acetic acid [Organic Chemical]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]
   770   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   715 E C0148405:Vinegar [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "(15%"

Phrase: ")"

Phrase: "and"

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "loaded onto a reversed phase-HPLC (RP-HPLC) column."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   748   C0008562:HPLC [Laboratory Procedure]
   748   C0205390:Phase [Temporal Concept]
   748   C1185738:Column [Body Part, Organ, or Organ Component]
   748   C1706132:Column [Idea or Concept]
   748   C1708715:Loaded [Activity]
   714 E C1550025:Load [Idea or Concept]
   714   C1555029:Reverse [Idea or Concept]
   714 E C1704782:Load [Manufactured Object]
Processing 00000000.tx.98: In some experiments, native glucagon was also digested in vitro with recombinant human furin. 

Phrase: "In some experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "native glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   861   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "was"

Phrase: "also"

Phrase: "digested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0868946:digested [Physiologic Function]

Phrase: "in vitro with recombinant human furin."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0021135:In Vitro [Intellectual Product]
   790   C1533691:in vitro [Qualitative Concept]
           vitro
   790   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.99: Glucagon (10-6 M) was incubated with 28 U/ml furin in 90 l of 0.1 M HEPES buffer (pH 7.4) containing 5 mM CaCl2. 

Phrase: "Glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(10-6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439187:/10^6 [Quantitative Concept]
  1000   C1881839:10^6 [Quantitative Concept]

Phrase: "M)"

Phrase: "was"

Phrase: "incubated with 28 U/ml furin"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0439340:U/ml [Quantitative Concept]
   790   C1880521:U/mL [Quantitative Concept]
   790   C2945590:U/mL [Quantitative Concept]
   753   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0439526:/mL [Quantitative Concept]
   753   C0919550:FURIN [Gene or Genome]
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "in 90 l"

Phrase: "of 0.1 M HEPES buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "5 mM CaCl2."
Processing 00000000.tx.100: After 15 min to 5 h of incubation at 37 C, the proteolytic reaction was stopped by adding acetic acid (15%), and the samples were analyzed by RP-HPLC. 

Phrase: "After 15 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "to 5 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "of incubation"

Phrase: "at 37 C,"

Phrase: "the proteolytic reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "stopped by adding acetic acid"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   806   C0000985:Acetic acid [Organic Chemical]
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   760   C1272691:stopped [Qualitative Concept]
   726   C1883712:Add [Functional Concept]
   726 E C1947925:Stop [Activity]
   726 E C2746065:Stop [Temporal Concept]
   704 E C0148405:Vinegar [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "(15%"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "analyzed by RP-HPLC."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0205390:Phase [Temporal Concept]
   760   C0936012:Analyzed [Research Activity]
   726   C1555029:Reverse [Idea or Concept]
Processing 00000000.tx.101: Immunodepletion studies In some experiments, EN was immunodepleted of active IDE, cathepsin B, cathepsin D, or furin before the digestion step by incubating EN (0.30 mg/ml) with antibodies coated to protein G-Sepharose beads for 16 h at 4 C in 800 l of 20 mM sodium phosphate buffer (pH 7), containing 0.1% Sarkosyl-30. 

Phrase: "Immunodepletion"

Phrase: "studies In some experiments,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   777   C0681814:experimental studies [Research Activity]
           Experiments
   770   C0557651:Study [Manufactured Object]
   770   C0947630:studies [Laboratory Procedure]
   770   C2603343:Study [Research Activity]
   737 E C1706386:Experiment [Conceptual Entity]

Phrase: "EN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "was"

Phrase: "immunodepleted of active IDE,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0205177:Active [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "cathepsin B,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0699919:Cathepsin B [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332804:CATHEPSIN B [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "cathepsin D,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "or"

Phrase: "furin before the digestion step"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0919550:FURIN [Gene or Genome]

Phrase: "by incubating EN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034850:Endosomes [Cell Component]

Phrase: "(0.30 mg/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439269:mg% [Quantitative Concept]
   827   C1960952:mg % [Quantitative Concept]
   827   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "ml) with antibodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439526:/mL [Quantitative Concept]

Phrase: "coated to protein G-Sepharose"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   781   C1423498:coat-protein [Gene or Genome]
   760   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0036681:Sepharose [Carbohydrate]
   760   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1522408:Coated [Qualitative Concept]
   726 E C0453946:Coat [Manufactured Object]
   726 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "beads for 16 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C0991566:Beads [Biomedical or Dental Material]
   770   C2346972:Bead [Spatial Concept]

Phrase: "at 4 C in 800 l"

Phrase: "of 20 mM sodium phosphate buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C3256935:sodium phosphate buffer [Pharmacologic Substance]
   840   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(pH 7"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:pH 7 [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.1% Sarkosyl-30."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0074071:sarkosyl [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.102: The fractions were then centrifuged for 5 min at 10,000 x gav, and the resultant immunodepleted supernatants were used in the glucagon degradation assay. 

Phrase: "The fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "centrifuged for 5 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0702093:/min [Temporal Concept]
   737   C0179834:centrifuge [Medical Device]

Phrase: "at 10,000 x gav,"

Phrase: "and"

Phrase: "the resultant immunodepleted supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "used in the glucagon degradation assay."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   753   C0005507:Assay [Laboratory Procedure]
   753   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   753   C0243073:assay [Qualitative Concept]
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]
   753   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1273517:used [Finding]
   753   C1510438:Assay [Laboratory Procedure]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.103: The reaction was terminated by the addition of 15% acetic acid and immediately assayed by RP-HPLC. 

Phrase: "The reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "terminated by the addition of 15% acetic acid"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   770   C0000985:Acetic acid [Organic Chemical]
   744   C0001128:Acid [Chemical]
   744   C0202406:Acid [Laboratory Procedure]
   744   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   744   C1553404:terminated [Idea or Concept]
   744   C1883712:Addition [Functional Concept]
   744   C2348570:Terminated [Functional Concept]

Phrase: "and"

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "assayed by RP-HPLC."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0205390:Phase [Temporal Concept]
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726   C1510438:Assay [Laboratory Procedure]
   726   C1555029:Reverse [Idea or Concept]
Processing 00000000.tx.104: In other experiments, the [125I]iodoglucagon/170-kDa cross-linked complex was incubated with anti-IDE or anti-furin antibodies coated to protein G-Sepharose for 15 h at 4 C in 600 l of 30 mM sodium phosphate buffer (pH 7), containing 0.1% Triton X-100 (Sigma-Aldrich). 

Phrase: "In other experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "the [125I"

Phrase: "]iodoglucagon/170-kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1532717:kDa [Quantitative Concept]

Phrase: "cross-linked"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178576:Cross Linked [Natural Phenomenon or Process]
  1000   C0332220:cross linked [Functional Concept]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "was"

Phrase: "incubated with anti-IDE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "or"

Phrase: "anti-furin antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "coated to protein G-Sepharose"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   781   C1423498:coat-protein [Gene or Genome]
   760   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0036681:Sepharose [Carbohydrate]
   760   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1522408:Coated [Qualitative Concept]
   726 E C0453946:Coat [Manufactured Object]
   726 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "for 15 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 4 C in 600 l"

Phrase: "of 30 mM sodium phosphate buffer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C3256935:sodium phosphate buffer [Pharmacologic Substance]
   840   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(pH 7"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:pH 7 [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.1% Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]

Phrase: "(Sigma-Aldrich"

Phrase: ")."
Processing 00000000.tx.105: The fractions were then centrifuged for 5 min at 10,000 x gav, and the resultant supernatants were subjected to SDS-PAGE as described above. 

Phrase: "The fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "centrifuged for 5 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0702093:/min [Temporal Concept]
   737   C0179834:centrifuge [Medical Device]

Phrase: "at 10,000 x gav,"

Phrase: "and"

Phrase: "the resultant supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "subjected to SDS-PAGE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "as described above."
Processing 00000000.tx.106: HPLC separation of unlabeled glucagon peptides RP-HPLC was performed on a Beckman Coulter (Fullerton, CA) System Gold model 127 liquid chromatograph equipped with a Rheodyne sample injector fitted with a 0.5-ml loop and a Bondapak C18 column (Waters, Milford, MA; 0.39 x 30 cm; 10-m particle size). 

Phrase: "HPLC separation of unlabeled glucagon peptides RP-HPLC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0036679:Separation [Pathologic Function]
   742   C0237868:Separation [Social Behavior]
   742   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "was"

Phrase: "performed on a Beckman Coulter"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0884358:Performed [Functional Concept]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(Fullerton,"

Phrase: "CA) System Gold model 127 liquid chromatograph"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0302647:chromatograph [Medical Device]
   768   C0008565:Liquid Chromatography [Laboratory Procedure]

Phrase: "equipped with a Rheodyne sample injector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0181342:Injector [Medical Device]
   753   C0370003:Sample [Substance]
   753   C2347026:Sample [Conceptual Entity]

Phrase: "fitted with a 0.5-ml loop"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   778   C0444499:0/5 [Quantitative Concept]
   748   C0036572:Fit [Sign or Symptom]
   748   C0419518:Loop [Medical Device]
   748   C0424576:Fit [Finding]
   748   C0439526:/mL [Quantitative Concept]
   748   C0445022:Loop [Spatial Concept]
   748   C2349186:Fit [Activity]

Phrase: "and"

Phrase: "a Bondapak C18 column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185738:Column [Body Part, Organ, or Organ Component]
   827   C1706132:Column [Idea or Concept]

Phrase: "(Waters,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0043047:Waters [Inorganic Chemical,Pharmacologic Substance]
   966 E C0599638:WATER [Substance]
   966 E C1550678:Water [Inorganic Chemical]
   916 E C0443350:Watery [Qualitative Concept]

Phrase: "Milford,"

Phrase: "MA"

Phrase: "; 0.39 x 30 cm"

Phrase: "; 10-m particle size"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0030608:Particle Size [Quantitative Concept]
   812   C0456389:size [Spatial Concept]
   812   C0597177:Particle [Chemical Viewed Structurally]

Phrase: ")."
Processing 00000000.tx.107: Samples were chromatographed using a mixture of 0.1% TFA in water (solvent A) and 0.1% TFA in acetonitrile (solvent B) with a flow rate of 1 ml/min. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "chromatographed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0302647:chromatograph [Medical Device]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a mixture of 0.1% TFA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439962:Mixture [Substance]

Phrase: "in water"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
  1000   C0599638:WATER [Substance]
  1000   C1550678:Water [Inorganic Chemical]
   928 E C0443350:Watery [Qualitative Concept]

Phrase: "(solvent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037638:Solvent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "A)"

Phrase: "and"

Phrase: "0.1% TFA in acetonitrile"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0040982:Trifluoroacetic Acid [Organic Chemical]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]

Phrase: "(solvent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037638:Solvent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "B) with a flow rate of 1 ml/min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.108: Elution was carried out using two sequential linear gradients of 025% solvent B (10 min) and 2537% solvent B (40 min), followed by an isocratic elution of 37% solvent B (10 min). 

Phrase: "Elution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441565:Elution [Laboratory Procedure]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "two sequential linear gradients of 025% solvent B (10 min)"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C0812409:gradients [Quantitative Concept]
   706 E C0439182:% gradient [Quantitative Concept]

Phrase: "and"

Phrase: "2537% solvent B (40 min),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0702093:/min [Temporal Concept]

Phrase: "followed by an isocratic elution"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C1441565:Elution [Laboratory Procedure]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "of 37% solvent B (10 min)."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0456692:/10 min [Temporal Concept]
   804   C0702093:/min [Temporal Concept]
Processing 00000000.tx.109: Eluates were monitored on-line for absorbance at 214 nm with a LC-166 spectrophotometer (Beckman Coulter). 

Phrase: "Eluates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0301870:Eluate [Body Substance]
   966   C1272724:Eluate [Substance]

Phrase: "were"

Phrase: "monitored"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]

Phrase: "on-line for absorbance"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205132:Line [Spatial Concept]
   770   C1550648:Line [Substance]
   770   C1552960:Line [Quantitative Concept]
   770   C1720176:On [Functional Concept]
   770   C1720294:On [Intellectual Product]

Phrase: "at 214 nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "with a LC-166 spectrophotometer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0183400:Spectrophotometer [Medical Device]

Phrase: "(Beckman Coulter"

Phrase: ")."
Processing 00000000.tx.110: The major components in the eluates were collected and submitted to mass spectrometry analysis. 

Phrase: "The major components in the eluates"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0449432:Components [Manufactured Object]
   719 E C1705248:Component [Conceptual Entity]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "submitted to mass spectrometry analysis."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0037813:Mass Spectrometry [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0436196:Spectrometry [Laboratory Procedure]
   760   C0577559:Mass [Finding]
   760   C0936012:Analysis [Research Activity]
   760   C1306372:*Mass [Quantitative Concept]
   760   C1515023:Submitted [Functional Concept]
   760   C1524024:analysis [Functional Concept]
   760   C3152252:Mass [Quantitative Concept]
Processing 00000000.tx.111: Mass spectrometry Samples were prepared and analyzed using ion spray mass spectrometry and HPLC-electron spray ionization mass spectrometry coupling as previously described (21, 33). 

Phrase: "Mass spectrometry Samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0370003:Sample [Substance]
   793   C2347026:Sample [Conceptual Entity]
   734   C0037813:Mass Spectrometry [Laboratory Procedure]

Phrase: "were"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "and"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ion spray mass spectrometry"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   861   C0037813:Mass Spectrometry [Laboratory Procedure]
   812   C0022023:Ion [Element, Ion, or Isotope]
   812   C0436196:Spectrometry [Laboratory Procedure]
   812   C0577559:Mass [Finding]
   812   C1306372:*Mass [Quantitative Concept]
   812   C1700702:ION [Functional Concept]
   812   C1704413:{Spray} [Quantitative Concept]
   812   C2003858:Spray [Functional Concept]
   812   C3152252:Mass [Quantitative Concept]

Phrase: "and"

Phrase: "HPLC-electron spray ionization mass spectrometry coupling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C1948027:Coupling [Functional Concept]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(21,"

Phrase: "33"

Phrase: ")."
Processing 00000000.tx.112: Ligand radioiodination and preparation of purified [125I]Tyr-labeled isomers Native glucagon and [Tyr12]-miniglucagon were radioiodinated by the lactoperoxidase method to specific activities of 6080 Ci/g as described previously (5, 7, 8, 27). 

Phrase: "Ligand radioiodination"

Phrase: "and"

Phrase: "preparation of purified"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0455052:Preparation [Health Care Activity]
   790   C1521827:Preparation [Functional Concept]

Phrase: "[125I"

Phrase: "]Tyr-labeled isomers Native glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   804   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and ["

Phrase: "Tyr12"

Phrase: "]-miniglucagon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0082712:miniglucagon [Amino Acid, Peptide, or Protein]

Phrase: "were"

Phrase: "radioiodinated by the lactoperoxidase method"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0022948:LACTOPEROXIDASE [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C0025663:Method [Intellectual Product]
   760   C0449851:Method [Functional Concept]
   760   C0871511:METHOD [Intellectual Product]
   760   C1416903:LACTOPEROXIDASE [Gene or Genome]

Phrase: "to specific activities"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0205369:Specific [Qualitative Concept]
   861   C0441655:Activities [Activity]
   861   C1552740:specific [Intellectual Product]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "of 6080 Ci/g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C2348019:Ci/g [Quantitative Concept]
   827   C0439267:g% [Quantitative Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "7,"

Phrase: "8,"

Phrase: "27"

Phrase: ")."
Processing 00000000.tx.113: Equimolar mixtures of [125I]Tyr10- and [125I]Tyr13-glucagon were purified by RP-HPLC as described previously (5). 

Phrase: "Equimolar mixtures of [125I"

Phrase: "]Tyr10-"

Phrase: "and ["

Phrase: "125I"

Phrase: "]Tyr13-glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   861   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "were"

Phrase: "purified by RP-HPLC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0205390:Phase [Temporal Concept]
   760   C1998793:Purified [Functional Concept]
   726   C1555029:Reverse [Idea or Concept]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.114: For [Tyr12]-miniglucagon, the iodination mixture was immediately loaded onto a RP-HPLC column (Waters Bondapak C18; 0.39 x 30 cm; 10-m particle size) and chromatographed with a mixture of 0.1% TFA in water (solvent A) and 0.1% TFA in acetonitrile (solvent B) and a flow rate of 1.2 ml/min. 

Phrase: "For"

Phrase: "[Tyr12"

Phrase: "]-miniglucagon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0082712:miniglucagon [Amino Acid, Peptide, or Protein]

Phrase: "the iodination mixture"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:Mixture [Substance]

Phrase: "was"

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "loaded onto a RP-HPLC column"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   748   C0008562:HPLC [Laboratory Procedure]
   748   C0205390:Phase [Temporal Concept]
   748   C1185738:Column [Body Part, Organ, or Organ Component]
   748   C1706132:Column [Idea or Concept]
   748   C1708715:Loaded [Activity]
   714 E C1550025:Load [Idea or Concept]
   714   C1555029:Reverse [Idea or Concept]
   714 E C1704782:Load [Manufactured Object]

Phrase: "(Waters Bondapak C18"

Phrase: "; 0.39 x 30 cm"

Phrase: "; 10-m particle size"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0030608:Particle Size [Quantitative Concept]
   812   C0456389:size [Spatial Concept]
   812   C0597177:Particle [Chemical Viewed Structurally]

Phrase: ")"

Phrase: "and"

Phrase: "chromatographed with a mixture of 0.1% TFA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0040982:Trifluoroacetic Acid [Organic Chemical]
   742   C0001128:Acid [Chemical]
   742   C0202406:Acid [Laboratory Procedure]
   742   C0439962:Mixture [Substance]
   708   C0302647:chromatograph [Medical Device]

Phrase: "in water"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
  1000   C0599638:WATER [Substance]
  1000   C1550678:Water [Inorganic Chemical]
   928 E C0443350:Watery [Qualitative Concept]

Phrase: "(solvent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037638:Solvent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "A)"

Phrase: "and"

Phrase: "0.1% TFA in acetonitrile"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0040982:Trifluoroacetic Acid [Organic Chemical]
   753   C0001128:Acid [Chemical]
   753   C0202406:Acid [Laboratory Procedure]

Phrase: "(solvent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037638:Solvent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "a flow rate of 1.2 ml/min."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C2826285:Flow Rate [Quantitative Concept]
   744   C0806140:Flow [Natural Phenomenon or Process]
   744   C0871208:Rate [Activity]
   744   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.115: Elution was carried out using a linear gradient of 050% over 60 min. 

Phrase: "Elution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441565:Elution [Laboratory Procedure]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a linear gradient of 050%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439182:% gradient [Quantitative Concept]
   760   C0812409:Gradient [Quantitative Concept]

Phrase: "over 60 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.116: Eluates were monitored on-line for radioactivity with a Berthold (Nashua, NH) LB 504 -detector connected to an Apple IIc computer (Apple Computer, Cupertino, CA). 

Phrase: "Eluates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0301870:Eluate [Body Substance]
   966   C1272724:Eluate [Substance]

Phrase: "were"

Phrase: "monitored"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]

Phrase: "on-line for radioactivity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205132:Line [Spatial Concept]
   770   C1550648:Line [Substance]
   770   C1552960:Line [Quantitative Concept]
   770   C1720176:On [Functional Concept]
   770   C1720294:On [Intellectual Product]

Phrase: "with a Berthold"

Phrase: "(Nashua,"

Phrase: "NH) LB 504 -detector"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0180392:Detector [Medical Device]
   812   C1705235:Detector [Manufactured Object]

Phrase: "connected to an Apple IIc computer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0003625:Apple [Plant]
   753   C0009622:Computer [Manufactured Object]
   753   C0475653:APPLE [Food]
   753   C1095830:Apple [Food]
   753   C3257517:apple [Pharmacologic Substance]
   719   C2986575:Connect [Activity]

Phrase: "(Apple Computer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0009622:Computer [Manufactured Object]

Phrase: "Cupertino,"

Phrase: "CA)."
Processing 00000000.tx.117: The major component in the eluates (retention time, 52 min; see Fig. 8) was collected and freeze-dried. 

Phrase: "The major component in the eluates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449432:Component [Manufactured Object]
   753   C1705248:Component [Conceptual Entity]

Phrase: "(retention time,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0035280:Retention [Mental Process]
   861   C0040223:Time [Temporal Concept]
   861   C0333117:Retention [Functional Concept]
   861   C1753315:retention [Cell Function]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "52 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: ";"

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "was"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "freeze-dried."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0016698:freeze-dried [Laboratory Procedure]
   861   C0016701:Freeze [Natural Phenomenon or Process]
   861   C1512080:Dried [Qualitative Concept]
   861   C2827485:Dried [Body Substance]
   827 E C0011682:Dry [Natural Phenomenon or Process]
   827 E C0205222:Dry [Qualitative Concept]
Processing 00000000.tx.118: View larger version (22K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(22K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.119: 8. 

Phrase: "8."
Processing 00000000.tx.120: Covalent binding of [125I]Tyr12-miniglucagon to the 170-kDa endosomal protein. 

Phrase: "Covalent binding of [125I"

Phrase: "]Tyr12-miniglucagon to the 170-kDa endosomal protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0082712:miniglucagon [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.121: A, Tyr12-miniglucagon was iodinated using the lactoperoxidase method. 

Phrase: "A,"

Phrase: "Tyr12-miniglucagon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0082712:miniglucagon [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "iodinated"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the lactoperoxidase method."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.122: The iodinated peptide was purified by RP-HPLC using a linear gradient of 050% acetonitrile. 

Phrase: "The iodinated peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "purified by RP-HPLC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0205390:Phase [Temporal Concept]
   760   C1998793:Purified [Functional Concept]
   726   C1555029:Reverse [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a linear gradient of 050% acetonitrile."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439182:% gradient [Quantitative Concept]
   753   C0812409:Gradient [Quantitative Concept]
Processing 00000000.tx.123: Under this condition, a major [125I]Tyr12-miniglucagon peptide was eluted with a retention time of 52 min. 

Phrase: "Under this condition,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0012634:condition [Disease or Syndrome]
  1000   C0348080:Condition [Qualitative Concept]
  1000   C1705253:Condition [Conceptual Entity]
   928 E C0009647:Conditioned [Mental Process]
   928 E C1701901:Conditional [Qualitative Concept]
   928 E C1963686:Conditional [Functional Concept]
   900 E C1519605:Conditionality [Conceptual Entity]

Phrase: "a major"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205164:Major [Qualitative Concept]

Phrase: "[125I"

Phrase: "]Tyr12-miniglucagon peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "eluted with a retention time of 52 min."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0035280:Retention [Mental Process]
   744   C0040223:Time [Temporal Concept]
   744   C0333117:Retention [Functional Concept]
   744   C0702093:/min [Temporal Concept]
   744   C1753315:retention [Cell Function]
   744   C3541383:Time [Temporal Concept]
Processing 00000000.tx.124: The dashed line indicates the position of native Tyr12-miniglucagon (42 min). 

Phrase: "The dashed line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "indicates"

Phrase: "the position of native Tyr12-miniglucagon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0733755:Position [Spatial Concept]

Phrase: "(42 min)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.125: B, [125I]Tyr12-miniglucagon (106 cpm) was cross-linked to proteins from the EN (0.4 mg/ml) using 50 mM EDC at pH 7 in the absence or presence of 10-5 M Tyr12-miniglucagon. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "[125I"

Phrase: "]Tyr12-miniglucagon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0082712:miniglucagon [Amino Acid, Peptide, or Protein]

Phrase: "(106 cpm)"

Phrase: "was"

Phrase: "cross-linked to proteins"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0178576:Cross Linked [Natural Phenomenon or Process]
   833   C0332220:cross linked [Functional Concept]
   802   C0065011:linked protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C2828360:Cross [Conceptual Entity]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "from the EN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "(0.4 mg/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439269:mg% [Quantitative Concept]
   827   C1960952:mg % [Quantitative Concept]
   827   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "50 mM EDC at pH 7"

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "presence of 10-5 M Tyr12-miniglucagon."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.126: The fractions were then subjected to SDS-PAGE in an 8% acrylamide resolving gel. 

Phrase: "The fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "subjected to SDS-PAGE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "in an 8% acrylamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0050587:Acrylamide [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "resolving"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514893:resolving [Idea or Concept]
   966 E C2699488:Resolve [Conceptual Entity]

Phrase: "gel."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017243:Gel [Biomedical or Dental Material]
  1000   C1382104:Gel [Substance]
Processing 00000000.tx.127: Molecular mass markers are indicated to the left of the panel. 

Phrase: "Molecular mass markers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0005516:molecular markers [Clinical Attribute]
           Marker
   734   C3152252:Molecular Mass [Quantitative Concept]

Phrase: "are"

Phrase: "indicated to the left of the panel."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0205091:Left [Spatial Concept]
   748   C0441833:Panel [Idea or Concept]
   748   C1444656:Indicated [Finding]
   748   C1552822:left [Functional Concept]
   748   C1999270:Panel [Intellectual Product]
   748   C3537156:Panel [Manufactured Object]
Processing 00000000.tx.128: The arrow indicates the mobility of the radioactive cross-linked complex (170 kDa).  

Phrase: "The arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: "indicates"

Phrase: "the mobility of the radioactive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0425245:Mobility [Finding]
   760   C0449580:Mobility [Qualitative Concept]

Phrase: "cross-linked"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178576:Cross Linked [Natural Phenomenon or Process]
  1000   C0332220:cross linked [Functional Concept]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(170 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.129: Cross-linking studies Affinity labeling of glucagon receptor by radiolabeled glucagon was performed as described by Authier et al. 

Phrase: "Cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "Affinity labeling of glucagon receptor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0178463:affinity labeling [Laboratory or Test Result]
   760   C1167624:Labeling [Mental Process]
   760   C1947902:Labeling [Manufactured Object]
   760   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "by radiolabeled glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   861   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "described by Authier et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1552738:described [Idea or Concept]
Processing 00000000.tx.130: (27) with 1,4-difluoro-2,5-dinitrobenzene (DFDNB) (final concentration, 2 mM) as cross-linker. 

Phrase: "(27"

Phrase: ")"

Phrase: "with 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "4-difluoro-2,"

Phrase: "5-dinitrobenzene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012459:Dinitrobenzene [Organic Chemical]

Phrase: "(DFDNB"

Phrase: ")"

Phrase: "(final concentration,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "2 mM)"

Phrase: "as"

Phrase: "cross-linker."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2828360:Cross [Conceptual Entity]
Processing 00000000.tx.131: Affinity labeling of endosomal neutral glucagonase activity was performed using EDC as cross-linker. 

Phrase: "Affinity labeling of endosomal neutral glucagonase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0178463:affinity labeling [Laboratory or Test Result]
   774   C2827499:Labeling Activity [Governmental or Regulatory Activity]
           Labeling
   748   C1167624:Labeling [Mental Process]
   748   C1947902:Labeling [Manufactured Object]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "EDC as cross-linker."
Processing 00000000.tx.132: The EN (80 g protein) was incubated in a final volume of 200 l of 30 mM sodium phosphate buffer (pH 7), with 105106 cpm of [125I]iodoglucagon or [125I]Tyr12-miniglucagon in the presence or absence of hormones, nucleotides, and protease inhibitors. 

Phrase: "The EN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "(80 g protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "incubated in a final volume of 200 l of 30 mM sodium phosphate buffer"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   763   C3256935:sodium phosphate buffer [Pharmacologic Substance]
   748   C0074757:sodium phosphate [Inorganic Chemical,Pharmacologic Substance]
   748   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   734   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   734   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   734   C0031701:phosphate [Organophosphorus Compound]
   734   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   734   C0205088:Final [Temporal Concept]
   734   C0449468:*Volume [Quantitative Concept]
   734   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   734   C1439852:Incubated [Laboratory Procedure]
   734   C1546485:Final [Idea or Concept]
   734   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   734   C1690016:% volume [Qualitative Concept]
   734   C1705102:Volume [Intellectual Product]
   734   C2700258:Volume [Laboratory Procedure]

Phrase: "(pH 7"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:pH 7 [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "with 105106 cpm of [125I"

Phrase: "]iodoglucagon or [125I"

Phrase: "]Tyr12-miniglucagon in the presence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0082712:miniglucagon [Amino Acid, Peptide, or Protein]

Phrase: "or"

Phrase: "absence of hormones,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   841   C0520972:Hormone absence [Laboratory or Test Result]
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "nucleotides,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "protease inhibitors."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   966 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1947941:Protease [Enzyme]
   827 E C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.133: After 30 min at 21 C, cross-linking was initiated by the addition of EDC to a final concentration of 1050 mM and allowed to proceed for 30 min at 21 C. 

Phrase: "After 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at 21 C,"

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "was"

Phrase: "initiated by the addition of EDC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1883712:Addition [Functional Concept]
   719   C1548602:Initiate [Idea or Concept]
   719   C1704686:Initiate [Functional Concept]

Phrase: "to a final concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 1050 mM"

Phrase: "and"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "proceed for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0456693:/30 min [Temporal Concept]
   833   C1442458:30 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]

Phrase: "at 21 C."
Processing 00000000.tx.134: The cross-linking reaction was terminated by adding 2 l of 1 M Tris-HCl (pH 7.4). 

Phrase: "The"

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "terminated by adding 2 l"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0947272:Add 2 [Quantitative Concept]
   760   C1553404:terminated [Idea or Concept]
   760   C2348570:Terminated [Functional Concept]
   726   C1883712:Add [Functional Concept]

Phrase: "of 1 M Tris-HCl (pH 7.4"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   877   C3541329:1-7 [Gene or Genome]
   861   C0950275:M 7 [Organic Chemical,Pharmacologic Substance]
   829   C2678549:PH-4 [Gene or Genome]
   818   C1882074:pH 7 [Qualitative Concept]
   795   C0020283:[pH] [Quantitative Concept]
   795   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   795   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   795   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0441923:M+ [Intellectual Product]
   795   C0450407:ph+ [Finding]
   795   C0450408:ph++ [Finding]
   795   C0450409:ph+++ [Finding]
   795   C0814229:TRI [Intellectual Product]
   795   C2827734:1+ [Quantitative Concept]
   795   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.135: The samples were heated for 1 min at 100 C in 1% sodium dodecyl sulfate and subjected to SDS-PAGE using an 8% acrylamide resolving gel according to the method of Laemmli (32).  

Phrase: "The samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "heated for 1 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C1301862:Min 1 [Temporal Concept]
   770   C0702093:/min [Temporal Concept]
   737   C0018837:Heat [Natural Phenomenon or Process]

Phrase: "at 100 C in 1% sodium dodecyl sulfate"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   845   C0037506:Sodium Dodecyl Sulfate [Biomedical or Dental Material,Lipid,Pharmacologic Substance]
   829   C0074769:Sodium sulphate [Inorganic Chemical,Pharmacologic Substance]
   818   C0058632:dodecyl sulfate [Lipid,Pharmacologic Substance]
   795   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   795   C0038720:Sulfate [Inorganic Chemical]
   795   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
   795   C0597484:Sodium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   795   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "subjected to SDS-PAGE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an 8% acrylamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0050587:Acrylamide [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "resolving"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514893:resolving [Idea or Concept]
   966 E C2699488:Resolve [Conceptual Entity]

Phrase: "gel according to the method of Laemmli"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C1382104:Gel [Substance]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.136: Results Top Abstract Introduction Materials and Methods Results Discussion References  Catalytic properties of endosomal neutral glucagonase activity Figure 1 shows the RP-HPLC elution profiles, measured by absorbance at 214 nm, of native glucagon peptide (A, HPLC profile A), and a mixture of glucagon and EN incubated for 60 min at pH 7 (A, HPLC profile B). 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Catalytic properties of endosomal neutral glucagonase activity Figure 1"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C1264638:Catalytic activity property [Functional Concept]
   742   C0871161:properties [Qualitative Concept]
   742   C1292721:properties [Functional Concept]
   708 E C1882134:Property [Conceptual Entity]
   708 E C2347695:Property [Entity]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the RP-HPLC elution profiles,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C1979963:Profile [Laboratory Procedure]
   771   C2003903:Profile [Functional Concept]

Phrase: "measured by absorbance"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0444706:Measured [Qualitative Concept]
   790   C1268822:Absorbance [Clinical Attribute]
   790   C2825050:Absorbance [Phenomenon or Process]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "at 214 nm,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "of native glucagon peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "(A,"

Phrase: "HPLC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008562:HPLC [Laboratory Procedure]

Phrase: "profile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1979963:Profile [Laboratory Procedure]
  1000   C2003903:Profile [Functional Concept]

Phrase: "A"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "a mixture of glucagon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439962:Mixture [Substance]

Phrase: "and"

Phrase: "EN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "incubated for 60 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0702093:/min [Temporal Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at pH 7"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:pH 7 [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "(A,"

Phrase: "HPLC profile B"

Phrase: ")."
Processing 00000000.tx.137: Major intermediate peptide peaks were observed in addition to the undegraded glucagon peptide (peak 10), which had decreased in peak height (Fig. 1A, HPLC profile B). 

Phrase: "Major intermediate peptide peaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0444505:peaks [Quantitative Concept]

Phrase: "were"

Phrase: "observed in addition to the undegraded glucagon peptide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   744   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   744   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1441672:Observed [Functional Concept]
   744   C1883712:Addition [Functional Concept]

Phrase: "(peak 10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "had"

Phrase: "decreased in peak height"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   870   C0424641:Decrease in height [Finding]
       E   height decrease
   819   C2732728:Decreased height [Finding]
   770   C0205216:Decreased [Quantitative Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   770   C0444505:Peak [Quantitative Concept]
   770   C0489786:Height [Organism Attribute]
   737 E C0547047:Decrease [Quantitative Concept]

Phrase: "(Fig. 1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "HPLC profile B"

Phrase: ")."
Processing 00000000.tx.138: View larger version (25K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(25K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.139: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.140: Processing of glucagon at neutral pH by hepatic endosomes. 

Phrase: "Processing of glucagon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1709694:Processing [Activity]

Phrase: "at neutral pH"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:Neutral pH [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "by hepatic endosomes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034850:Endosomes [Cell Component]
Processing 00000000.tx.141: A, Shown are representative RP-HPLC profiles resulting from the incubation of native glucagon (1 M) with EN (1 g) at 37 C for 60 min in 50 mM citrate-phosphate buffer (pH 7), in the absence (HPLC profile B) or presence of 1 mM PMSF (HPLC profile C) or 50 g/ml bacitracin (HPLC profile D). 

Phrase: "A,"

Phrase: "Shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "representative RP-HPLC profiles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C1979963:Profile [Laboratory Procedure]
   771   C2003903:Profile [Functional Concept]

Phrase: "resulting from the incubation of native glucagon"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   748   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   748   C0302891:Native [Functional Concept]
   748   C0678226:resulting [Functional Concept]
   748   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   714 E C1274040:Result [Functional Concept]
   714 E C1546471:Result [Idea or Concept]
   714 E C2825142:Result [Finding]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "M) with EN"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0034850:Endosomes [Cell Component]
   790   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   790   C0441923:M+ [Intellectual Product]

Phrase: "(1 g) at 37 C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0720544:G-1 [Organic Chemical,Pharmacologic Substance]
   760   C0439267:g% [Quantitative Concept]

Phrase: "for 60 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "in 50 mM citrate-phosphate buffer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C3256468:citrate buffer [Pharmacologic Substance]
   840   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   804   C0031701:phosphate [Organophosphorus Compound]
   804   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "(pH 7"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:pH 7 [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "(HPLC profile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1979963:Profile [Laboratory Procedure]
   861   C2003903:Profile [Functional Concept]

Phrase: "B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "or"

Phrase: "presence of 1 mM PMSF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(HPLC profile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1979963:Profile [Laboratory Procedure]
   861   C2003903:Profile [Functional Concept]

Phrase: "C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "or"

Phrase: "50 g/ml bacitracin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   756 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "(HPLC profile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1979963:Profile [Laboratory Procedure]
   861   C2003903:Profile [Functional Concept]

Phrase: "D)."
Processing 00000000.tx.142: All panels show absorbance profiles at 214 nm. 

Phrase: "All panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "absorbance profiles at 214 nm."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1979963:Profile [Laboratory Procedure]
   726   C2003903:Profile [Functional Concept]
Processing 00000000.tx.143: Intact glucagon (G) had an elution time of 51 min (HPLC profile A). 

Phrase: "Intact glucagon (G)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   861   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "had"

Phrase: "an elution time of 51 min (HPLC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0040223:Time [Temporal Concept]
   748   C3541383:Time [Temporal Concept]

Phrase: "profile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1979963:Profile [Laboratory Procedure]
  1000   C2003903:Profile [Functional Concept]

Phrase: "A"

Phrase: ")."
Processing 00000000.tx.144: The endosomal proteins alone did not give any detectable peak (results not shown). 

Phrase: "The endosomal proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "any detectable peak"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.145: Asterisks in HPLC profile C indicate absorbance peaks resulting from the presence of protease inhibitor in the incubation medium. 

Phrase: "Asterisks in HPLC profile C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2945706:asterisks [Conceptual Entity]

Phrase: "indicate"

Phrase: "absorbance peaks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:peaks [Quantitative Concept]

Phrase: "resulting from the presence of protease inhibitor"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   778   C0033607:Protease Inhibitor [Biologically Active Substance,Pharmacologic Substance]
   778   C3536890:Protease Inhibitor [Pharmacologic Substance]
   748   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C0678226:resulting [Functional Concept]
   748   C1947941:Protease [Enzyme]
   748   C1999216:Inhibitor [Qualitative Concept]
   714 E C1274040:Result [Functional Concept]
   714 E C1546471:Result [Idea or Concept]
   714 E C2825142:Result [Finding]

Phrase: "in the incubation medium."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]
Processing 00000000.tx.146: B, EN (1 g) was incubated with 1 M native glucagon at 37 C for 60 min in 50 mM citrate-phosphate buffer (pH 7), in the absence or presence of 1 mM PMSF, 1 mM EDTA, 1 mM 1,10-phenanthroline, 5 mM EGTA, 0.1 M E64, 1% Me2SO (DMSO), 5 g/ml pepstatin-A, or 50 g/ml bacitracin. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "EN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "(1 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "was"

Phrase: "incubated with 1 M native glucagon"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   753   C0302891:Native [Functional Concept]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   753   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 37 C"

Phrase: "for 60 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "in 50 mM citrate-phosphate buffer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   853   C3256468:citrate buffer [Pharmacologic Substance]
   840   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   804   C0031701:phosphate [Organophosphorus Compound]
   804   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "(pH 7"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:pH 7 [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "presence of 1 mM PMSF,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "1 mM EDTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "1 mM 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]

Phrase: "10-phenanthroline,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031370:phenanthroline [Organic Chemical]

Phrase: "5 mM EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "0.1 M E64,"

Phrase: "1% Me2SO"

Phrase: "(DMSO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012403:DMSO [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "5 g/ml pepstatin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "A,"

Phrase: "or"

Phrase: "50 g/ml bacitracin."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   756 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]
Processing 00000000.tx.147: At the end of the incubation, the proteolytic reaction was stopped with acetic acid (15%), and the incubation mixtures were analyzed by RP-HPLC as described in Materials and Methods. 

Phrase: "At the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of the incubation,"

Phrase: "the proteolytic reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "stopped with acetic acid"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   833   C0000985:Acetic acid [Organic Chemical]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]
   770   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   770   C1272691:stopped [Qualitative Concept]
   737 E C1947925:Stop [Activity]
   737 E C2746065:Stop [Temporal Concept]
   715 E C0148405:Vinegar [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "(15%"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the incubation mixtures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:mixtures [Substance]

Phrase: "were"

Phrase: "analyzed by RP-HPLC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0205390:Phase [Temporal Concept]
   760   C0936012:Analyzed [Research Activity]
   726   C1555029:Reverse [Idea or Concept]

Phrase: "as"

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.148: The rate of glucagon proteolysis was determined by following the disappearance of the peak area corresponding to the parent peptide. 

Phrase: "The rate of glucagon proteolysis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "determined by"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the disappearance of the peak area"

Phrase: "corresponding to the parent peptide."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030551:parent [Family Group]
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   760   C2699423:Parent [Conceptual Entity]
Processing 00000000.tx.149: The results are expressed as glucagon degraded (percentage of control) and normalized to that seen in the absence of added compound. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "expressed as glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   790   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "(percentage of control"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0439165:Percentage [Quantitative Concept]
   790   C1549488:Percentage [Idea or Concept]
   790   C1561533:Percentage [Idea or Concept]

Phrase: ")"

Phrase: "and"

Phrase: "normalized to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1882115:Normalized [Research Activity]

Phrase: "seen in the absence of added compound."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   748   C0205198:Compound [Qualitative Concept]
   748   C0205397:Seen [Qualitative Concept]
   748   C0332197:absence [Quantitative Concept]
   748   C1524062:Added [Functional Concept]
   748   C1689985:Absence [Anatomical Abnormality]
   748   C1706082:Compound [Chemical]
   714 E C0042789:see [Organism Function]
   714 E C1883712:Add [Functional Concept]
   714 E C1947903:See [Activity]
Processing 00000000.tx.150: The results are the mean  SD of three to five different experiments performed on ENs prepared from separate liver fractionations.  

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "the mean  SD of three to five different experiments"

Phrase: "performed on ENs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0884358:Performed [Functional Concept]
   790   C1417023:ENS [Gene or Genome]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "prepared from separate liver fractionations."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   760   C0023884:Liver [Body Part, Organ, or Organ Component]
   760   C0443299:Separate [Spatial Concept]
   760   C0736268:LIVER [Body Part, Organ, or Organ Component]
   760   C1278929:Liver [Body Part, Organ, or Organ Component]
   760   C2346688:LIVER [Food]
   726   C0016640:fractionation [Laboratory Procedure]
   726   C0524811:fractionation [Therapeutic or Preventive Procedure]
   726   C1521827:Prepare [Functional Concept]
   726   C3161031:Fractionation [Therapeutic or Preventive Procedure]
   704 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.151: We evaluated the effect of various protease inhibitors on the neutral glucagon-degrading activity contained in hepatic endosomes (Fig. 1, A, HPLC profiles C and D, and B). 

Phrase: "We"

Phrase: "evaluated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluated [Functional Concept]

Phrase: "the effect of various protease inhibitors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on the neutral glucagon-degrading activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "contained in hepatic endosomes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0034850:Endosomes [Cell Component]
   770   C0205054:Hepatic [Body Location or Region]
   770   C0332256:contained [Functional Concept]
   770   C2700400:Contained [Activity]

Phrase: "(Fig. 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A,"

Phrase: "HPLC profiles C"

Phrase: "and"

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.152: The glucagonase activity was strongly inhibited (>88%) by the serine protease inhibitor PMSF (HPLC profile C) and the peptide antibiotic bacitracin (HPLC profile D). 

Phrase: "The glucagonase activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "strongly"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "("

Phrase: ">88%"

Phrase: ")"

Phrase: "by the serine protease inhibitor PMSF"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   804   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]
   717   C0036733:Serine protease inhibitor [Biologically Active Substance,Pharmacologic Substance]

Phrase: "(HPLC profile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1979963:Profile [Laboratory Procedure]
   861   C2003903:Profile [Functional Concept]

Phrase: "C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "the peptide antibiotic bacitracin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   771 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "(HPLC profile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1979963:Profile [Laboratory Procedure]
   861   C2003903:Profile [Functional Concept]

Phrase: "D)."
Processing 00000000.tx.153: Metal-chelating agents such as EDTA, 1,10-phenanthroline, and EGTA had no significant effect. 

Phrase: "Metal-chelating agents such as EDTA,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   816   C3537172:Metal Chelating Agent [Pharmacologic Substance]
   790   C0007974:Chelating Agents [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C3537131:Chelating [Molecular Function]
   719   C0450442:Agent [Chemical Viewed Functionally]
   719   C1254351:Agent [Pharmacologic Substance]
   719   C1521826:Agent [Intellectual Product]

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "10-phenanthroline,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031370:phenanthroline [Organic Chemical]

Phrase: "and"

Phrase: "EGTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "had"

Phrase: "no significant effect."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.154: Hepatic endosomes were next assessed for their ability to degrade native glucagon peptide in vitro at acidic (pH 4 and 5) and neutral pH (pH 7) (Fig. 2A). 

Phrase: "Hepatic endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034850:Endosomes [Cell Component]

Phrase: "were"

Phrase: "next"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "assessed for their ability to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0085732:Ability [Organism Attribute]
   760   C1516048:Assessed [Activity]

Phrase: "degrade"

Phrase: "native glucagon peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "in vitro at acidic"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0021135:In Vitro [Intellectual Product]
   833   C1533691:in vitro [Qualitative Concept]
           vitro
   833   C2827718:In Vitro [Functional Concept]

Phrase: "(pH 4"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2678549:PH-4 [Gene or Genome]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "neutral pH (pH 7"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   875   C1882074:pH 7 [Qualitative Concept]
           Neutral pH
           Neutral
   812   C0020283:[pH] [Quantitative Concept]
   812   C0450407:ph+ [Finding]
   812   C0450408:ph++ [Finding]
   812   C0450409:ph+++ [Finding]
   812   C2825492:Neutral [Phenomenon or Process]

Phrase: ")"

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.155: Degradation of glucagon was pH dependent with maximal degradation obtained at pH 4. 

Phrase: "Degradation of glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0243125:degradation [Functional Concept]
   790   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "pH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0020283:[pH] [Quantitative Concept]
  1000   C0450407:ph+ [Finding]
  1000   C0450408:ph++ [Finding]
  1000   C0450409:ph+++ [Finding]

Phrase: "dependent with maximal degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0851827:Dependent [Qualitative Concept]
   770   C1701901:Dependent [Qualitative Concept]
   770   C3244310:dependent [Functional Concept]

Phrase: "obtained at pH 4."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C2678549:PH-4 [Gene or Genome]
   773   C0221106:increase ph [Disease or Syndrome]
   770   C0020283:[pH] [Quantitative Concept]
   770   C0450407:ph+ [Finding]
   770   C0450408:ph++ [Finding]
   770   C0450409:ph+++ [Finding]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]
Processing 00000000.tx.156: However, a significant rate of hydrolysis of glucagon at pH 7 was observed and suggested the involvement of a specific endosomal neutral glucagonase activity (Fig. 2A). 

Phrase: "However,"

Phrase: "a significant rate of hydrolysis of glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0871208:Rate [Activity]
   748   C1521828:Rate [Quantitative Concept]

Phrase: "at pH 7"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:pH 7 [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the involvement of a specific endosomal neutral glucagonase activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1314939:Involvement [Functional Concept]

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.157: View larger version (39K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(39K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.158: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.159: Assessment of endosomal neutral glucagonase activity. 

Phrase: "Assessment of endosomal neutral glucagonase activity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1261322:Assessment [Health Care Activity]
   753   C1516048:Assessment [Activity]
Processing 00000000.tx.160: A, EN was incubated with 10-6 M glucagon for the indicated times at 37 C and pH 7, 5, or 4. 

Phrase: "A,"

Phrase: "EN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "was"

Phrase: "incubated with 10-6 M glucagon"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0439187:/10^6 [Quantitative Concept]
   790   C1881839:10^6 [Quantitative Concept]
   753   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   753   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "for the indicated times"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:times [Temporal Concept]
   861   C1632851:Times [Quantitative Concept]
   827 E C3541383:Time [Temporal Concept]
   789 E C0442043:Temporal [Spatial Concept]
   789 E C2362314:Temporal [Temporal Concept]

Phrase: "at 37 C"

Phrase: "and"

Phrase: "pH 7,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:pH 7 [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "or"

Phrase: "4."
Processing 00000000.tx.161: The proteolytic reaction was stopped with acetic acid (15%), and the incubation mixtures were analyzed by RP-HPLC. 

Phrase: "The proteolytic reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "stopped with acetic acid"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0000983:Acetic Acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   833   C0000985:Acetic acid [Organic Chemical]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]
   770   C0981805:ACETIC [Organic Chemical,Pharmacologic Substance]
   770   C1272691:stopped [Qualitative Concept]
   737 E C1947925:Stop [Activity]
   737 E C2746065:Stop [Temporal Concept]
   715 E C0148405:Vinegar [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: "(15%"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the incubation mixtures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439962:mixtures [Substance]

Phrase: "were"

Phrase: "analyzed by RP-HPLC."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0008562:HPLC [Laboratory Procedure]
   760   C0205390:Phase [Temporal Concept]
   760   C0936012:Analyzed [Research Activity]
   726   C1555029:Reverse [Idea or Concept]
Processing 00000000.tx.162: Results are expressed as the amount of peptide degraded (percentage of control) at the end of incubation. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "expressed as the amount of peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   753   C1265611:Amount [Quantitative Concept]

Phrase: "degraded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "(percentage of control"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0439165:Percentage [Quantitative Concept]
   790   C1549488:Percentage [Idea or Concept]
   790   C1561533:Percentage [Idea or Concept]

Phrase: ")"

Phrase: "at the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of incubation."
Processing 00000000.tx.163: Results are the mean of two (pH 4 and 5) and seven (pH 7) different experiments performed on ENs prepared from separate liver fractionations. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "the mean of two"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0444504:Mean [Quantitative Concept]
   770   C2347634:Mean [Quantitative Concept]
   770   C2348143:Mean [Quantitative Concept]

Phrase: "(pH 4"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2678549:PH-4 [Gene or Genome]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "seven"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205453:Seven [Quantitative Concept]

Phrase: "(pH 7"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:pH 7 [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "different experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "performed on ENs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0884358:Performed [Functional Concept]
   790   C1417023:ENS [Gene or Genome]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "prepared from separate liver fractionations."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   760   C0023884:Liver [Body Part, Organ, or Organ Component]
   760   C0443299:Separate [Spatial Concept]
   760   C0736268:LIVER [Body Part, Organ, or Organ Component]
   760   C1278929:Liver [Body Part, Organ, or Organ Component]
   760   C2346688:LIVER [Food]
   726   C0016640:fractionation [Laboratory Procedure]
   726   C0524811:fractionation [Therapeutic or Preventive Procedure]
   726   C1521827:Prepare [Functional Concept]
   726   C3161031:Fractionation [Therapeutic or Preventive Procedure]
   704 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.164: B, EN was immunodepleted of active IDE (anti-IDE), cathepsin B (anti-CB), cathepsin D (anti-CD), or furin (anti-Furin) using monoclonal (IDE) or polyclonal antibodies (CB, CD, and furin) coated to protein G-Sepharose beads. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "EN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "was"

Phrase: "immunodepleted of active IDE (anti-IDE),"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   753   C0014442:Enzyme [Enzyme,Organic Chemical]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0205177:Active [Functional Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "cathepsin B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0699919:Cathepsin B [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332804:CATHEPSIN B [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(anti-CB"

Phrase: ")"

Phrase: ","

Phrase: "cathepsin D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(anti-CD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   913   C0140430:Anti D [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1332805:CATHEPSIN D [Gene or Genome]
   827   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: ","

Phrase: "or"

Phrase: "furin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0919550:FURIN [Gene or Genome]

Phrase: "(anti-Furin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0919550:FURIN [Gene or Genome]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "monoclonal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0746619:monoclonal [Finding]

Phrase: "(IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "or"

Phrase: "polyclonal antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(CB,"

Phrase: "CD,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "furin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0919550:FURIN [Gene or Genome]

Phrase: ")"

Phrase: "coated to protein G-Sepharose beads."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   767   C1423498:coat-protein [Gene or Genome]
   753   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   753   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0036681:Sepharose [Carbohydrate]
   753   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0991566:Beads [Biomedical or Dental Material]
   753   C1522408:Coated [Qualitative Concept]
   719 E C0453946:Coat [Manufactured Object]
   719 E C2346972:Bead [Spatial Concept]
   719 E C2987482:Coat [Body Part, Organ, or Organ Component]
Processing 00000000.tx.165: After centrifugation, the resultant immunodepleted supernatants were tested for their ability to degrade native glucagon at pH 7 and 4 using RP-HPLC. 

Phrase: "After centrifugation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "the resultant immunodepleted supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "tested for their ability to"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   781   C0003647:ability test [Diagnostic Procedure]
   760   C0085732:Ability [Organism Attribute]
   760   C0392366:tested [Intellectual Product]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0039593:Test [Functional Concept]

Phrase: "degrade"

Phrase: "native glucagon at pH 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   760   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "4"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "RP-HPLC."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0008562:HPLC [Laboratory Procedure]
Processing 00000000.tx.166: The results were normalized (100%) to that seen in the absence of antibody. 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "were"

Phrase: "normalized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalized [Research Activity]

Phrase: "(100%"

Phrase: ")"

Phrase: "to that"

Phrase: "seen in the absence of antibody."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0205397:Seen [Qualitative Concept]
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]
   719 E C0042789:see [Organism Function]
   719 E C1947903:See [Activity]
Processing 00000000.tx.167: The results are the mean  SD of three different experiments performed on ENs prepared from separate liver fractionations, except for the immunodepletion experiments done at pH 4 with anti-IDE antibody and at pH 7 with anti-CB and -CD antibodies, which are mean  half-variation (n = 2).  

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "the mean  SD of three different experiments"

Phrase: "performed on ENs"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0884358:Performed [Functional Concept]
   790   C1417023:ENS [Gene or Genome]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "prepared from separate liver fractionations,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   760   C0023884:Liver [Body Part, Organ, or Organ Component]
   760   C0443299:Separate [Spatial Concept]
   760   C0736268:LIVER [Body Part, Organ, or Organ Component]
   760   C1278929:Liver [Body Part, Organ, or Organ Component]
   760   C2346688:LIVER [Food]
   726   C0016640:fractionation [Laboratory Procedure]
   726   C0524811:fractionation [Therapeutic or Preventive Procedure]
   726   C1521827:Prepare [Functional Concept]
   726   C3161031:Fractionation [Therapeutic or Preventive Procedure]
   704 E C0205054:Hepatic [Body Location or Region]

Phrase: "except for the immunodepletion experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "done at pH 4"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C2678549:PH-4 [Gene or Genome]
   770   C0020283:[pH] [Quantitative Concept]
   770   C0450407:ph+ [Finding]
   770   C0450408:ph++ [Finding]
   770   C0450409:ph+++ [Finding]
   770   C1272695:Done [Qualitative Concept]
   770   C2746065:Done [Temporal Concept]

Phrase: "with anti-IDE antibody"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   911   C0021644:Anti-insulin antibody [Immunologic Factor]
           Insulin antibody
   897   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   717   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   717   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]

Phrase: "and at pH 7"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1882074:pH 7 [Qualitative Concept]
   770   C0020283:[pH] [Quantitative Concept]
   770   C0450407:ph+ [Finding]
   770   C0450408:ph++ [Finding]
   770   C0450409:ph+++ [Finding]
   770   C1515981:And [Idea or Concept]

Phrase: "with anti-CB"

Phrase: "and -"

Phrase: "CD antibodies,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   734   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1332805:CATHEPSIN D [Gene or Genome]

Phrase: "which"

Phrase: "are"

Phrase: "mean  half-variation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:Variation [Qualitative Concept]

Phrase: "(n = 2)."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.168: Hepatic ENs are known to contain neutral and acidic peptidases such as IDE (10), cathepsin D (8, 21), cathepsin B (8, 22), -site APP cleaving enzyme (21), and furin (34, 35) as well as undefined tripeptidylaminopeptidase activity (8). 

Phrase: "Hepatic ENs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1417023:ENS [Gene or Genome]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "neutral"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1882074:Neutral [Qualitative Concept]
  1000   C2825492:Neutral [Phenomenon or Process]

Phrase: "and"

Phrase: "acidic peptidases such as IDE"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0030940:Peptidases [Amino Acid, Peptide, or Protein,Enzyme]
   714 E C1947941:Peptidase [Enzyme]

Phrase: "(10"

Phrase: ")"

Phrase: ","

Phrase: "cathepsin D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(8,"

Phrase: "21"

Phrase: ")"

Phrase: ","

Phrase: "cathepsin B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0699919:Cathepsin B [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332804:CATHEPSIN B [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(8,"

Phrase: "22"

Phrase: ")"

Phrase: ", -"

Phrase: "site APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538722:APP [Laboratory Procedure]

Phrase: "cleaving"

Phrase: "enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "(21"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "furin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0919550:FURIN [Gene or Genome]

Phrase: "(34,"

Phrase: "35"

Phrase: ")"

Phrase: "as well as"

Phrase: "undefined tripeptidylaminopeptidase activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.169: We therefore used well-characterized antibodies to assess the neutral and acidic endosomal glucagonase activities (Fig. 2B). 

Phrase: "We therefore"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "well-characterized antibodies to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "the neutral"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1882074:Neutral [Qualitative Concept]
  1000   C2825492:Neutral [Phenomenon or Process]

Phrase: "and"

Phrase: "acidic endosomal glucagonase activities"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0441655:Activities [Activity]
   779 E C0205177:Activity [Functional Concept]
   779 E C0439167:% activity [Quantitative Concept]
   779 E C1561536:*Activity [Idea or Concept]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.170: As expected, more than 50% of endosomal acidic glucagonase activity was depleted by anti-cathepsin B or anti-cathepsin D antibodies (8). 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "more than 50% of endosomal acidic glucagonase activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0001128:Acidic [Chemical]
   744   C0205172:More [Functional Concept]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "depleted by anti-cathepsin B"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0699919:Cathepsin B [Amino Acid, Peptide, or Protein,Enzyme]
   806   C1332804:CATHEPSIN B [Gene or Genome]
   797   C0432618:Anti-B [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0333668:Depleted [Functional Concept]

Phrase: "or"

Phrase: "anti-cathepsin D antibodies"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   923   C1304674:Anti-D antibodies [Disease or Syndrome]
   912 E C0140430:anti-d antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Anti D
   902   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   886 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.171: However, immunoprecipitation with antibodies to cathepsin B, cathepsin D, IDE, or furin failed to remove the glucagonase activity observed at pH 7 (Fig. 2B). 

Phrase: "However,"

Phrase: "immunoprecipitation with antibodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "to cathepsin B,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0699919:Cathepsin B [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332804:CATHEPSIN B [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "cathepsin D,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "IDE,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "or"

Phrase: "furin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0919550:FURIN [Gene or Genome]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "the glucagonase activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "observed at pH 7"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1882074:pH 7 [Qualitative Concept]
   770   C0020283:[pH] [Quantitative Concept]
   770   C0450407:ph+ [Finding]
   770   C0450408:ph++ [Finding]
   770   C0450409:ph+++ [Finding]
   770   C1441672:Observed [Functional Concept]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")."
Processing 00000000.tx.172: Sites of cleavage of endosomal glucagon intermediates generated at neutral pH Each of the major RP-HPLC peaks (see Fig. 1A, HPLC profile B) was analyzed using mass spectrometry to determine the molecular mass of peptide products (Table 1). 

Phrase: "Sites of cleavage of endosomal glucagon intermediates"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   762   C2945843:Site of [Qualitative Concept]
   748   C0205145:Sites [Spatial Concept]
   714 E C1515974:Site [Body Location or Region]
   714 E C2825164:Site [Spatial Concept]

Phrase: "generated at neutral pH"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C1882074:Neutral pH [Qualitative Concept]
           Neutral
   770   C0020283:[pH] [Quantitative Concept]
   770   C0450407:ph+ [Finding]
   770   C0450408:ph++ [Finding]
   770   C0450409:ph+++ [Finding]
   770   C2825492:Neutral [Phenomenon or Process]
   770   C3146294:Generated [Activity]

Phrase: "Each of the major RP-HPLC peaks"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0008562:HPLC [Laboratory Procedure]
   744   C0205164:Major [Qualitative Concept]
   744   C0205390:Phase [Temporal Concept]
   744   C0444505:peaks [Quantitative Concept]
   744   C1457900:Each [Quantitative Concept]
   711   C1555029:Reverse [Idea or Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "HPLC profile"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1979963:Profile [Laboratory Procedure]
   861   C2003903:Profile [Functional Concept]

Phrase: "B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "was"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "mass spectrometry to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0037813:Mass Spectrometry [Laboratory Procedure]
   827   C0436196:Spectrometry [Laboratory Procedure]
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]
   827   C3152252:Mass [Quantitative Concept]

Phrase: "determine"

Phrase: "the molecular mass of peptide products"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   753   C0577559:Mass [Finding]
   753   C1306372:*Mass [Quantitative Concept]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.173: Glucagon was cleaved at its N terminus at Ser2-Gln3, Gln3-Gly4, and Gly4-Thr5 bonds, and C terminus at Trp25-Leu26 and Leu26-Met27 bonds, thereby releasing the C-terminal peptides Gln3-Thr29 (peak 10), Gly4-Thr29 (product 9b), and Thr5-Thr29 (product 9c), and the N-terminal peptide His1-Trp25 (product 4a). 

Phrase: "Glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "was"

Phrase: "cleaved at its N terminus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205242:Cleaved [Spatial Concept]
   760   C0333853:Cleaved [Cell]
   760   C0521447:Nuclear [Spatial Concept]

Phrase: "at Ser2-Gln3,"

Phrase: "Gln3-Gly4,"

Phrase: "and"

Phrase: "Gly4-Thr5 bonds,"

Phrase: "and"

Phrase: "C terminus at Trp25-Leu26"

Phrase: "and"

Phrase: "Leu26-Met27 bonds,"

Phrase: "thereby"

Phrase: "releasing"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C1283071:Releasing [Functional Concept]
   966 E C0030685:Release [Health Care Activity]
   966 E C0391871:Release [Functional Concept]
   966 E C0439180:% release [Quantitative Concept]
   966 E C0680255:release [Health Care Activity]
   966 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "the C-terminal peptides Gln3-Thr29"

Phrase: "(peak 10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "Gly4-Thr29"

Phrase: "(product 9b"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "Thr5-Thr29"

Phrase: "(product 9c"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the N-terminal peptide His1-Trp25"

Phrase: "(product 4a"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.174: Products 4b (Gln3-Trp25) and 6 (Gln3-Leu26) correspond to the above peptide products cleaved at both the N- and C-terminal regions. 

Phrase: "Products 4b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: "(Gln3-Trp25"

Phrase: ")"

Phrase: "and"

Phrase: "6"

Phrase: "(Gln3-Leu26"

Phrase: ")"

Phrase: "correspond to the above peptide products"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   753   C1514468:Products [Entity]
   719 E C1704444:Product [Quantitative Concept]

Phrase: "cleaved at both"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205242:Cleaved [Spatial Concept]
   790   C0333853:Cleaved [Cell]

Phrase: "the N-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521447:Nuclear [Spatial Concept]

Phrase: "and"

Phrase: "C-terminal regions."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C1707271:C-Terminal [Amino Acid Sequence]
   827   C0205088:Terminal [Temporal Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   793   C0017446:Region [Geographic Area]
   793   C0205147:Region [Spatial Concept]
   743 E C0205276:Regional [Spatial Concept]
   743 E C1947913:Regional [Spatial Concept]
Processing 00000000.tx.175: Other products revealed cleavage sites in the central region of glucagon between residues Lys12 and Tyr13, Asp15 and Ser16, Arg17 and Arg18, and Arg18 and Ala19, as evidenced by fragments Tyr13-Arg17 (peak 1), His1-Lys12 (peak 2), His1-Arg18 (product 3a), His1-Arg17 (product 3b), Arg18-Thr29 (peak 7), and Ala19-Thr29 (peak 8) (Table 1). 

Phrase: "Other products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514468:Products [Entity]
   966 E C1704444:Product [Quantitative Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "cleavage sites in the central region of glucagon"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   750   C2827466:Central Site [Professional or Occupational Group]
   750   C2945843:Site of [Qualitative Concept]
   744   C0205145:Sites [Spatial Concept]
   711 E C1515974:Site [Body Location or Region]
   711 E C2825164:Site [Spatial Concept]

Phrase: "between residues Lys12"

Phrase: "and"

Phrase: "Tyr13,"

Phrase: "Asp15"

Phrase: "and"

Phrase: "Ser16,"

Phrase: "Arg17"

Phrase: "and"

Phrase: "Arg18,"

Phrase: "and"

Phrase: "Arg18"

Phrase: "and"

Phrase: "Ala19,"

Phrase: "as"

Phrase: "evidenced by fragments Tyr13-Arg17"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0332255:fragments [Functional Concept]
   760   C0486805:Fragments [Body Substance]
   726   C0332120:Evidence [Functional Concept]
   726 E C1708096:Fragment [Qualitative Concept]

Phrase: "(peak 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "His1-Lys12"

Phrase: "(peak 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "His1-Arg18"

Phrase: "(product 3a"

Phrase: ")"

Phrase: ","

Phrase: "His1-Arg17"

Phrase: "(product 3b"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")"

Phrase: ","

Phrase: "Arg18-Thr29"

Phrase: "(peak 7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "Ala19-Thr29"

Phrase: "(peak 8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444505:Peak [Quantitative Concept]

Phrase: ")"

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.176: View this table: [in this window] [in a new window]  TABLE 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.177: Masses and assigned structures of the cleavage products generated from native glucagon by endosomal neutral glucagonase activity  Identification of MGE as a mitochondrial protein MGE, a neutral thiol-metalloendopeptidase of 100 kDa, has been proposed to process glucagon to its bioactive fragment glucagon-(1929) (15, 16). 

Phrase: "Masses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0577559:Mass [Finding]
   966   C1306372:*Mass [Quantitative Concept]
   966   C3152252:Mass [Quantitative Concept]

Phrase: "and"

Phrase: "assigned structures of the cleavage products"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0678594:structures [Spatial Concept]

Phrase: "generated from native glucagon"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   770   C0302891:Native [Functional Concept]
   770   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C3146294:Generated [Activity]

Phrase: "by endosomal neutral glucagonase activity  Identification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0020792:Identification [Mental Process]
   804   C0205396:Identification [Qualitative Concept]

Phrase: "of MGE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "as a mitochondrial protein MGE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "a neutral thiol-metalloendopeptidase of 100 kDa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1442934:Metalloendopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "has"

Phrase: "been"

Phrase: "proposed to process glucagon"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   770   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1184743:Process [Body Part, Organ, or Organ Component]
   770   C1441414:PROPOSED [Idea or Concept]
   770   C1522240:Process [Phenomenon or Process]
   770   C1553874:Proposed [Qualitative Concept]
   770   C1578820:Proposed [Idea or Concept]

Phrase: "to its bioactive fragment glucagon-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   827   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(1929"

Phrase: ")"

Phrase: "(15,"

Phrase: "16"

Phrase: ")."
Processing 00000000.tx.178: Consequently, we attempted to evaluate the contribution of MGE to the endosomal degradation of glucagon at neutral pH by assessment of the content of MGE in hepatic endosomes using immunoblot analysis (Fig. 3). 

Phrase: "Consequently,"

Phrase: "we"

Phrase: "attempted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1516084:Attempt [Event]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "the contribution of MGE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880177:Contribution [Activity]

Phrase: "to the endosomal degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "of glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "at neutral pH"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:Neutral pH [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "by assessment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1261322:Assessment [Health Care Activity]
  1000   C1516048:Assessment [Activity]

Phrase: "of the content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0423896:Content [Mental Process]
  1000   C0456205:Content [Conceptual Entity]

Phrase: "of MGE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "in hepatic endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034850:Endosomes [Cell Component]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "immunoblot analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.179: Established protocols were followed to isolate from rat liver homogenate (Hm) nuclear (N), large-granule (ML), microsomal (P), and cytosolic (S) fractions (Fig. 3A). 

Phrase: "Established protocols"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0442711:Protocols [Intellectual Product]
   827 E C1507394:Protocol [Intellectual Product]
   827 E C1522729:Protocol [Intellectual Product]
   827 E C2348563:Protocol [Intellectual Product]

Phrase: "were"

Phrase: "followed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332283:followed [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "isolate from rat liver homogenate (Hm)"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   760   C0023884:Liver [Body Part, Organ, or Organ Component]
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C0370215:Isolate [Substance]
   760   C0736268:LIVER [Body Part, Organ, or Organ Component]
   760   C1278929:Liver [Body Part, Organ, or Organ Component]
   760   C1875400:ISOLATE [Pharmacologic Substance]
   760   C2346688:LIVER [Food]
   704 E C0205054:Hepatic [Body Location or Region]

Phrase: "nuclear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521447:Nuclear [Spatial Concept]

Phrase: "(N"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521447:Nuclear [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "large-granule"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0010837:Granule [Cell Component]
   861   C0993609:Granule [Biomedical or Dental Material]
   789 E C0205248:Granular [Qualitative Concept]

Phrase: "(ML"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0521450:Lysosomal [Body Location or Region]
   789 E C0024369:Lysosome [Cell Component]
   789 E C2984253:Lysosome [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "microsomal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1979928:Microsomal [Qualitative Concept]
   928 E C0026029:Microsome [Cell Component]

Phrase: "(P"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "cytosolic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosolic [Cell Component]

Phrase: "("

Phrase: "S)"

Phrase: "fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.180: Equal amounts of protein from these fractions were evaluated for their MGE content using a polyclonal antiserum produced against the N-terminal sequence REARPTTE of rat MGE (16) as described in Materials and Methods. 

Phrase: "Equal amounts of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:amounts [Quantitative Concept]

Phrase: "from these fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "evaluated for their MGE content"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   753   C0082712:miniglucagon [Amino Acid, Peptide, or Protein]
   753   C0220825:Evaluated [Functional Concept]
   753   C0423896:Content [Mental Process]
   753   C0456205:Content [Conceptual Entity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a polyclonal antiserum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "produced against the N-terminal sequence REARPTTE of rat MGE"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   738   C0004793:Sequence [Nucleotide Sequence]
   738   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   738   C0034693:Rat, NOS [Mammal]
   738   C0034721:Rat [Mammal]
   738   C0082712:miniglucagon [Amino Acid, Peptide, or Protein]
   738   C0162326:Sequence [Nucleotide Sequence]
   738   C0162327:Sequence [Nucleotide Sequence]
   738   C0205088:Terminal [Temporal Concept]
   738   C0521447:Nuclear [Spatial Concept]
   738   C1519249:Sequence [Functional Concept]
   738   C1705314:Terminal [Manufactured Object]
   738   C1705315:Terminal [Spatial Concept]

Phrase: "(16"

Phrase: ")"

Phrase: "as"

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.181: The large-granule (ML) fraction contained the highest concentration of antigen (100 kDa), although immunoreactivity was also found in the low-speed nuclear (N) fraction (Fig. 3A). 

Phrase: "The large-granule"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0010837:Granule [Cell Component]
   861   C0993609:Granule [Biomedical or Dental Material]
   789 E C0205248:Granular [Qualitative Concept]

Phrase: "(ML"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0521450:Lysosomal [Body Location or Region]
   789 E C0024369:Lysosome [Cell Component]
   789 E C2984253:Lysosome [Functional Concept]

Phrase: ")"

Phrase: "fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1264633:Fraction [Quantitative Concept]
  1000   C1554103:Fraction [Idea or Concept]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "the highest concentration of antigen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "(100 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "also"

Phrase: "found in the low-"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0150312:Found [Quantitative Concept]
   770   C0205251:low [Qualitative Concept]
   770   C1299352:Low [Qualitative Concept]
   770   C1550472:low [Idea or Concept]
   737 E C0243095:Find [Finding]

Phrase: "speed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678536:Speed [Quantitative Concept]

Phrase: "nuclear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521447:Nuclear [Spatial Concept]

Phrase: "(N"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521447:Nuclear [Spatial Concept]

Phrase: ")"

Phrase: "fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1264633:Fraction [Quantitative Concept]
  1000   C1554103:Fraction [Idea or Concept]

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.182: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.183: 3B, the 100-kDa polypeptide was not observed when the antiserum was preincubated with the antigenic peptide. 

Phrase: "3B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450365:3b [Intellectual Product]
  1000   C1706097:3B [Research Activity]

Phrase: "the 100-kDa polypeptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "when"

Phrase: "the antiserum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "preincubated with the antigenic peptide."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030956:Peptide [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.184: Hence, the 100-kDa polypeptide detected in the ML fraction was not due to nonspecific binding. 

Phrase: "Hence,"

Phrase: "the 100-kDa polypeptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "detected in the ML fraction"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0026237:Mitochondrial [Cell Component]
   753   C0442726:Detected [Finding]
   753   C0521450:Lysosomal [Body Location or Region]
   753   C0521451:Mitochondrial [Functional Concept]
   753   C1264633:Fraction [Quantitative Concept]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "not due to nonspecific binding."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0205370:Non-specific [Qualitative Concept]
   760   C0243122:binding [Functional Concept]
   760   C0750540:Nonspecific [Idea or Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]
   760   C1518422:Not [Functional Concept]
   760   C3146286:Due [Idea or Concept]
Processing 00000000.tx.185: View larger version (9K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(9K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.186: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.187: Assessment of MGE by immunoblot analysis of subcellular fractions isolated from rat liver. 

Phrase: "Assessment of MGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1261322:Assessment [Health Care Activity]
   770   C1516048:Assessment [Activity]

Phrase: "by immunoblot analysis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "of subcellular fractions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0038528:Subcellular Fractions [Cell Component]
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "isolated from rat liver."
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   833   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   770   C0023884:Liver [Body Part, Organ, or Organ Component]
   770   C0034693:Rat, NOS [Mammal]
   770   C0034721:Rat [Mammal]
   770   C0205409:Isolated [Functional Concept]
   770   C0736268:LIVER [Body Part, Organ, or Organ Component]
   770   C1278929:Liver [Body Part, Organ, or Organ Component]
   770   C1548221:Isolated [Idea or Concept]
   770   C2346688:LIVER [Food]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]
   715 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.188: A, Nuclear (N), mitochondrial-lysosomal (ML), microsomal (P), and cytosolic (S) fractions, as well as the isotonic homogenate (Hm) were evaluated by immunoblotting for their content of MGE using polyclonal antiserum made to a synthetic peptide of MGE (CREARPTTE). 

Phrase: "A,"

Phrase: "Nuclear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521447:Nuclear [Spatial Concept]

Phrase: "(N"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521447:Nuclear [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "mitochondrial-lysosomal (ML), microsomal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1979928:Microsomal [Qualitative Concept]
   755 E C0026029:Microsome [Cell Component]

Phrase: "(P"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "cytosolic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosolic [Cell Component]

Phrase: "("

Phrase: "S)"

Phrase: "fractions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "as well as"

Phrase: "the isotonic homogenate"

Phrase: "(Hm"

Phrase: ")"

Phrase: "were"

Phrase: "evaluated by immunoblotting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0220825:Evaluated [Functional Concept]

Phrase: "for their content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0423896:Content [Mental Process]
  1000   C0456205:Content [Conceptual Entity]

Phrase: "of MGE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "polyclonal antiserum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "made to a synthetic peptide of MGE"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   744   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   744   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   744   C0082712:miniglucagon [Amino Acid, Peptide, or Protein]
   744   C1883254:synthetic [Activity]
   711   C1881534:Make [Functional Concept]

Phrase: "("

Phrase: "CREARPTTE"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205088:Terminal [Temporal Concept]
   753   C1705314:Terminal [Manufactured Object]
   753   C1705315:Terminal [Spatial Concept]
   719   C1709915:Residue [Conceptual Entity]
   719   C1882936:RESIDUE [Phenomenon or Process]

Phrase: ")."
Processing 00000000.tx.189: Thirty micrograms of protein were loaded onto each lane. 

Phrase: "Thirty micrograms of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439211:microgram [Quantitative Concept]

Phrase: "were"

Phrase: "loaded onto each lane."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C1708639:Lane [Spatial Concept]
   770   C1708715:Loaded [Activity]
   737 E C1550025:Load [Idea or Concept]
   737 E C1704782:Load [Manufactured Object]
Processing 00000000.tx.190: B, The ML fraction was evaluated by immunoblotting for its content of MGE using the polyclonal anti-MGE peptide antiserum, which had been preincubated (+) or not (-) with the antigenic synthetic peptide CREARPTTE. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "The ML fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "evaluated by immunoblotting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0220825:Evaluated [Functional Concept]

Phrase: "for its content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0423896:Content [Mental Process]
  1000   C0456205:Content [Conceptual Entity]

Phrase: "of MGE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the polyclonal anti-MGE peptide antiserum,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "which"

Phrase: "had"

Phrase: "been"

Phrase: "preincubated"

Phrase: "(+"

Phrase: ")"

Phrase: "or"

Phrase: "not (-) with the antigenic synthetic peptide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   753   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   753   C1518422:Not [Functional Concept]
   753   C1883254:synthetic [Activity]
   748   C0039115:Antigens, Synthetic [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "CREARPTTE."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205088:Terminal [Temporal Concept]
   753   C1705314:Terminal [Manufactured Object]
   753   C1705315:Terminal [Spatial Concept]
   719   C1709915:Residue [Conceptual Entity]
   719   C1882936:RESIDUE [Phenomenon or Process]
Processing 00000000.tx.191: Thirty micrograms of protein were loaded onto each lane. 

Phrase: "Thirty micrograms of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439211:microgram [Quantitative Concept]

Phrase: "were"

Phrase: "loaded onto each lane."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C1708639:Lane [Spatial Concept]
   770   C1708715:Loaded [Activity]
   737 E C1550025:Load [Idea or Concept]
   737 E C1704782:Load [Manufactured Object]
Processing 00000000.tx.192: C, The ML fraction (Total) was partitioned using Triton X-114 into the aqueous (Aq) and detergent (Det) phases according to the procedure of Bordier (31 ). 

Phrase: "C,"

Phrase: "The ML fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]

Phrase: "(Total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "partitioned"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Triton X-114 into the aqueous (Aq)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0146953:Triton X-114 [Organic Chemical,Pharmacologic Substance]
   790   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   753   C0242759:Triton [Geographic Area]

Phrase: "and"

Phrase: "detergent (Det) phases according to the procedure of Bordier"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   750   C1292431:Procedure phase [Temporal Concept]
   744   C0585064:Phases [Temporal Concept]
   744   C1067936:Phasis [Eukaryote]
   711 E C0205390:Phase [Temporal Concept]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.193: Samples were then processed for SDS-PAGE with 150 g of protein loaded in lane Total. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "processed for SDS-PAGE"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1522240:Processed [Phenomenon or Process]
   770   C1704732:Page [Intellectual Product]
   737 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "with 150 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "loaded in lane Total."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0439175:% total [Quantitative Concept]
   770   C0439810:Total [Qualitative Concept]
   770   C1708639:Lane [Spatial Concept]
   770   C1708715:Loaded [Activity]
   737 E C1550025:Load [Idea or Concept]
   737 E C1704782:Load [Manufactured Object]
Processing 00000000.tx.194: Gels were subjected to SDS-PAGE in an 8% acrylamide resolving gel, transferred to nitrocellulose, and immunoblotted with rabbit antiserum as described in Materials and Methods. 

Phrase: "Gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0017243:Gels [Biomedical or Dental Material]
   966 E C1382104:Gel [Substance]

Phrase: "were"

Phrase: "subjected to SDS-PAGE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "in an 8% acrylamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0050587:Acrylamide [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "resolving"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514893:resolving [Idea or Concept]
   966 E C2699488:Resolve [Conceptual Entity]

Phrase: "gel,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017243:Gel [Biomedical or Dental Material]
  1000   C1382104:Gel [Substance]

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "to nitrocellulose,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   777 E C0009357:Collodion Cotton [Biomedical or Dental Material,Pharmacologic Substance]

Phrase: "and"

Phrase: "immunoblotted with rabbit antiserum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0034493:Rabbit [Mammal]
   737   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "as"

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.195: Molecular mass markers are indicated to the left of each panel. 

Phrase: "Molecular mass markers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0005516:molecular markers [Clinical Attribute]
           Marker
   734   C3152252:Molecular Mass [Quantitative Concept]

Phrase: "are"

Phrase: "indicated to the left of each panel."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0205091:Left [Spatial Concept]
   748   C0441833:Panel [Idea or Concept]
   748   C1444656:Indicated [Finding]
   748   C1552822:left [Functional Concept]
   748   C1999270:Panel [Intellectual Product]
   748   C3537156:Panel [Manufactured Object]
Processing 00000000.tx.196: The arrows indicate the mobility of immunoreactive MGE (100 kDa).  

Phrase: "The arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: "indicate"

Phrase: "the mobility of immunoreactive MGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0425245:Mobility [Finding]
   753   C0449580:Mobility [Qualitative Concept]

Phrase: "(100 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.197: Phase partitioning with the detergent Triton X-114 was carried out on the ML fraction (Fig. 3C). 

Phrase: "Phase partitioning with the detergent Triton X-114"

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out on the ML fraction"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0026237:Mitochondrial [Cell Component]
   753   C0439787:Out [Spatial Concept]
   753   C0521450:Lysosomal [Body Location or Region]
   753   C0521451:Mitochondrial [Functional Concept]
   753   C0849355:Out [Qualitative Concept]
   753   C1264633:Fraction [Quantitative Concept]
   753   C1554103:Fraction [Idea or Concept]

Phrase: "(Fig. 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.198: Immunoblot analysis of the Triton X-114-extracted ML fraction using polyclonal anti-MGE revealed that the 100-kDa polypeptide preferentially partitioned into the aqueous phase. 

Phrase: "Immunoblot analysis of the Triton X-114-extracted ML fraction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   738   C0002778:Analysis [Laboratory Procedure]
   738   C0936012:Analysis [Research Activity]
   738   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "polyclonal anti-MGE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the 100-kDa polypeptide preferentially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "partitioned into the aqueous phase."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205390:Phase [Temporal Concept]
   760   C0599956:Aqueous [Qualitative Concept]
Processing 00000000.tx.199: Consequently, organelles expected to sediment in the ML fraction, i.e. plasma membrane (PM), endosomes (EN), endoplasmic reticulum (ER), mitochondria (Mit), peroxisomes (Per), and lysosomes (Lys) were partially purified using established procedures and evaluated for their content of MGE as assessed by immunoblotting with the polyclonal antiserum anti-MGE (Fig. 4). 

Phrase: "Consequently,"

Phrase: "organelles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0029219:Organelles [Cell Component]

Phrase: "expected to sediment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1517001:Expected [Idea or Concept]
   790   C1550099:Sediment [Body Substance]

Phrase: "in the ML fraction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]

Phrase: "i.e. plasma membrane (PM),"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0007603:Plasma membrane [Cell Component]
   812   C0025255:Membrane [Tissue]
   812   C0032105:Plasma [Body Substance]
   812   C0596901:Membrane [Cell Component]
   812   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   812   C1706182:Membrane [Manufactured Object]
   741 E C0205287:Membranous [Qualitative Concept]

Phrase: "endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "(EN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: ")"

Phrase: ","

Phrase: "endoplasmic reticulum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "(ER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: ")"

Phrase: ","

Phrase: "mitochondria (Mit),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "peroxisomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0752063:Peroxisomes [Cell Component]
   966 E C2984308:Peroxisome [Functional Concept]
   916 E C3546463:peroxisomal [Cell Component]

Phrase: "(Per"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0752063:Peroxisomes [Cell Component]
   966 E C2984308:Peroxisome [Functional Concept]
   916 E C3546463:peroxisomal [Cell Component]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "lysosomes (Lys)"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0024369:Lysosomes [Cell Component]
   966 E C2984253:Lysosome [Functional Concept]
   916 E C0521450:Lysosomal [Body Location or Region]

Phrase: "were"

Phrase: "partially"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "established procedures"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0025664:procedures [Intellectual Product]
   861   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C2700391:procedures [Activity]
   827 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   827 E C3274430:PROCEDURE [Health Care Activity]
   827 E C3538935:Procedure [Idea or Concept]
   827 E C3539779:Procedure [Intellectual Product]

Phrase: "and"

Phrase: "evaluated for their content of MGE"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C0082712:miniglucagon [Amino Acid, Peptide, or Protein]
   748   C0220825:Evaluated [Functional Concept]
   748   C0423896:Content [Mental Process]
   748   C0456205:Content [Conceptual Entity]

Phrase: "as"

Phrase: "assessed by immunoblotting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C1516048:Assessed [Activity]

Phrase: "with the polyclonal antiserum anti-MGE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.200: Immunoreactivity was restricted to the mitochondrial (Mit) fraction with none detectable in the plasma membrane (PM) fraction. 

Phrase: "Immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "restricted to the mitochondrial"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0026237:Mitochondrial [Cell Component]
   770   C0443288:Restricted [Functional Concept]
   770   C0521451:Mitochondrial [Functional Concept]

Phrase: "(Mit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: ")"

Phrase: "fraction with none detectable"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1264633:Fraction [Quantitative Concept]
   770   C1554103:Fraction [Idea or Concept]

Phrase: "in the plasma membrane"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "(PM"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: ")"

Phrase: "fraction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1264633:Fraction [Quantitative Concept]
  1000   C1554103:Fraction [Idea or Concept]
Processing 00000000.tx.201: Control immunoblots for the marker enzymes Hsp-60, thiolase (Th), and cathepsin D (CD) revealed the expected immunoreactivity, respectively, in mitochondria (Mit), peroxisomes (Per), and the endolysosomal compartment (Fig. 4). 

Phrase: "Control immunoblots for the marker enzymes Hsp-60,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "thiolase (Th),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001019:Thiolase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "cathepsin D (CD)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "the expected immunoreactivity,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597879:immunoreactivity [Molecular Function]

Phrase: "respectively,"

Phrase: "in mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "(Mit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: ")"

Phrase: ","

Phrase: "peroxisomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0752063:Peroxisomes [Cell Component]
   966 E C2984308:Peroxisome [Functional Concept]
   916 E C3546463:peroxisomal [Cell Component]

Phrase: "(Per"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0752063:Peroxisomes [Cell Component]
   966 E C2984308:Peroxisome [Functional Concept]
   916 E C3546463:peroxisomal [Cell Component]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the endolysosomal compartment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185625:Compartment [Body Space or Junction]
   861   C2986730:Compartment [Spatial Concept]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.202: View larger version (34K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(34K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.203: 4. 

Phrase: "4."
Processing 00000000.tx.204: Association of MGE with the mitochondrial fraction of rat liver. 

Phrase: "Association of MGE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0004083:Association [Mental Process]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]

Phrase: "with the mitochondrial fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: "of rat liver."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   861   C0023884:Liver [Body Part, Organ, or Organ Component]
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]
   861   C0736268:LIVER [Body Part, Organ, or Organ Component]
   861   C1278929:Liver [Body Part, Organ, or Organ Component]
   861   C2346688:LIVER [Food]
   805 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.205: Plasma membrane (PM), endosomal (EN), rough endoplasmic reticulum (ER), mitochondrial (Mit), peroxisomal (Per), and lysosomal (Lys) fractions were evaluated by immunoblotting for their content of MGE, mitochondrial heat-shock protein 60 (Hsp 60), peroxisomal 3-ketoacyl-CoA thiolase (Th), and endolysosomal cathepsin D (CD). 

Phrase: "Plasma membrane"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "(PM"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "endosomal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0034850:Endosome [Cell Component]

Phrase: "(EN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: ")"

Phrase: ","

Phrase: "rough endoplasmic reticulum"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0230779:Rough endoplasmic reticulum [Cell Component]
   901   C0014239:Endoplasmic Reticulum [Cell Component]
   827   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   755   C0598268:Endoplasm [Cell Component]

Phrase: "(ER"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: ")"

Phrase: ","

Phrase: "mitochondrial"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026237:Mitochondrial [Cell Component]
  1000   C0521451:Mitochondrial [Functional Concept]

Phrase: "(Mit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: ")"

Phrase: ","

Phrase: "peroxisomal"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C3546463:peroxisomal [Cell Component]
   928 E C0752063:Peroxisomes [Cell Component]
   928 E C2984308:Peroxisome [Functional Concept]

Phrase: "(Per"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0752063:Peroxisomes [Cell Component]
   966 E C2984308:Peroxisome [Functional Concept]
   916 E C3546463:peroxisomal [Cell Component]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "lysosomal"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0521450:Lysosomal [Body Location or Region]
   928 E C0024369:Lysosome [Cell Component]
   928 E C2984253:Lysosome [Functional Concept]

Phrase: "(Lys"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0024369:Lysosomes [Cell Component]
   966 E C2984253:Lysosome [Functional Concept]
   916 E C0521450:Lysosomal [Body Location or Region]

Phrase: ")"

Phrase: "fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "evaluated by immunoblotting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0220825:Evaluated [Functional Concept]

Phrase: "for their content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0423896:Content [Mental Process]
  1000   C0456205:Content [Conceptual Entity]

Phrase: "of MGE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "mitochondrial heat-shock protein 60 (Hsp 60),"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   937   C0109272:Heat-Shock Protein 60 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C3539602:Heat Shock Protein 60 [Amino Acid, Peptide, or Protein]
   884   C0018850:Heat-Shock Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   875   C0949610:Mitochondrial Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0282498:Heat Shock [Physiologic Function]
   804   C0018837:Heat [Natural Phenomenon or Process]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0036974:Shock [Pathologic Function]

Phrase: "peroxisomal 3-ketoacyl-CoA thiolase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   895   C0443563:Peroxisomal thiolase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0001019:Thiolase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Th"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001019:Thiolase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "endolysosomal cathepsin D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
   901   C1332805:CATHEPSIN D [Gene or Genome]
   827   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(CD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")."
Processing 00000000.tx.206: Sixty micrograms of protein were loaded onto each lane. 

Phrase: "Sixty micrograms of protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439211:microgram [Quantitative Concept]

Phrase: "were"

Phrase: "loaded onto each lane."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C1708639:Lane [Spatial Concept]
   770   C1708715:Loaded [Activity]
   737 E C1550025:Load [Idea or Concept]
   737 E C1704782:Load [Manufactured Object]
Processing 00000000.tx.207: Gels were subjected to SDS-PAGE in an 8% (-MGE) or 12% (-Hsp 60, -Th, and -CD) acrylamide resolving gel, transferred to nitrocellulose, and immunoblotted with their respective polyclonal antibodies as described in Materials and Methods. 

Phrase: "Gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0017243:Gels [Biomedical or Dental Material]
   966 E C1382104:Gel [Substance]

Phrase: "were"

Phrase: "subjected to SDS-PAGE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "in an 8%"

Phrase: "(-MGE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: ")"

Phrase: "or"

Phrase: "12%"

Phrase: "(-Hsp 60, -"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0109272:Heat-Shock Protein 60 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C3539602:Heat Shock Protein 60 [Amino Acid, Peptide, or Protein]
   923   C0018850:Heat-Shock Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0282498:Heat Shock [Physiologic Function]
   812   C0018837:Heat [Natural Phenomenon or Process]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0036974:Shock [Pathologic Function]

Phrase: "Th,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001019:Thiolase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and -"

Phrase: "CD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ")"

Phrase: "acrylamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0050587:Acrylamide [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "resolving"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514893:resolving [Idea or Concept]
   966 E C2699488:Resolve [Conceptual Entity]

Phrase: "gel,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017243:Gel [Biomedical or Dental Material]
  1000   C1382104:Gel [Substance]

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "to nitrocellulose,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   777 E C0009357:Collodion Cotton [Biomedical or Dental Material,Pharmacologic Substance]

Phrase: "and"

Phrase: "immunoblotted with their respective polyclonal antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   756   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   719   C0020985:Immunoblot [Laboratory Procedure]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "as"

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.208: Molecular mass markers are indicated to the left of the upper blot. 

Phrase: "Molecular mass markers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0005516:molecular markers [Clinical Attribute]
           Marker
   734   C3152252:Molecular Mass [Quantitative Concept]

Phrase: "are"

Phrase: "indicated to the left of the upper blot."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0205091:Left [Spatial Concept]
   744   C1282910:Upper [Spatial Concept]
   744   C1444656:Indicated [Finding]
   744   C1552822:left [Functional Concept]
Processing 00000000.tx.209: The arrows indicate the mobility of immunoreactive MGE (100 kDa), Hsp 60 (60 kDa), Th (41 kDa), and CD (64 kDa for the proenzyme and 45 kDa for the mature enzyme).  

Phrase: "The arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: "indicate"

Phrase: "the mobility of immunoreactive MGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0425245:Mobility [Finding]
   753   C0449580:Mobility [Qualitative Concept]

Phrase: "(100 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "Hsp 60"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0109272:Heat-Shock Protein 60 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C3539602:Heat Shock Protein 60 [Amino Acid, Peptide, or Protein]
   923   C0018850:Heat-Shock Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0282498:Heat Shock [Physiologic Function]
   812   C0018837:Heat [Natural Phenomenon or Process]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0036974:Shock [Pathologic Function]

Phrase: "(60 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "Th"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001019:Thiolase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(41 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "CD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(64 kDa for the proenzyme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1532717:kDa [Quantitative Concept]

Phrase: "and"

Phrase: "45 kDa for the mature enzyme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1532717:kDa [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.210: Using a variety of immunofluorescence protocols, the polyclonal anti-MGE antibody did not give any immunolocalization above that of nonimmune serum (results not shown). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a variety of immunofluorescence protocols,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1883525:Variety [Conceptual Entity]
   760   C2346866:Variety [Conceptual Entity]

Phrase: "the polyclonal anti-MGE antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   897   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "give"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947971:Give [Functional Concept]

Phrase: "any immunolocalization above that of nonimmune serum"

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.211: Hence, we were unable to evaluate morphologically the intracellular localization of MGE. 

Phrase: "Hence,"

Phrase: "we"

Phrase: "were"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "morphologically"

Phrase: "the intracellular localization of MGE."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1660749:intracellular localization [Cell Function]
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]
Processing 00000000.tx.212: Identification of an endosomal glucagon-binding protein by affinity labeling Cross-linking protocols have been successfully used to identify and characterize proteolytic activities degrading polypeptides such as insulin (25), glucagon (8), and epidermal growth factor (EGF) (22). 

Phrase: "Identification of an endosomal glucagon-binding protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0020792:Identification [Mental Process]
   748   C0205396:Identification [Qualitative Concept]

Phrase: "by affinity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "labeling"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1167624:Labeling [Mental Process]
  1000   C1947902:Labeling [Manufactured Object]
  1000   C2827499:Labeling [Governmental or Regulatory Activity]
   966 E C0181496:Label [Manufactured Object]

Phrase: "Cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "protocols"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0442711:Protocols [Intellectual Product]
   966 E C1507394:Protocol [Intellectual Product]
   966 E C1522729:Protocol [Intellectual Product]
   966 E C2348563:Protocol [Intellectual Product]

Phrase: "have"

Phrase: "been"

Phrase: "successfully"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "and"

Phrase: "characterize"

Phrase: "proteolytic activities"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0441655:Activities [Activity]
   861   C0597304:Proteolytic [Molecular Function]
   861   C1947941:proteolytic [Enzyme]
   827 E C0205177:Activity [Functional Concept]
   827 E C0439167:% activity [Quantitative Concept]
   827 E C1561536:*Activity [Idea or Concept]

Phrase: "degrading"

Phrase: "polypeptides such as insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1305923:Polypeptides [Amino Acid, Peptide, or Protein]

Phrase: "(25"

Phrase: ")"

Phrase: ","

Phrase: "glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(8"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "epidermal growth factor (EGF)"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1323367:epidermal growth factor [Molecular Function]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0014520:Epidermal [Tissue]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C0221920:Epidermal [Spatial Concept]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]
   711 E C3496194:Epidermis [Cell]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.213: Consequently, a cross-linking approach was attempted to identify the relevant protease(s) responsible for the endosomal proteolysis of glucagon at neutral pH. 

Phrase: "Consequently,"

Phrase: "a"

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "was"

Phrase: "attempted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1516084:Attempt [Event]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "the relevant protease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Protease [Enzyme]

Phrase: "("

Phrase: "s)"

Phrase: "responsible for the endosomal proteolysis of glucagon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1273518:Responsible [Finding]

Phrase: "at neutral pH."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:Neutral pH [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]
Processing 00000000.tx.214: Chemical-affinity labeling was performed using the zero-length water-soluble cross-linker EDC after incubation of the EN with [125I]iodoglucagon for 30 min at 21 C and pH 7 (Fig. 5). 

Phrase: "Chemical-affinity labeling"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0178463:affinity labeling [Laboratory or Test Result]
   827   C1167624:Labeling [Mental Process]
   827   C1947902:Labeling [Manufactured Object]
   827   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the zero-length water-soluble cross-linker EDC after incubation"

Phrase: "of the EN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "with"

Phrase: "[125I"

Phrase: "]iodoglucagon for 30 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0063780:iodoglucagon [Amino Acid, Peptide, or Protein]

Phrase: "at 21 C"

Phrase: "and"

Phrase: "pH 7"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:pH 7 [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "(Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.215: Autoradiographic analysis of the cross-linked proteins following SDS-PAGE under nonreducing conditions revealed the presence of a 170-kDa protein (Fig. 5A, lane -). 

Phrase: "Autoradiographic analysis of the"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "cross-linked"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178576:Cross Linked [Natural Phenomenon or Process]
  1000   C0332220:cross linked [Functional Concept]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "SDS-PAGE under nonreducing conditions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   760   C1704732:Page [Intellectual Product]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "the presence of a 170-kDa protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 5A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: "lane -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.216: Under reducing conditions, the relative mobility of the 170-kDa protein was not altered (Fig. 5A, lane 2-mercaptoethanol). 

Phrase: "Under reducing conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "the relative mobility of the 170-kDa protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0080103:Relative [Family Group]
   744   C0205345:Relative [Qualitative Concept]
   744   C0425245:Mobility [Finding]
   744   C0449580:Mobility [Qualitative Concept]
   744   C1547039:*Relative [Quantitative Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "altered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Altered [Functional Concept]

Phrase: "(Fig. 5A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: "lane 2-mercaptoethanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0025402:Mercaptoethanol [Organic Chemical]

Phrase: ")."
Processing 00000000.tx.217: The binding of [125I]iodoglucagon to the 170-kDa protein was completely inhibited with 10-5 M unlabeled glucagon (Fig. 5A, lane glucagon), indicating specific binding of the glucagon peptide to the 170-kDa protein. 

Phrase: "The binding of [125I"

Phrase: "]iodoglucagon to the 170-kDa protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0063780:iodoglucagon [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "inhibited with 10-5 M unlabeled glucagon"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   774   C1440942:M-5 [Immunologic Factor]
   748   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   748   C0311403:Inhibited [Qualitative Concept]
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441923:M+ [Intellectual Product]
   748   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(Fig. 5A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: "lane glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   861   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "specific binding of the glucagon peptide"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   783   C1149098:peptide binding [Molecular Function]
   753   C0205369:Specific [Qualitative Concept]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1552740:specific [Intellectual Product]

Phrase: "to the 170-kDa protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.218: The ability of unlabeled glucagon to compete for [125I]iodoglucagon cross-linking to the 170-kDa protein was dose dependent with labeling reduced by 22% at 10-7 M and 85% at 10-6 M (Fig. 5B). 

Phrase: "The ability of unlabeled glucagon to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "compete for"

Phrase: "[125I"

Phrase: "]iodoglucagon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0063780:iodoglucagon [Amino Acid, Peptide, or Protein]

Phrase: "cross-linking to the 170-kDa protein"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   778   C0332220:Cross-linking [Functional Concept]
   762 E C0178576:Cross link [Natural Phenomenon or Process]
   757   C0065011:link protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C1532717:kDa [Quantitative Concept]
   748   C2828360:Cross [Conceptual Entity]
   714   C1517892:Link [Intellectual Product]
   714   C1704666:Link [Intellectual Product]

Phrase: "was"

Phrase: "dose dependent with labeling"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1512045:Dose-dependent [Quantitative Concept]
   770   C0178602:Dose [Quantitative Concept]
   770   C0851827:Dependent [Qualitative Concept]
   770   C0869039:Dose [Quantitative Concept]
   770   C1114758:Dose # [Clinical Attribute]
   770   C1701901:Dependent [Qualitative Concept]
   770   C3244310:dependent [Functional Concept]

Phrase: "reduced by 22%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0392756:Reduced [Qualitative Concept]

Phrase: "at 10-7 M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "85% at 10-6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0439187:/10^6 [Quantitative Concept]
   833   C1881839:10^6 [Quantitative Concept]

Phrase: "M ("

Phrase: "Fig. 5B"

Phrase: ")."
Processing 00000000.tx.219: In contrast, unlabeled insulin (Fig. 5, A, lane insulin, and B) and GTP (A, lane GTP) had no discernible effect on the efficiency of cross-linking. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "unlabeled insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(Fig. 5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A,"

Phrase: "lane insulin,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "GTP (A,"

Phrase: "lane GTP)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "had"

Phrase: "no discernible effect on the efficiency of"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C1301751:No effect [Qualitative Concept]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "cross-linking."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]
Processing 00000000.tx.220: View larger version (38K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(38K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.221: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.222: Detection of an endosomal glucagon-binding protein by affinity labeling. 

Phrase: "Detection of an endosomal glucagon-binding protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "by affinity labeling."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0178463:affinity labeling [Laboratory or Test Result]
   861   C1167624:Labeling [Mental Process]
   861   C1947902:Labeling [Manufactured Object]
   861   C2827499:Labeling [Governmental or Regulatory Activity]
Processing 00000000.tx.223: A, [125I]Iodoglucagon (105106 cpm) was cross-linked to proteins from the EN (0.4 mg/ml) with 20 mM EDC at pH 7 in the absence (-) or presence of 10-5 M glucagon, 1 mM GTP, or 10-5 M insulin. 

Phrase: "A,"

Phrase: "[125I"

Phrase: "]Iodoglucagon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0063780:iodoglucagon [Amino Acid, Peptide, or Protein]

Phrase: "(105106 cpm)"

Phrase: "was"

Phrase: "cross-linked to proteins"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0178576:Cross Linked [Natural Phenomenon or Process]
   833   C0332220:cross linked [Functional Concept]
   802   C0065011:linked protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C2828360:Cross [Conceptual Entity]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "from the EN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "(0.4 mg/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439269:mg% [Quantitative Concept]
   827   C1960952:mg % [Quantitative Concept]
   827   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "ml) with 20 mM EDC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439526:/mL [Quantitative Concept]

Phrase: "at pH 7"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:pH 7 [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "(-"

Phrase: ")"

Phrase: "or"

Phrase: "presence of 10-5 M glucagon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "1 mM GTP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "or"

Phrase: "10-5 M insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.224: The fractions were then either reduced in 2% -mercaptoethanol (lane 2-mercaptoethanol) and/or subjected to SDS-PAGE in an 8% acrylamide resolving gel. 

Phrase: "The fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "then either"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883708:Then [Temporal Concept]

Phrase: "reduced in 2% -mercaptoethanol"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0025402:Mercaptoethanol [Organic Chemical]
   770   C0392756:Reduced [Qualitative Concept]

Phrase: "(lane 2-mercaptoethanol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0025402:Mercaptoethanol [Organic Chemical]

Phrase: ")"

Phrase: "and/or"

Phrase: "subjected to SDS-PAGE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "in an 8% acrylamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0050587:Acrylamide [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "resolving"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514893:resolving [Idea or Concept]
   966 E C2699488:Resolve [Conceptual Entity]

Phrase: "gel."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017243:Gel [Biomedical or Dental Material]
  1000   C1382104:Gel [Substance]
Processing 00000000.tx.225: B, Cross-linking was performed as described above in the absence (lanes -) or presence of 10-710-5 M glucagon and 10-610-5 M insulin. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "was"

Phrase: "performed as described above"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0884358:Performed [Functional Concept]
   770   C1552738:described [Idea or Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "(lanes -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "or"

Phrase: "presence of 10-710-5 M glucagon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "10-610-5 M insulin."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.226: C, Cross-linked proteins (300 g protein) were incubated with N-glycanase, and the samples were subjected to electrophoresis in an 8% acrylamide resolving gel. 

Phrase: "C,"

Phrase: "Cross-linked"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178576:Cross Linked [Natural Phenomenon or Process]
  1000   C0332220:cross linked [Functional Concept]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(300 g protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "incubated with N-glycanase,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0061534:glycanase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0521447:Nuclear [Spatial Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "and"

Phrase: "the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "subjected to electrophoresis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0013855:Electrophoresis [Laboratory Procedure]
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "in an 8% acrylamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0050587:Acrylamide [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "resolving"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514893:resolving [Idea or Concept]
   966 E C2699488:Resolve [Conceptual Entity]

Phrase: "gel."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017243:Gel [Biomedical or Dental Material]
  1000   C1382104:Gel [Substance]
Processing 00000000.tx.227: Molecular mass markers are indicated to the left of each panel. 

Phrase: "Molecular mass markers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0005516:molecular markers [Clinical Attribute]
           Marker
   734   C3152252:Molecular Mass [Quantitative Concept]

Phrase: "are"

Phrase: "indicated to the left of each panel."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0205091:Left [Spatial Concept]
   748   C0441833:Panel [Idea or Concept]
   748   C1444656:Indicated [Finding]
   748   C1552822:left [Functional Concept]
   748   C1999270:Panel [Intellectual Product]
   748   C3537156:Panel [Manufactured Object]
Processing 00000000.tx.228: The arrows indicate the mobility of the intact (170 kDa) and deglycosylated (140 kDa) radioactive cross-linked complex.  

Phrase: "The arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: "indicate"

Phrase: "the mobility of the intact"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0425245:Mobility [Finding]
   760   C0449580:Mobility [Qualitative Concept]

Phrase: "(170 kDa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "and"

Phrase: "deglycosylated"

Phrase: "(140 kDa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "radioactive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034553:radioactive [Natural Phenomenon or Process]

Phrase: "cross-linked"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178576:Cross Linked [Natural Phenomenon or Process]
  1000   C0332220:cross linked [Functional Concept]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "complex."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]
Processing 00000000.tx.229: Digestion of the radiolabeled cross-linked complex with N-glycanase reduced the mobility of the iodinated complex to an apparent molecular mass of 140 kDa (Fig. 5C). 

Phrase: "Digestion of the radiolabeled"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0012238:Digestion [Organism Function]
   770   C2349986:Digestion [Research Activity]
   715 E C0443277:Peptic [Functional Concept]

Phrase: "cross-linked"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178576:Cross Linked [Natural Phenomenon or Process]
  1000   C0332220:cross linked [Functional Concept]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "complex with N-glycanase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439855:Complex [Qualitative Concept]
   770   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the mobility of the iodinated complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0425245:Mobility [Finding]
   753   C0449580:Mobility [Qualitative Concept]

Phrase: "to an apparent molecular mass"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   827   C0577559:Mass [Finding]
   827   C1306372:*Mass [Quantitative Concept]

Phrase: "of 140 kDa (Fig. 5C"

Phrase: ")."
Processing 00000000.tx.230: Hence, the 170-kDa glucagon-binding protein was N-glycosylated. 

Phrase: "Hence,"

Phrase: "the 170-kDa glucagon-binding protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]

Phrase: "was"

Phrase: "N-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521447:Nuclear [Spatial Concept]

Phrase: "glycosylated."
Processing 00000000.tx.231: The 170-kDa endosomal protein displays affinity for bacitracin and is unrelated to glucagon receptor, IDE, and furin Binding of [125I]iodoglucagon to the 170-kDa endosomal protein was competitively inhibited by the nonspecific protease inhibitor bacitracin (Fig. 6). 

Phrase: "The 170-kDa endosomal protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "displays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870432:displays [Functional Concept]
  1000   C1705417:Display [Manufactured Object]

Phrase: "affinity for bacitracin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "is"

Phrase: "unrelated to glucagon receptor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0445356:Unrelated [Finding]
   770   C1704623:Unrelated [Qualitative Concept]

Phrase: "IDE,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "furin Binding of [125I"

Phrase: "]iodoglucagon to the 170-kDa endosomal protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0063780:iodoglucagon [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "competitively"

Phrase: "inhibited by the nonspecific protease inhibitor bacitracin"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0033607:Protease Inhibitor [Biologically Active Substance,Pharmacologic Substance]
   778   C3536890:Protease Inhibitor [Pharmacologic Substance]
   748   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   748   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C0205370:Non-specific [Qualitative Concept]
   748   C0311403:Inhibited [Qualitative Concept]
   748   C0750540:Nonspecific [Idea or Concept]
   748   C1947941:Protease [Enzyme]
   748   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.232: Bacitracin reduced cross-linking by 92% at 5 g/ml (Fig. 6B), whereas other protease inhibitors were not as effective at reducing the labeling (A). 

Phrase: "Bacitracin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   944 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "cross-linking by 92%"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0332220:Cross-linking [Functional Concept]
   816 E C0178576:Cross link [Natural Phenomenon or Process]
   770   C2828360:Cross [Conceptual Entity]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "at 5 g/ml (Fig. 6B"

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "other protease inhibitors"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0033607:Protease Inhibitors [Biologically Active Substance,Pharmacologic Substance]
   966 E C3536890:Protease Inhibitor [Pharmacologic Substance]
   861   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C0243077:inhibitors [Chemical Viewed Functionally]
   861   C1947941:Protease [Enzyme]
   827 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "were"

Phrase: "not as effective"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1280519:effective [Qualitative Concept]
   790   C1518422:Not [Functional Concept]
   790   C1704419:Effective [Qualitative Concept]

Phrase: "at reducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reducing [Qualitative Concept]

Phrase: "the labeling"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1167624:Labeling [Mental Process]
  1000   C1947902:Labeling [Manufactured Object]
  1000   C2827499:Labeling [Governmental or Regulatory Activity]
   966 E C0181496:Label [Manufactured Object]

Phrase: "(A"

Phrase: ")."
Processing 00000000.tx.233: Hence, the 170-kDa protein likely corresponds to a bacitracin-sensitive endosomal glucagonase. 

Phrase: "Hence,"

Phrase: "the 170-kDa protein likely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "corresponds to a bacitracin-sensitive endosomal glucagonase."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0332324:Sensitive to [Functional Concept]
           Sensitive
   748   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   748   C1550474:sensitive [Idea or Concept]
Processing 00000000.tx.234: View larger version (49K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(49K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.235: 6. 

Phrase: "6."
Processing 00000000.tx.236: Effect of protease inhibitors on the binding of [125I]iodoglucagon to the 170-kDa endosomal protein. 

Phrase: "Effect of protease inhibitors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "on the binding of [125I"

Phrase: "]iodoglucagon to the 170-kDa endosomal protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0063780:iodoglucagon [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.237: [125I]Iodoglucagon (105106 cpm) was cross-linked to proteins from the EN (0.4 mg/ml) with 20 mM EDC at pH 7 in the absence (lanes -) or presence of 0.1 mM N-ethylmaleimide (NEM), 0.1 mM 1,10-phenanthroline, 5 g/ml pepstatin-A, 0.1 mM p-hydroxymercuribenzoate (pHMB), 50 g/ml bacitracin, or 5 mM EGTA (A), and in the absence (lane -) or presence of bacitracin at the indicated concentrations (B). 

Phrase: "[125I"

Phrase: "]Iodoglucagon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0063780:iodoglucagon [Amino Acid, Peptide, or Protein]

Phrase: "(105106 cpm)"

Phrase: "was"

Phrase: "cross-linked to proteins"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0178576:Cross Linked [Natural Phenomenon or Process]
   833   C0332220:cross linked [Functional Concept]
   802   C0065011:linked protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C2828360:Cross [Conceptual Entity]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "from the EN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "(0.4 mg/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439269:mg% [Quantitative Concept]
   827   C1960952:mg % [Quantitative Concept]
   827   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "ml) with 20 mM EDC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439526:/mL [Quantitative Concept]

Phrase: "at pH 7"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:pH 7 [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "(lanes -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "or"

Phrase: "presence of 0.1 mM N-ethylmaleimide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(NEM"

Phrase: ")"

Phrase: ","

Phrase: "0.1 mM 1,"

Phrase: "10-phenanthroline,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031370:phenanthroline [Organic Chemical]

Phrase: "5 g/ml pepstatin-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0070329:pepstatin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "A,"

Phrase: "0.1 mM p-hydroxymercuribenzoate (pHMB),"

Phrase: "50 g/ml bacitracin,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   756 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "or"

Phrase: "5 mM EGTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(A"

Phrase: ")"

Phrase: ","

Phrase: "and in the absence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332197:absence [Quantitative Concept]
   770   C1515981:And [Idea or Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "(lane -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "or"

Phrase: "presence of bacitracin"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0392148:Presence [Therapeutic or Preventive Procedure]
   718 E C0150312:Present [Quantitative Concept]
   718 E C0449450:Present [Idea or Concept]

Phrase: "at the indicated concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.238: The fractions were then subjected to SDS-PAGE in an 8% acrylamide resolving gel. 

Phrase: "The fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "subjected to SDS-PAGE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "in an 8% acrylamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0050587:Acrylamide [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "resolving"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514893:resolving [Idea or Concept]
   966 E C2699488:Resolve [Conceptual Entity]

Phrase: "gel."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017243:Gel [Biomedical or Dental Material]
  1000   C1382104:Gel [Substance]
Processing 00000000.tx.239: Molecular mass markers are indicated to the left of each panel. 

Phrase: "Molecular mass markers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0005516:molecular markers [Clinical Attribute]
           Marker
   734   C3152252:Molecular Mass [Quantitative Concept]

Phrase: "are"

Phrase: "indicated to the left of each panel."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0205091:Left [Spatial Concept]
   748   C0441833:Panel [Idea or Concept]
   748   C1444656:Indicated [Finding]
   748   C1552822:left [Functional Concept]
   748   C1999270:Panel [Intellectual Product]
   748   C3537156:Panel [Manufactured Object]
Processing 00000000.tx.240: The arrows indicate the mobility of the radioactive cross-linked complex (170 kDa).  

Phrase: "The arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: "indicate"

Phrase: "the mobility of the radioactive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0425245:Mobility [Finding]
   760   C0449580:Mobility [Qualitative Concept]

Phrase: "cross-linked"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178576:Cross Linked [Natural Phenomenon or Process]
  1000   C0332220:cross linked [Functional Concept]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(170 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.241: Previous studies have described chemical cross-linking experiments using DFDNB as cross-linker to study the hepatic glucagon receptor (27). 

Phrase: "Previous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "described chemical"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0220806:Chemical [Chemical]
   861   C3272558:Chemical [Intellectual Product]

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "DFDNB as cross-linker to"

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the hepatic glucagon receptor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0061352:Glucagon Receptor [Amino Acid, Peptide, or Protein,Receptor]
   901   C1415011:GLUCAGON RECEPTOR [Gene or Genome]
   827   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.242: Accordingly, an iodinated complex of approximately 57 kDa was identified when cross-linking was done using an EN prepared from glucagon-injected rats (Fig. 7A, endosomes, lane -) or a PM fraction prepared from control rats (A, plasma membrane, lane -). 

Phrase: "Accordingly,"

Phrase: "an iodinated complex of approximately 57 kDa"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0439855:Complex [Qualitative Concept]
   748   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "was"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "when"

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "was"

Phrase: "done"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an EN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "prepared from glucagon-injected rats"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   760   C0034693:rats [Mammal]
   760   C0034721:Rats [Mammal]
   760   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   726   C1521827:Prepare [Functional Concept]

Phrase: "(Fig. 7A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "endosomes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "lane -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "or"

Phrase: "a PM fraction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]
   734   C0007603:Plasma membrane [Cell Component]

Phrase: "prepared from control rats"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0034693:rats [Mammal]
   770   C0034721:Rats [Mammal]
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737   C1521827:Prepare [Functional Concept]

Phrase: "(A,"

Phrase: "plasma membrane,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "lane -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.243: In contrast to the 170-kDa endosomal glucagon-binding protein, cross-linking of [125I]iodoglucagon to the 57-kDa glucagon receptor was partially (Fig. 7A, endosomes) or totally inhibited (A, plasma membrane) by GTP. 

Phrase: "In contrast to the 170-kDa endosomal glucagon-binding protein,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0243122:binding [Functional Concept]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "of [125I"

Phrase: "]iodoglucagon to the 57-kDa glucagon receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0063780:iodoglucagon [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "partially"

Phrase: "(Fig. 7A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: ")"

Phrase: "or"

Phrase: "totally"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "(A,"

Phrase: "plasma membrane"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0007603:Plasma membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C0596901:Membrane [Cell Component]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: ")"

Phrase: "by GTP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.244: Moreover, bacitracin did not inhibit cross-linking of [125I]iodoglucagon to the glucagon receptor in the plasma membrane fraction (Fig. 7A). 

Phrase: "Moreover,"

Phrase: "bacitracin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   944 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "of [125I"

Phrase: "]iodoglucagon to the glucagon receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0063780:iodoglucagon [Amino Acid, Peptide, or Protein]

Phrase: "in the plasma membrane fraction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]
   734   C0007603:Plasma membrane [Cell Component]

Phrase: "(Fig. 7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.245: Hence, the 170-kDa endosomal glucagon-binding protein is structurally and functionally distinct from the glucagon receptor. 

Phrase: "Hence,"

Phrase: "the 170-kDa endosomal glucagon-binding protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0243122:binding [Functional Concept]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]

Phrase: "is"

Phrase: "structurally"

Phrase: "and"

Phrase: "functionally distinct from the glucagon receptor."
Processing 00000000.tx.246: View larger version (41K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(41K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.247: 7. 

Phrase: "7."
Processing 00000000.tx.248: The 170-kDa endosomal protein is unrelated to glucagon receptor, IDE, and furin. 

Phrase: "The 170-kDa endosomal protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "unrelated to glucagon receptor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0445356:Unrelated [Finding]
   770   C1704623:Unrelated [Qualitative Concept]

Phrase: "IDE,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "furin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0919550:FURIN [Gene or Genome]
Processing 00000000.tx.249: A, Cross-linking of [125I]iodoglucagon to hepatic glucagon receptor. 

Phrase: "A,"

Phrase: "Cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "of [125I"

Phrase: "]iodoglucagon to hepatic glucagon receptor."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0063780:iodoglucagon [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.250: [125I]Iodoglucagon (106 cpm) was cross-linked to proteins from the EN (1 mg/ml), isolated from rats injected with 15 g glucagon per 100 g body weight, using 2 mM DFDNB as the cross-linker in the absence (Endosomes, lane -) or presence of 0.1 mM GTP (Endosomes, lane GTP). 

Phrase: "[125I"

Phrase: "]Iodoglucagon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0063780:iodoglucagon [Amino Acid, Peptide, or Protein]

Phrase: "(106 cpm)"

Phrase: "was"

Phrase: "cross-linked to proteins"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0178576:Cross Linked [Natural Phenomenon or Process]
   833   C0332220:cross linked [Functional Concept]
   802   C0065011:linked protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C2828360:Cross [Conceptual Entity]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "from the EN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "(1 mg/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439294:mg ml [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "isolated from rats"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0034693:rats [Mammal]
   790   C0034721:Rats [Mammal]
   790   C0205409:Isolated [Functional Concept]
   790   C1548221:Isolated [Idea or Concept]
   756 E C0370215:Isolate [Substance]
   756 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "injected with 15 g glucagon"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   760   C0439267:g% [Quantitative Concept]
   760   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   726   C1720154:Inject [Functional Concept]

Phrase: "per 100 g body weight,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   861   C0005910:Body Weight [Organism Attribute]
           weight
   861   C1305866:body weight [Diagnostic Procedure]
           weight
   812   C0043100:Weight [Quantitative Concept]
   812   C0242821:body [Human]
   812   C0460148:Body [Anatomical Structure]
   812   C1268086:Body [Anatomical Structure]
   812   C1705104:Weight [Idea or Concept]
   729 E C1995017:Bodies [Cell Component]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "2 mM DFDNB as the cross-linker"

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "(Endosomes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "lane -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "or"

Phrase: "presence of 0.1 mM GTP (Endosomes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "lane GTP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")."
Processing 00000000.tx.251: Alternatively, [125I]iodoglucagon (106 cpm) was cross-linked to proteins from the plasma membrane fraction (0.1 mg/ml), prepared from noninjected rats, using 2 mM DFDNB in the absence (lane -) or presence of 0.1 mM GTP or 50 g/ml bacitracin. 

Phrase: "Alternatively,"

Phrase: "[125I"

Phrase: "]iodoglucagon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0063780:iodoglucagon [Amino Acid, Peptide, or Protein]

Phrase: "(106 cpm)"

Phrase: "was"

Phrase: "cross-linked to proteins"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0178576:Cross Linked [Natural Phenomenon or Process]
   833   C0332220:cross linked [Functional Concept]
   802   C0065011:linked protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C2828360:Cross [Conceptual Entity]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "from the plasma membrane fraction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1264633:Fraction [Quantitative Concept]
   827   C1554103:Fraction [Idea or Concept]
   734   C0007603:Plasma membrane [Cell Component]

Phrase: "(0.1 mg/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439294:mg ml [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "prepared from noninjected rats,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0034693:rats [Mammal]
   770   C0034721:Rats [Mammal]
   737   C1521827:Prepare [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "2 mM DFDNB in the absence"

Phrase: "(lane -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "or"

Phrase: "presence of 0.1 mM GTP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "50 g/ml bacitracin."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   756 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]
Processing 00000000.tx.252: The fractions were then subjected to SDS-PAGE in a 12% acrylamide resolving gel. 

Phrase: "The fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "subjected to SDS-PAGE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "in a 12% acrylamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0050587:Acrylamide [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "resolving"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514893:resolving [Idea or Concept]
   966 E C2699488:Resolve [Conceptual Entity]

Phrase: "gel."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017243:Gel [Biomedical or Dental Material]
  1000   C1382104:Gel [Substance]
Processing 00000000.tx.253: Molecular mass markers are indicated to the left of the panel. 

Phrase: "Molecular mass markers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0005516:molecular markers [Clinical Attribute]
           Marker
   734   C3152252:Molecular Mass [Quantitative Concept]

Phrase: "are"

Phrase: "indicated to the left of the panel."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0205091:Left [Spatial Concept]
   748   C0441833:Panel [Idea or Concept]
   748   C1444656:Indicated [Finding]
   748   C1552822:left [Functional Concept]
   748   C1999270:Panel [Intellectual Product]
   748   C3537156:Panel [Manufactured Object]
Processing 00000000.tx.254: The arrow indicates the mobility of the radioactive cross-linked complex (57 kDa). 

Phrase: "The arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: "indicates"

Phrase: "the mobility of the radioactive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0425245:Mobility [Finding]
   760   C0449580:Mobility [Qualitative Concept]

Phrase: "cross-linked"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178576:Cross Linked [Natural Phenomenon or Process]
  1000   C0332220:cross linked [Functional Concept]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(57 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.255: B, Effect of immunodepletion of IDE and furin on the endosomal 170-kDa polypeptide. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Effect of immunodepletion of IDE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "furin on the endosomal 170-kDa polypeptide."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0919550:FURIN [Gene or Genome]
Processing 00000000.tx.256: [125I]Iodoglucagon (106 cpm) was cross-linked to proteins from the EN (0.5 mg/ml) with 20 mM EDC at pH 7. 

Phrase: "[125I"

Phrase: "]Iodoglucagon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0063780:iodoglucagon [Amino Acid, Peptide, or Protein]

Phrase: "(106 cpm)"

Phrase: "was"

Phrase: "cross-linked to proteins"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0178576:Cross Linked [Natural Phenomenon or Process]
   833   C0332220:cross linked [Functional Concept]
   802   C0065011:linked protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C2828360:Cross [Conceptual Entity]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "from the EN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "(0.5 mg/"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0439269:mg% [Quantitative Concept]
   827   C1960952:mg % [Quantitative Concept]
   827   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
   734   C0444499:0/5 [Quantitative Concept]

Phrase: "ml) with 20 mM EDC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439526:/mL [Quantitative Concept]

Phrase: "at pH 7."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:pH 7 [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]
Processing 00000000.tx.257: The fractions were then immunodepleted of IDE (-IDE) or furin (-Furin) in the presence of 0.1% Triton X-100. 

Phrase: "The fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "immunodepleted of IDE"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   862   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   862   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(-IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "or"

Phrase: "furin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0919550:FURIN [Gene or Genome]

Phrase: "(-Furin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0919550:FURIN [Gene or Genome]

Phrase: ")"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 0.1% Triton X-100."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]
Processing 00000000.tx.258: After immunoprecipitation and centrifugation, the resultant supernatants were subjected to SDS-PAGE in an 8% acrylamide resolving gel. 

Phrase: "After immunoprecipitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021069:Immunoprecipitation [Laboratory Procedure]

Phrase: "and"

Phrase: "centrifugation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "the resultant supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "subjected to SDS-PAGE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "in an 8% acrylamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0050587:Acrylamide [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "resolving"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514893:resolving [Idea or Concept]
   966 E C2699488:Resolve [Conceptual Entity]

Phrase: "gel."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017243:Gel [Biomedical or Dental Material]
  1000   C1382104:Gel [Substance]
Processing 00000000.tx.259: Molecular mass markers are indicated to the left of the panel. 

Phrase: "Molecular mass markers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0005516:molecular markers [Clinical Attribute]
           Marker
   734   C3152252:Molecular Mass [Quantitative Concept]

Phrase: "are"

Phrase: "indicated to the left of the panel."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0205091:Left [Spatial Concept]
   748   C0441833:Panel [Idea or Concept]
   748   C1444656:Indicated [Finding]
   748   C1552822:left [Functional Concept]
   748   C1999270:Panel [Intellectual Product]
   748   C3537156:Panel [Manufactured Object]
Processing 00000000.tx.260: The arrow indicates the mobility of the radioactive cross-linked complex (170 kDa). 

Phrase: "The arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: "indicates"

Phrase: "the mobility of the radioactive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0425245:Mobility [Finding]
   760   C0449580:Mobility [Qualitative Concept]

Phrase: "cross-linked"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178576:Cross Linked [Natural Phenomenon or Process]
  1000   C0332220:cross linked [Functional Concept]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(170 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.261: C, Assessment of endosomal furin by immunoblot analysis. 

Phrase: "C,"

Phrase: "Assessment of endosomal furin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1261322:Assessment [Health Care Activity]
   770   C1516048:Assessment [Activity]

Phrase: "by immunoblot analysis."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.262: The EN (50 g) was evaluated by immunoblotting for its content of furin with polyclonal antibody (lane 1). 

Phrase: "The EN"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "(50 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "was"

Phrase: "evaluated by immunoblotting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0220825:Evaluated [Functional Concept]

Phrase: "for its content"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0423896:Content [Mental Process]
  1000   C0456205:Content [Conceptual Entity]

Phrase: "of furin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0919550:FURIN [Gene or Genome]

Phrase: "with polyclonal antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.263: Alternatively, native glucagon (30 g) was incubated with the EN (100 g of protein) in sodium phosphate buffer (pH 7). 

Phrase: "Alternatively,"

Phrase: "native glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   861   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(30 g)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "was"

Phrase: "incubated with the EN"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0034850:Endosomes [Cell Component]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "(100 g of protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0060916:protein g [Amino Acid, Peptide, or Protein]
   819   C0086376:G-Protein [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "in sodium phosphate buffer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3256935:sodium phosphate buffer [Pharmacologic Substance]
   901   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   734   C0074757:sodium phosphate [Inorganic Chemical,Pharmacologic Substance]

Phrase: "(pH 7"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:pH 7 [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: ")."
Processing 00000000.tx.264: After 30 min at 21 C, cross-linking was performed using 20 mM EDC as described in Materials and Methods. 

Phrase: "After 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at 21 C,"

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "20 mM EDC"

Phrase: "as"

Phrase: "described in Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0520510:Materials [Substance]
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.265: The fraction was then subjected to SDS-PAGE in an 8% acrylamide resolving gel, transferred to nitrocellulose, and immunoblotted with anti-furin antibody (lane 2). 

Phrase: "The fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1264633:Fraction [Quantitative Concept]
  1000   C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "subjected to SDS-PAGE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737   C0681850:Subject [Group]
   737   C1550501:{Subject} [Idea or Concept]
   737   C1706203:Subject [Idea or Concept]
   737   C2349001:Subject [Human]
   737   C2697811:Subject [Functional Concept]

Phrase: "in an 8% acrylamide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0050587:Acrylamide [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "resolving"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1514893:resolving [Idea or Concept]
   966 E C2699488:Resolve [Conceptual Entity]

Phrase: "gel,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017243:Gel [Biomedical or Dental Material]
  1000   C1382104:Gel [Substance]

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "to nitrocellulose,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   777 E C0009357:Collodion Cotton [Biomedical or Dental Material,Pharmacologic Substance]

Phrase: "and"

Phrase: "immunoblotted with anti-furin antibody"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   797   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0919550:FURIN [Gene or Genome]
   726   C0020985:Immunoblot [Laboratory Procedure]

Phrase: "(lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.266: Molecular mass markers are indicated to the left of the panel. 

Phrase: "Molecular mass markers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0005516:molecular markers [Clinical Attribute]
           Marker
   734   C3152252:Molecular Mass [Quantitative Concept]

Phrase: "are"

Phrase: "indicated to the left of the panel."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0205091:Left [Spatial Concept]
   748   C0441833:Panel [Idea or Concept]
   748   C1444656:Indicated [Finding]
   748   C1552822:left [Functional Concept]
   748   C1999270:Panel [Intellectual Product]
   748   C3537156:Panel [Manufactured Object]
Processing 00000000.tx.267: The arrow indicates the mobility of the radioactive cross-linked complex (90 kDa).  

Phrase: "The arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: "indicates"

Phrase: "the mobility of the radioactive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0425245:Mobility [Finding]
   760   C0449580:Mobility [Qualitative Concept]

Phrase: "cross-linked"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178576:Cross Linked [Natural Phenomenon or Process]
  1000   C0332220:cross linked [Functional Concept]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(90 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.268: Neutral proteases displaying a lower molecular mass than the 170-kDa cross-linked complex have been already identified in hepatic endosomes. 

Phrase: "Neutral proteases"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1882074:Neutral [Qualitative Concept]
   861   C1947941:Proteases [Enzyme]
   861   C2825492:Neutral [Phenomenon or Process]

Phrase: "displaying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displaying [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "a lower molecular mass than the 170-kDa"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   767   C0577559:A mass [Finding]
           Mass
   744   C1306372:*Mass [Quantitative Concept]

Phrase: "cross-linked"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178576:Cross Linked [Natural Phenomenon or Process]
  1000   C0332220:cross linked [Functional Concept]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "have"

Phrase: "been"

Phrase: "already"

Phrase: "identified in hepatic endosomes."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0034850:Endosomes [Cell Component]
   770   C0205054:Hepatic [Body Location or Region]
   770   C0205396:Identified [Qualitative Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]
Processing 00000000.tx.269: Thus, we investigated whether EDC cross-linked glucagon to a multiprotein complex harboring polypeptides of a molecular mass lower than 170 kDa, such as IDE (110 kDa) and furin (85 kDa), using immunodepletion protocols (Fig. 7B). 

Phrase: "Thus,"

Phrase: "we"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "whether"

Phrase: "EDC"

Phrase: "cross-linked"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178576:Cross Linked [Natural Phenomenon or Process]
  1000   C0332220:cross linked [Functional Concept]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "glucagon to a multiprotein complex harboring polypeptides of a molecular mass"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   738   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "lower than 170 kDa,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0441994:Lower [Spatial Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]

Phrase: "such as IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(110 kDa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "and"

Phrase: "furin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0919550:FURIN [Gene or Genome]

Phrase: "(85 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "immunodepletion protocols"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0442711:Protocols [Intellectual Product]
   827 E C1507394:Protocol [Intellectual Product]
   827 E C1522729:Protocol [Intellectual Product]
   827 E C2348563:Protocol [Intellectual Product]

Phrase: "(Fig. 7B"

Phrase: ")."
Processing 00000000.tx.270: No detectable change in the 170-kDa cross-linked complex was observed after immunodepletion with antibodies to either furin or IDE (Fig. 7B, cf. lanes 2 and 3 with lane 1), ruling out IDE and furin as the endosomal glucagon-binding protein. 

Phrase: "No detectable change in the 170-kDa"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C0442739:No change [Finding]
   774   C1548568:No change [Intellectual Product]
   748   C0392747:Change [Functional Concept]
   748   C0443172:change [Quantitative Concept]
   748   C1705241:Change [Quantitative Concept]

Phrase: "cross-linked"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178576:Cross Linked [Natural Phenomenon or Process]
  1000   C0332220:cross linked [Functional Concept]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "was"

Phrase: "observed after immunodepletion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1441672:Observed [Functional Concept]

Phrase: "with antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "to either furin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0919550:FURIN [Gene or Genome]

Phrase: "or"

Phrase: "IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(Fig. 7B,"

Phrase: "cf. lanes 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "3 with lane 1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439086:<3 [Quantitative Concept]
   770   C1708639:Lane [Spatial Concept]
   770   C2827736:3+ [Quantitative Concept]
   770   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "ruling"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1446409:ruling [Qualitative Concept]
   966 E C0805874:Rule [Idea or Concept]
   966 E C0870077:Rule [Intellectual Product]

Phrase: "out IDE"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   923   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   923   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C0014445:enzymes [Functional Concept]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "furin as the endosomal glucagon-binding protein."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0287990:Furin Protein [Amino Acid, Peptide, or Protein,Enzyme]
           Furin
   748   C0919550:FURIN [Gene or Genome]
Processing 00000000.tx.271: Finally, to test whether furin was present in the EDC cross-linked complex, proteins from noniodinated glucagon/170-kDa polypeptide cross-linked complex were analyzed on Western blots using anti-furin antibody (Fig. 7C). 

Phrase: "Finally,"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "whether"

Phrase: "furin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0919550:FURIN [Gene or Genome]

Phrase: "was"

Phrase: "present in the EDC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "cross-linked"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178576:Cross Linked [Natural Phenomenon or Process]
  1000   C0332220:cross linked [Functional Concept]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "complex,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "proteins from noniodinated glucagon/170-kDa polypeptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "cross-linked"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178576:Cross Linked [Natural Phenomenon or Process]
  1000   C0332220:cross linked [Functional Concept]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "were"

Phrase: "analyzed on Western blots"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0949466:Western Blots [Laboratory Procedure]
   799 E C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0936012:Analyzed [Research Activity]
   770   C1705493:Western [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-furin antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Fig. 7C"

Phrase: ")."
Processing 00000000.tx.272: Endosomal proteins alone (lane 1) or treated with glucagon and EDC (lane 2) exhibited an immunoreactive band at approximately 90 kDa with no immunoreactivity at 170 kDa. 

Phrase: "Endosomal proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "or"

Phrase: "treated with glucagon"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   790   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "EDC (lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "exhibited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015272:Exhibit [Intellectual Product]

Phrase: "an immunoreactive band at approximately 90 kDa"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0175723:Band [Medical Device]
   748   C0439645:Band [Spatial Concept]
   748   C1521913:band [Cell Component]

Phrase: "with no immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597879:immunoreactivity [Molecular Function]

Phrase: "at 170 kDa."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]
Processing 00000000.tx.273: In addition, in vitro incubation of glucagon at 37 C and pH 7 with furin (28 U/ml) in the presence of 5 mM CaCl2 followed by RP-HPLC analysis did not reveal any detectable degradation of glucagon even up to 5 h of incubation (results not shown), suggesting that the endosomal endopeptidase is distinct from furin. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "in vitro incubation of glucagon"

Phrase: "at 37 C"

Phrase: "and"

Phrase: "pH 7 with furin"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1882074:pH 7 [Qualitative Concept]
   770   C0020283:[pH] [Quantitative Concept]
   770   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0450407:ph+ [Finding]
   770   C0450408:ph++ [Finding]
   770   C0450409:ph+++ [Finding]
   770   C0919550:FURIN [Gene or Genome]

Phrase: "(28 U/ml) in the presence of 5 mM CaCl2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439340:U/ml [Quantitative Concept]
   760   C1880521:U/mL [Quantitative Concept]
   760   C2945590:U/mL [Quantitative Concept]
   739   C0439526:/mL [Quantitative Concept]

Phrase: "followed by RP-HPLC analysis"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   790   C0332283:Followed by [Temporal Concept]
           followed
   783   C2986798:Phase Analysis [Occupational Activity]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0008562:HPLC [Laboratory Procedure]
   753   C0205390:Phase [Temporal Concept]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
   719   C1555029:Reverse [Idea or Concept]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reveal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:reveal [Qualitative Concept]

Phrase: "any detectable degradation of glucagon even"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "up to 5 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "of incubation"

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the endosomal endopeptidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "is"

Phrase: "distinct from furin."
Processing 00000000.tx.274: To investigate whether miniglucagon was a potential ligand for the 170-kDa endosomal glucagon-binding protein, we used a synthetic peptide corresponding to the 11 amino acids of the (19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29) miniglucagon peptide with an additional C-terminal tyrosine residue (designated Tyr12-miniglucagon) (Fig. 8). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "whether"

Phrase: "miniglucagon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0082712:miniglucagon [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "a potential ligand for the 170-kDa endosomal glucagon-binding protein,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   772   C0242210:Ligand Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   754   C1517880:Ligand Binding [Molecular Function]
   738   C0023688:Ligand [Chemical]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a synthetic peptide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0597551:synthetic peptide [Amino Acid, Peptide, or Protein]
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   861   C1883254:synthetic [Activity]

Phrase: "corresponding to the 11 amino acids of the (19,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   764   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   742   C0001128:Acids [Chemical]
   731 E C2917660:Amino Acid [Pharmacologic Substance]
   708 E C0202406:Acid [Laboratory Procedure]

Phrase: "20,"

Phrase: "21,"

Phrase: "22,"

Phrase: "23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "24,"

Phrase: "25,"

Phrase: "26,"

Phrase: "27,"

Phrase: "28,"

Phrase: "29"

Phrase: ")"

Phrase: "miniglucagon peptide with an additional C-terminal tyrosine residue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0071642:peptide C [Amino Acid, Peptide, or Protein]
   742   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "(designated Tyr12-miniglucagon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0082712:miniglucagon [Amino Acid, Peptide, or Protein]

Phrase: ")"

Phrase: "(Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.275: Iodination of Tyr12-miniglucagon was conducted using the lactoperoxidase method and the iodinated peptide was purified using the RP-HPLC method (Fig. 8A). 

Phrase: "Iodination of Tyr12-miniglucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0430302:Iodination [Laboratory Procedure]
   770   C0542502:Iodination [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "conducted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0004927:Conduct [Individual Behavior]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the lactoperoxidase method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "the iodinated peptide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the RP-HPLC method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025663:Method [Intellectual Product]
   812   C0449851:Method [Functional Concept]
   812   C0871511:METHOD [Intellectual Product]

Phrase: "(Fig. 8A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553640:8a [Medical Device]

Phrase: ")."
Processing 00000000.tx.276: [125I]Tyr12-miniglucagon (elution time, 52 min) was well resolved from native Tyr12-miniglucagon (elution time, 42 min) and free iodine (elution time, 4 min). 

Phrase: "[125I"

Phrase: "]Tyr12-miniglucagon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0082712:miniglucagon [Amino Acid, Peptide, or Protein]

Phrase: "(elution time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "52 min)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "was"

Phrase: "well resolved from native Tyr12-miniglucagon"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205170:Well [Qualitative Concept]
   753   C1514893:Resolved [Idea or Concept]
   753   C2699488:Resolved [Conceptual Entity]
   753   C3146287:Well [Manufactured Object]

Phrase: "(elution time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "42 min)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "and"

Phrase: "free iodine"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021966:Iodine- [Inorganic Chemical]
   861   C0021968:Iodine [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0885449:iodine [Pharmacologic Substance]
   861   C2348268:Iodine [Element, Ion, or Isotope]

Phrase: "(elution time,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "4 min)."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.277: The radiolabeled Tyr12-miniglucagon was then tested as a potential ligand for affinity labeling of the 170-kDa endosomal glucagon-binding protein using the cross-linker EDC (Fig. 8B). 

Phrase: "The radiolabeled Tyr12-miniglucagon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0082712:miniglucagon [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "tested as a potential ligand"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0023688:Ligand [Chemical]
   760   C0392366:tested [Intellectual Product]
   760   C3245505:Potential [Qualitative Concept]
   726 E C0022885:Test [Laboratory Procedure]
   726 E C0039593:Test [Functional Concept]

Phrase: "for affinity labeling"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0178463:affinity labeling [Laboratory or Test Result]
   861   C1167624:Labeling [Mental Process]
   861   C1947902:Labeling [Manufactured Object]
   861   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "of the 170-kDa endosomal glucagon-binding protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0243122:binding [Functional Concept]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the cross-linker EDC (Fig. 8B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1424736:8B [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.278: Cross-linking of the 170-kDa endosomal protein was observed (Fig. 8B, lane 1) and the cross-linking could be blocked with an excess of unlabeled Tyr12-miniglucagon (10-5 M) (B, lane 2). 

Phrase: "Cross-linking of the 170-kDa endosomal protein"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0332220:Cross-linking [Functional Concept]
   754 E C0178576:Cross link [Natural Phenomenon or Process]
   750   C0065011:link protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1532717:kDa [Quantitative Concept]
   744   C2828360:Cross [Conceptual Entity]
   711   C1517892:Link [Intellectual Product]
   711   C1704666:Link [Intellectual Product]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(Fig. 8B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1424736:8B [Gene or Genome]

Phrase: "lane 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "the"

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "could"

Phrase: "be"

Phrase: "blocked with an excess of unlabeled Tyr12-miniglucagon"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   744   C0028778:Blocked [Pathologic Function]
   744   C0082712:miniglucagon [Amino Acid, Peptide, or Protein]
   744   C0332206:Blocked [Functional Concept]
   744   C1979886:Excess [Qualitative Concept]
   744   C2983591:BLOCKED [Research Activity]
   711 E C1533157:Block [Substance]
   711 E C1706084:Block [Geographic Area]
   711 E C2828370:Block [Quantitative Concept]

Phrase: "(10-5 M) (B,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441923:M+ [Intellectual Product]

Phrase: "lane 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.279: A diffuse radiolabeled band of 100105 kDa was also observed and was not reduced by addition of unlabeled Tyr12-miniglucagon, suggesting that it may represent a nonspecifically bound protein(s).  

Phrase: "A diffuse radiolabeled band of 100105 kDa"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0230715:A band [Cell Component]
   748   C0175723:Band [Medical Device]
   748   C0439645:Band [Spatial Concept]
   748   C1521913:band [Cell Component]

Phrase: "was"

Phrase: "also"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "reduced by addition of unlabeled Tyr12-miniglucagon,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0082712:miniglucagon [Amino Acid, Peptide, or Protein]
   748   C0392756:Reduced [Qualitative Concept]
   748   C1883712:Addition [Functional Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "it"

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a nonspecifically bound protein(s"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0072393:Protein S [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418948:PROTEIN S [Gene or Genome]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.280: Discussion Top Abstract Introduction Materials and Methods Results Discussion References  Experiments using semipurified endosomal vesicles containing various internalized ligands have shown that proteolysis can be observed at acidic as well as neutral pH (reviewed in Ref. 36). 

Phrase: "Discussion Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "semipurified endosomal vesicles"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0333262:VESICLES [Acquired Abnormality]
   793 E C1622418:vesicle [Cell Component]
   743 E C0205378:Vesicular [Qualitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "various internalized ligands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023688:Ligands [Chemical]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that proteolysis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0597304:Proteolysis [Molecular Function]
   928 E C1947941:proteolytic [Enzyme]

Phrase: "can"

Phrase: "be"

Phrase: "observed at acidic"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0001128:Acidic [Chemical]
   790   C1441672:Observed [Functional Concept]
   718 E C0202406:Acid [Laboratory Procedure]

Phrase: "as well as"

Phrase: "neutral pH ("
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:Neutral pH [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "reviewed in Ref. 36"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0282443:reviewed [Intellectual Product]
   770   C1425988:REF [Gene or Genome]
   770   C1709940:Reviewed [Qualitative Concept]
   737 E C1552617:Review [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.281: These data demonstrate that proteases with a neutral pH optimum are present in endosomes. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "demonstrate"

Phrase: "that proteases with a neutral pH optimum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C1947941:Proteases [Enzyme]

Phrase: "are"

Phrase: "present in endosomes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0150312:Present [Quantitative Concept]
   790   C0449450:Present [Idea or Concept]
Processing 00000000.tx.282: Thus, it has been proposed that ATP-dependent acidification of hepatic endosomes was not required for the initial step of insulin degradation, and that IDE, a neutral metalloendopeptidase, may operate in the endosomal lumen before the progressive decrease in endosomal pH (10). 

Phrase: "Thus,"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "that ATP-dependent acidification of hepatic endosomes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1522821:acidification [Cell Function]
   748   C2987513:Acidification [Phenomenon or Process]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "required for the initial step of insulin degradation,"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   770   C3547574:insulin degradation [Molecular Function]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0205265:Initial [Temporal Concept]
   744   C0243125:degradation [Functional Concept]
   744   C0699900:Degradation [Organism Function]
   744   C1261552:Step [Conceptual Entity]
   744   C1279901:Initial [Qualitative Concept]
   744   C1514873:Required [Functional Concept]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1555582:Initial [Idea or Concept]
   744   C1579433:Insulin [Pharmacologic Substance]
   744   C1704379:Step [Functional Concept]
   744   C1705117:Step [Quantitative Concept]
   744   C1705685:INITIAL [Functional Concept]
   744   C2825408:Step [Manufactured Object]

Phrase: "and"

Phrase: "that IDE,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "a neutral metalloendopeptidase,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442934:Metalloendopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "may"

Phrase: "operate in the endosomal lumen"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1179919:endosome lumen [Cell Component]
   760   C0524461:Lumen [Body Space or Junction]
   760   C1282864:Lumen [Body Space or Junction]
   760   C1301906:Lumen [Qualitative Concept]
   760   C1551056:Lumen [Quantitative Concept]
   760   C3242339:operate [Functional Concept]

Phrase: "before the progressive decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392756:Decrease [Qualitative Concept]
   861   C0547047:Decrease [Quantitative Concept]

Phrase: "in endosomal pH (10"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
   755   C0034850:Endosome [Cell Component]

Phrase: ")."
Processing 00000000.tx.283: Using hepatic endosomes, Renfrew and Hubbard (37) have identified truncated forms of EGF that were generated by a carboxypeptidase B-like and a trypsin-like endosomal protease at neutral pH. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "hepatic endosomes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034850:Endosomes [Cell Component]

Phrase: "Renfrew"

Phrase: "and"

Phrase: "Hubbard"

Phrase: "(37"

Phrase: ")"

Phrase: "have"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "truncated forms of EGF"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0348078:forms [Qualitative Concept]
   753   C0376315:Forms [Manufactured Object]
   719 E C1522492:Form [Functional Concept]

Phrase: "that"

Phrase: "were"

Phrase: "generated by a carboxypeptidase B-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0054756:Carboxypeptidase B [Amino Acid, Peptide, or Protein,Enzyme]
   797   C0054755:Carboxypeptidase A [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0007075:Carboxypeptidase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C3146294:Generated [Activity]
   760   C3265462:Carboxypeptidase [Pharmacologic Substance]

Phrase: "like"

Phrase: "and"

Phrase: "a trypsin-like endosomal protease at neutral pH."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1705965:Trypsin-like protease [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   744   C1947941:Protease [Enzyme]
Processing 00000000.tx.284: Finally, using the plant toxin ricin A chain, Blum et al. 

Phrase: "Finally,"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the plant toxin ricin A chain,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0035570:Ricin A Chain [Amino Acid, Peptide, or Protein,Hazardous or Poisonous Substance]
   804   C0035569:Ricin [Amino Acid, Peptide, or Protein,Hazardous or Poisonous Substance]
   804   C0337112:Chain [Manufactured Object]
   804   C1150029:ricin [Genetic Function]
   804   C1524075:Chain [Idea or Concept]

Phrase: "Blum et al."
Processing 00000000.tx.285: (38) have identified an endosomal cathepsin that catalyzed toxin proteolysis at pH 4.5 and 7, and was primarily responsible for toxin cytotoxicity. 

Phrase: "(38"

Phrase: ")"

Phrase: "have"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "an endosomal cathepsin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "that catalyzed toxin proteolysis at pH 4.5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0597304:Proteolysis [Molecular Function]

Phrase: "and"

Phrase: "7,"

Phrase: "and"

Phrase: "was"

Phrase: "primarily responsible for toxin cytotoxicity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]
Processing 00000000.tx.286: Our results extend these observations to glucagon and suggest that endosomal processing of internalized ligands mediated by endosomal proteases with different pH optima may be regulated by changes in endosomal pH. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "extend"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "these observations to glucagon"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0302523:observations [Research Activity]
   770   C0700325:observations [Health Care Activity]
   770   C3244290:observations [Functional Concept]
   737 E C1964257:Observation [Diagnostic Procedure]

Phrase: "and"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that endosomal processing of internalized ligands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1709694:Processing [Activity]

Phrase: "mediated by endosomal proteases"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   770   C1947941:Proteases [Enzyme]

Phrase: "with different pH optima"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C2698651:Optimum [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "regulated by changes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   790   C0851285:Regulated [Governmental or Regulatory Activity]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "in endosomal pH."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]
Processing 00000000.tx.287: According to the sequences of peptide products, the main proteolytic activity participating in endosomal glucagon degradation at neutral pH can be attributed to an endopeptidase activity that generates eight major glucagon metabolites. 

Phrase: "According to the sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0162326:Sequences [Nucleotide Sequence]
   966 E C0004793:Sequence [Nucleotide Sequence]
   966 E C0162327:Sequence [Nucleotide Sequence]
   966 E C1519249:Sequence [Functional Concept]
   916 E C1548958:Sequential [Idea or Concept]
   916 E C1705294:Sequential [Qualitative Concept]

Phrase: "of peptide products,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "the main proteolytic activity participating in endosomal glucagon degradation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0679823:Participating [Functional Concept]

Phrase: "at neutral pH"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:Neutral pH [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "can"

Phrase: "be"

Phrase: "attributed to an endopeptidase activity"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   806   C1150171:endopeptidase activity [Molecular Function]
   781   C1879549:Activity Attribute [Qualitative Concept]
   760   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]
   726   C0449234:Attribute [Idea or Concept]
   726   C1704772:Attribute [Conceptual Entity]
   726   C1882133:Attribute [Qualitative Concept]

Phrase: "that"

Phrase: "generates"

Phrase: "eight major glucagon metabolites."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0870883:Metabolites [Biologically Active Substance]
   812   C2698672:METABOLITES [Regulation or Law]
Processing 00000000.tx.288: Thus, endosomal proteolysis of glucagon at pH 7 resulted in three major cleavages in the N-terminal region (i.e. Ser2-Gln3, Gln3-Gly4, and Gly4-Thr5) as evidenced by the glucagon fragments (329), (429), and (529), and in the central region (i.e. Lys12-Tyr13, Arg17-Arg18, and Arg18-Ala19) as evidenced by the glucagon fragments (112), (117), (1829), (118), and (1929). 

Phrase: "Thus,"

Phrase: "endosomal proteolysis of glucagon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0597304:Proteolysis [Molecular Function]

Phrase: "at pH 7"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:pH 7 [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "resulted in three major cleavages"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0205164:Major [Qualitative Concept]
   760   C0205449:Three [Quantitative Concept]
   726   C0010813:cleavage [Cell Function]
   726   C0596311:Cleavage [Phenomenon or Process]
   726   C1274040:Result [Functional Concept]
   726   C1330957:cleavage [Cell Function]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "in the N-terminal region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "(i.e. Ser2-Gln3,"

Phrase: "Gln3-Gly4,"

Phrase: "and"

Phrase: "Gly4-Thr5"

Phrase: ")"

Phrase: "as"

Phrase: "evidenced by the glucagon fragments"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   760   C0332255:fragments [Functional Concept]
   760   C0486805:Fragments [Body Substance]
   760   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   726   C0332120:Evidence [Functional Concept]
   726 E C1708096:Fragment [Qualitative Concept]

Phrase: "(329"

Phrase: ")"

Phrase: ","

Phrase: "(429"

Phrase: ")"

Phrase: ","

Phrase: "and ("

Phrase: "529"

Phrase: ")"

Phrase: ","

Phrase: "and in the central region"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0454907:Central region [Geographic Area]
   760   C0017446:Region [Geographic Area]
   760   C0205099:Central [Spatial Concept]
   760   C0205147:Region [Spatial Concept]
   760   C1515981:And [Idea or Concept]
   760   C1879652:Central - [Laboratory Procedure]

Phrase: "(i.e. Lys12-Tyr13,"

Phrase: "Arg17-Arg18,"

Phrase: "and"

Phrase: "Arg18-Ala19"

Phrase: ")"

Phrase: "as"

Phrase: "evidenced by the glucagon fragments"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   760   C0332255:fragments [Functional Concept]
   760   C0486805:Fragments [Body Substance]
   760   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   726   C0332120:Evidence [Functional Concept]
   726 E C1708096:Fragment [Qualitative Concept]

Phrase: "(112"

Phrase: ")"

Phrase: ","

Phrase: "(117"

Phrase: ")"

Phrase: ","

Phrase: "(1829"

Phrase: ")"

Phrase: ","

Phrase: "(118"

Phrase: ")"

Phrase: ","

Phrase: "and ("

Phrase: "1929"

Phrase: ")."
Processing 00000000.tx.289: Based on the location of the major cleavage sites, our data suggest that Ser2-Thr5 and Ser16-Ala19 may contain at least a portion of the residues important for the binding of glucagon to the neutral endosomal glucagonase. 

Phrase: "Based on the location of the major cleavage sites,"
Meta Candidates (Total=15; Excluded=5; Pruned=0; Remaining=10)
   745   C2945843:Site of [Qualitative Concept]
   742   C0010813:cleavage [Cell Function]
   742   C0205145:Sites [Spatial Concept]
   742   C0205164:Major [Qualitative Concept]
   742   C0450429:Location [Spatial Concept]
   742   C0596311:Cleavage [Phenomenon or Process]
   742   C1330957:cleavage [Cell Function]
   742   C1515974:Location [Body Location or Region]
       E   Site
   742   C1527178:Based [Functional Concept]
   742   C1705938:Based [Idea or Concept]
   708 E C0002055:base [Inorganic Chemical]
   708 E C0178499:Base [Chemical Viewed Functionally]
   708 E C1880279:Base [Biomedical or Dental Material]
   708 E C2825164:Site [Spatial Concept]

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that Ser2-Thr5"

Phrase: "and"

Phrase: "Ser16-Ala19"

Phrase: "may"

Phrase: "contain at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332256:contain [Functional Concept]
   790   C2700400:Contain [Activity]

Phrase: "a portion of the residues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449719:Portion [Spatial Concept]

Phrase: "important for the binding of glucagon"

Phrase: "to the neutral endosomal glucagonase."
Processing 00000000.tx.290: Other minor sites of cleavage were also identified at the C-terminal region (Trp25-Leu26 and Leu26-Met27 peptide bonds) and have been previously identified within hepatic endosomes at acidic pH (pH 4) (8). 

Phrase: "Other minor sites of cleavage"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C2945843:Site of [Qualitative Concept]
   760   C0205145:Sites [Spatial Concept]
   726 E C1515974:Site [Body Location or Region]
   726 E C2825164:Site [Spatial Concept]

Phrase: "were"

Phrase: "also"

Phrase: "identified at the C-terminal region"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C1707271:C-Terminal [Amino Acid Sequence]
   753   C0017446:Region [Geographic Area]
   753   C0205088:Terminal [Temporal Concept]
   753   C0205147:Region [Spatial Concept]
   753   C0205396:Identified [Qualitative Concept]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]
   753   C1705314:Terminal [Manufactured Object]
   753   C1705315:Terminal [Spatial Concept]

Phrase: "(Trp25-Leu26"

Phrase: "and"

Phrase: "Leu26-Met27 peptide bonds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0678595:peptide bond [Natural Phenomenon or Process]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: ")"

Phrase: "and"

Phrase: "have"

Phrase: "been"

Phrase: "previously"

Phrase: "identified within hepatic endosomes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0034850:Endosomes [Cell Component]
   770   C0205054:Hepatic [Body Location or Region]
   770   C0205396:Identified [Qualitative Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]

Phrase: "at acidic pH (pH 4"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   875   C2678549:PH-4 [Gene or Genome]
   812   C0001128:Acidic [Chemical]
   812   C0020283:[pH] [Quantitative Concept]
   812   C0450407:ph+ [Finding]
   812   C0450408:ph++ [Finding]
   812   C0450409:ph+++ [Finding]
   741 E C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.291: Consequently, we cannot be sure whether these two minor cleavages arise from the endosomal neutral glucagonase activity or from endosomal acidic cathepsins B and D, which may still remain active at neutral pH (22). 

Phrase: "Consequently,"

Phrase: "we"

Phrase: "cannot"

Phrase: "be"

Phrase: "sure"

Phrase: "whether"

Phrase: "these two minor cleavages"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0010813:cleavage [Cell Function]
   793   C0596311:Cleavage [Phenomenon or Process]
   793   C1330957:cleavage [Cell Function]

Phrase: "arise from the endosomal neutral glucagonase activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]
   748   C1882074:Neutral [Qualitative Concept]
   748   C2825492:Neutral [Phenomenon or Process]

Phrase: "or from endosomal acidic cathepsins B"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0699919:Cathepsins B [Amino Acid, Peptide, or Protein,Enzyme]
   773 E C1332804:CATHEPSIN B [Gene or Genome]
   753   C0001128:Acidic [Chemical]
   753   C0007428:Cathepsins [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "which"

Phrase: "may"

Phrase: "still"

Phrase: "remain"

Phrase: "active at neutral pH (22"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205177:Active [Functional Concept]

Phrase: ")."
Processing 00000000.tx.292: In either case, it is clear that the endosomal neutral glucagonase activity mainly favors cleavage of glucagon at polar amino acid residues (N-terminal region) and basic amino acid residues (central region), and that it exhibits additional specificity that limits further proteolysis of the C-terminal (1929) bioactive degradation product. 

Phrase: "In either case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0868928:Case [Functional Concept]
   861   C1706255:CASE [Medical Device]
   861   C1706256:Case [Conceptual Entity]

Phrase: "it"

Phrase: "is"

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "that"

Phrase: "the endosomal neutral glucagonase activity mainly"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0205177:Activity [Functional Concept]
   804   C0439167:% activity [Quantitative Concept]
   804   C0441655:Activity [Activity]
   804   C1561536:*Activity [Idea or Concept]

Phrase: "favors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "cleavage of glucagon"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0010813:cleavage [Cell Function]
   790   C0596311:Cleavage [Phenomenon or Process]
   790   C1330957:cleavage [Cell Function]

Phrase: "at polar amino acid residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   779   C1709915:Residue [Conceptual Entity]
   779   C1882936:RESIDUE [Phenomenon or Process]
   729 E C1609982:Residual [Qualitative Concept]

Phrase: "(N-terminal region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0017446:Region [Geographic Area]
   827   C0205147:Region [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "basic amino acid residues"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   779   C1709915:Residue [Conceptual Entity]
   779   C1882936:RESIDUE [Phenomenon or Process]
   756   C0301714:Basic Amino Acid [Amino Acid, Peptide, or Protein]
   729 E C1609982:Residual [Qualitative Concept]

Phrase: "(central region"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0454907:Central region [Geographic Area]
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "that"

Phrase: "it"

Phrase: "exhibits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "additional specificity"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0037791:Specificity [Quantitative Concept]
   861   C1511884:Specificity [Quantitative Concept]
   789 E C0205369:Specific [Qualitative Concept]
   789 E C1552740:specific [Intellectual Product]

Phrase: "that"

Phrase: "limits"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439801:limit [Functional Concept]
  1000   C1549649:Limit [Idea or Concept]
  1000   C2349209:Limit [Conceptual Entity]

Phrase: "further proteolysis of the C-terminal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0597304:Proteolysis [Molecular Function]

Phrase: "(1929"

Phrase: ")"

Phrase: "bioactive degradation product."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1514468:product [Entity]
   827   C1704444:Product [Quantitative Concept]
Processing 00000000.tx.293: It remains unclear as to how the endosomal (1929) fragment would come into contact with the plasma membrane Ca2+-Mg2+-adenosine triphosphatase. 

Phrase: "It"

Phrase: "remains"

Phrase: "unclear as to how"

Phrase: "the endosomal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0034850:Endosome [Cell Component]

Phrase: "(1929"

Phrase: ")"

Phrase: "fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "would"

Phrase: "come into contact"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0332158:contact [Functional Concept]
   790   C0337611:Contact [Population Group]
   790   C1705415:Contact [Idea or Concept]

Phrase: "with the plasma membrane Ca2+-Mg2+-adenosine triphosphatase."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0001473:Adenosine Triphosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1706373:Adenosine Triphosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0001443:Adenosine [Nucleic Acid, Nucleoside, or Nucleotide,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   799   C0312235:Triphosphatase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.294: Changes in the biological activity of molecules following processing in endosomes have previously been observed for PTH-(184) (Ref. 39), as well as endocytosed protein antigens for major histocompatibility class II presentation (40), with bioactive fragments released from the cells without delivery to lysosomes. 

Phrase: "Changes in the biological activity of molecules"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0392747:changes [Functional Concept]
   748   C0443172:changes [Quantitative Concept]
   714 E C1705241:Change [Quantitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "processing in endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1709694:Processing [Activity]

Phrase: "have"

Phrase: "previously"

Phrase: "been"

Phrase: "observed for PTH-(184"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1441672:Observed [Functional Concept]

Phrase: ")"

Phrase: "(Ref. 39"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "as well as"

Phrase: "endocytosed protein antigens for major histocompatibility class II presentation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0019630:Class II Major Histocompatibility Antigens [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Class II Histocompatibility Antigens
           Class II Antigens
   762   C0019628:Histocompatibility Antigens [Immunologic Factor]
   748   C1291777:Protein antigen [Immunologic Factor]
   745   C0206431:Antigen Presentation [Cell Function]
   742   C0003320:Antigens [Immunologic Factor]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "with bioactive fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "released from the cells"
Meta Candidates (Total=11; Excluded=7; Pruned=0; Remaining=4)
   770   C0007634:Cells [Cell]
   770   C0391871:Released [Functional Concept]
   770   C1283071:Released [Functional Concept]
   770   C3282337:Cells [Cell]
   737 E C0030685:Release [Health Care Activity]
   737 E C0439180:% release [Quantitative Concept]
   737 E C0680255:release [Health Care Activity]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "without delivery"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011209:Delivery [Therapeutic or Preventive Procedure]
  1000   C0559563:delivery [Finding]
  1000   C1705822:Delivery [Activity]

Phrase: "to lysosomes."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0024369:Lysosomes [Cell Component]
   966 E C2984253:Lysosome [Functional Concept]
   916 E C0521450:Lysosomal [Body Location or Region]
Processing 00000000.tx.295: Interestingly, activation of PTH-(184) to its bioactive peptide PTH-(134), a potent inhibitor of the (Ca2+-Mg2+)-adenosine triphosphatase activity (as is miniglucagon) at a concentration of 100 nM (41), is mediated in endosomes by cathepsin D and released to the extracellular medium within 1015 min (39). 

Phrase: "Interestingly,"

Phrase: "activation of PTH-(184"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: ")"

Phrase: "to its bioactive peptide PTH-(134"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: ")"

Phrase: ","

Phrase: "a potent inhibitor of the (Ca2+-Mg2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1999216:Inhibitor [Qualitative Concept]

Phrase: ")-"

Phrase: "adenosine triphosphatase activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C1148926:adenosine triphosphatase activity [Molecular Function]
   901   C1323433:triphosphatase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0001473:Adenosine Triphosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   734   C1706373:Adenosine Triphosphatase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(as is miniglucagon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0082712:miniglucagon [Amino Acid, Peptide, or Protein]

Phrase: ")"

Phrase: "at a concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 100 nM (41"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: ")"

Phrase: ","

Phrase: "is"

Phrase: "mediated in endosomes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0034850:Endosomes [Cell Component]
   790   C0086597:mediated [Social Behavior]
   790   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "by cathepsin D"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "released to the extracellular medium"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   760   C0009458:Medium [Intellectual Product]
   760   C0391871:Released [Functional Concept]
   760   C0439536:Medium [Quantitative Concept]
   760   C0521119:Extracellular [Cell Component]
   760   C1283071:Released [Functional Concept]
   760   C1705217:Medium [Substance]
   760   C3244283:medium [Intellectual Product]
   726 E C0030685:Release [Health Care Activity]
   726 E C0439180:% release [Quantitative Concept]
   726 E C0680255:release [Health Care Activity]
   726 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "within 1015 min (39"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0702093:/min [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.296: Our previous work on the glucagon receptor in rat liver showed that internalized endosomal glucagon receptors were recycled back to the cell surface with changes in glucagon-binding activity in plasma membrane completely reversed in less than 2 h (27). 

Phrase: "Our previous work on the glucagon receptor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0043227:Work [Occupational Activity]

Phrase: "in rat liver"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   861   C0023884:Liver [Body Part, Organ, or Organ Component]
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]
   861   C0736268:LIVER [Body Part, Organ, or Organ Component]
   861   C1278929:Liver [Body Part, Organ, or Organ Component]
   861   C2346688:LIVER [Food]
   805 E C0205054:Hepatic [Body Location or Region]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that internalized endosomal glucagon receptors"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0061352:Receptors, Glucagon [Amino Acid, Peptide, or Protein,Receptor]
   827 E C1415011:GLUCAGON RECEPTOR [Gene or Genome]
   812   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   812   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   812   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "were"

Phrase: "recycled"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282114:recycled [Human-caused Phenomenon or Process]

Phrase: "back to the cell surface"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0817086:Back surface [Body Location or Region]
   760   C0004600:Back [Body Location or Region]
   760   C0205095:Back [Spatial Concept]
   760   C0460009:Back [Body Location or Region]
   760   C1995000:Back [Body Location or Region]

Phrase: "with changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "in glucagon-binding activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C2266866:Binding Activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "in plasma membrane completely"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0007603:Plasma membrane [Cell Component]
   827   C0025255:Membrane [Tissue]
   827   C0032105:Plasma [Body Substance]
   827   C0596901:Membrane [Cell Component]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827   C1706182:Membrane [Manufactured Object]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "reversed in less"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1555029:Reverse [Idea or Concept]

Phrase: "than 2 h (27"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0011744:2 H [Element, Ion, or Isotope]
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]
   827   C0740116:+2 [Quantitative Concept]
   827   C2827735:2+ [Quantitative Concept]
   827   C2981700:2+ [Classification]

Phrase: ")."
Processing 00000000.tx.297: Thus, a retroendocytosis pathway, previously described for various ligands such as insulin (42), may also apply to the endosome-associated miniglucagon. 

Phrase: "Thus,"

Phrase: "a retroendocytosis pathway,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "previously"

Phrase: "described for various ligands"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0023688:Ligands [Chemical]
   770   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   770   C1552738:described [Idea or Concept]

Phrase: "such as insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(42"

Phrase: ")"

Phrase: ","

Phrase: "may"

Phrase: "also"

Phrase: "apply to the endosome-associated miniglucagon."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   753   C0034850:Endosome [Cell Component]
   753   C0082712:miniglucagon [Amino Acid, Peptide, or Protein]
   753   C0185125:Apply [Health Care Activity]
   753   C0332281:Associated [Qualitative Concept]
   753   C1632850:Apply [Functional Concept]
   753   C1879355:Apply [Functional Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.298: In support of this hypothesis, biochemical assays have shown that plasma membranes were able to fuse with early endosomes containing previously internalized ligands (43). 

Phrase: "In support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "of this hypothesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "biochemical assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that plasma membranes"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0007603:Plasma Membranes [Cell Component]
   861   C0025255:Membranes [Tissue]
   861   C0032105:Plasma [Body Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   827 E C0596901:Membrane [Cell Component]
   827 E C1706182:Membrane [Manufactured Object]
   777 E C0205287:Membranous [Qualitative Concept]

Phrase: "were"

Phrase: "able to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0085732:Able [Organism Attribute]
   861   C1299581:Able [Finding]

Phrase: "fuse with early endosomes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   816   C0887883:Early endosome [Cell Component]
   770   C0034850:Endosomes [Cell Component]
   770   C0699952:fuse [Functional Concept]
   770   C1279919:Early [Temporal Concept]
   770   C1414861:FUSE [Gene or Genome]
   770   C1708111:Fuse [Manufactured Object]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "previously internalized ligands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023688:Ligands [Chemical]

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.299: Interestingly, using circular dichroism and fluorescence spectroscopy, it has been shown that the Ca2+-binding capacity of glucagon is maintained in the (1929) fragment, and that both peptides display some ability to penetrate the lipid bilayer in a hydrophobic environment with the bound Ca2+ ion (44). 

Phrase: "Interestingly,"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "circular dichroism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0008813:Circular Dichroism [Laboratory Procedure]
   861   C0596436:dichroism [Natural Phenomenon or Process]
   861   C1282913:Circular [Spatial Concept]

Phrase: "and"

Phrase: "fluorescence spectroscopy,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0242506:Fluorescence Spectroscopy [Laboratory Procedure]
   861   C0037812:spectroscopy [Laboratory Procedure]
   861   C2713504:Spectroscopy [Occupation or Discipline]
   861   C2984732:SPECTROSCOPY [Functional Concept]

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the Ca2+-binding capacity of glucagon"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0439155:Binding capacity [Quantitative Concept]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]
   753   C1516240:Capacity [Quantitative Concept]

Phrase: "is"

Phrase: "maintained in the (1929"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1314677:Maintained [Functional Concept]
   737 E C0024501:Maintain [Activity]

Phrase: ")"

Phrase: "fragment,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "and"

Phrase: "that"

Phrase: "both peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "display"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705417:Display [Manufactured Object]

Phrase: "some ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "penetrate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205321:penetrate [Functional Concept]

Phrase: "the lipid bilayer in a hydrophobic environment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0023768:Lipid bilayer [Cell Component]
   774   C0023767:Lipid A [Immunologic Factor,Lipid]
   748   C0023779:Lipid [Lipid]

Phrase: "with the bound Ca2+ ion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0022023:Ion [Element, Ion, or Isotope]
   827   C1700702:ION [Functional Concept]

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.300: Thus, translocation of the (1929) bioactive glucagon fragment across the endosomal membrane, comparable to that observed for bacterial and plant toxins (45), cannot be formally excluded. 

Phrase: "Thus,"

Phrase: "translocation of the (1929"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040715:Translocation [Cell or Molecular Dysfunction]
   770   C2987521:Translocation [Activity]

Phrase: ")"

Phrase: "bioactive glucagon fragment across the endosomal membrane,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332255:fragment [Functional Concept]
   748   C1708096:Fragment [Qualitative Concept]

Phrase: "comparable to that"

Phrase: "observed for bacterial"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0521009:Bacterial [Qualitative Concept]
   790   C1441672:Observed [Functional Concept]
   718 E C0004611:Bacteria [Bacterium]
   718 E C1510439:bacteria [Functional Concept]
   718 E C2347473:% Bacteria [Quantitative Concept]

Phrase: "and"

Phrase: "plant toxins"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0032086:plant toxins [Biologically Active Substance,Hazardous or Poisonous Substance,Organic Chemical]
   861   C0032098:Plant [Plant]
   861   C0040549:Toxins [Biologically Active Substance,Hazardous or Poisonous Substance]
   768 E C0006038:Botany [Occupation or Discipline]
   750 E C1456557:Botanical [Organic Chemical,Pharmacologic Substance]

Phrase: "(45"

Phrase: ")"

Phrase: ","

Phrase: "cannot"

Phrase: "be"

Phrase: "formally"

Phrase: "excluded."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]
Processing 00000000.tx.301: Additionally, the endocytic breakdown pathway may also represent an intermediate stage before endolysosomal transfer and subsequent lysosomal degradation of glucagon metabolites. 

Phrase: "Additionally,"

Phrase: "the endocytic breakdown pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "may"

Phrase: "also"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "an intermediate stage before endolysosomal transfer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205390:Stage [Temporal Concept]
   753   C1300072:Stage [Clinical Attribute]
   753   C1306673:Stage [Qualitative Concept]

Phrase: "and"

Phrase: "subsequent lysosomal degradation of glucagon metabolites."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]
Processing 00000000.tx.302: Cross-linking has been shown to be effective in the detection of non-covalently associated radiolabeled substrate-protease complexes (8, 25). 

Phrase: "Cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "effective in the detection of non-covalently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280519:effective [Qualitative Concept]
   748   C1704419:Effective [Qualitative Concept]

Phrase: "associated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332281:Associated [Qualitative Concept]
   966 E C0750490:Associate [Idea or Concept]
   966 E C1706221:Associate [Professional or Occupational Group]

Phrase: "radiolabeled substrate-protease complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1704241:Complexes [Chemical Viewed Structurally]
   779 E C0439855:Complex [Qualitative Concept]

Phrase: "(8,"

Phrase: "25"

Phrase: ")."
Processing 00000000.tx.303: Thus, following incubation of cytosol with [125I]iodoinsulin (25) or [125I]iodoglucagon (8) at neutral pH in the presence of disuccinimidyl suberate or bis(sulfosuccinimidyl) suberate (BS3), radiolabeled ligands were found in cross-linked IDE complexes of 110 kDa. 

Phrase: "Thus,"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "incubation of cytosol"

Phrase: "with"

Phrase: "[125I"

Phrase: "]iodoinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0063651:insulin, iodo- [Amino Acid, Peptide, or Protein]

Phrase: "(25"

Phrase: ")"

Phrase: "or [125I"

Phrase: "]iodoglucagon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0063780:iodoglucagon [Amino Acid, Peptide, or Protein]

Phrase: "(8"

Phrase: ")"

Phrase: "at neutral pH"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:Neutral pH [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of disuccinimidyl suberate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0058479:disuccinimidyl suberate [Organic Chemical,Pharmacologic Substance]
   861   C0947344:Suberate [Organic Chemical]

Phrase: "or"

Phrase: "bis("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0556985:BIS [Temporal Concept]
  1000   C2247301:BIS [Molecular Function]
  1000   C3540495:BIS [Intellectual Product]

Phrase: "sulfosuccinimidyl"

Phrase: ")"

Phrase: "suberate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0947344:Suberate [Organic Chemical]

Phrase: "(BS3"

Phrase: ")"

Phrase: ","

Phrase: "radiolabeled ligands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023688:Ligands [Chemical]

Phrase: "were"

Phrase: "found in"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C0150312:Found [Quantitative Concept]
   799 E C0243095:Find [Finding]

Phrase: "cross-linked"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178576:Cross Linked [Natural Phenomenon or Process]
  1000   C0332220:cross linked [Functional Concept]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "IDE complexes of 110 kDa."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C1704241:Complexes [Chemical Viewed Structurally]
   745   C0026741:enzyme complex [Amino Acid, Peptide, or Protein,Enzyme]
   714 E C0439855:Complex [Qualitative Concept]
Processing 00000000.tx.304: Using a similar approach, we have previously reported the affinity labeling at acidic pH of [125I]iodo-EGF and [125I]iodoglucagon to endosomal cathepsin B using BS3 as the cross-linker (8, 22). 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a similar approach,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449445:Approach [Spatial Concept]

Phrase: "we"

Phrase: "have"

Phrase: "previously"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "the affinity labeling at acidic pH of [125I"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0178463:affinity labeling [Laboratory or Test Result]
   744   C1167624:Labeling [Mental Process]
   744   C1947902:Labeling [Manufactured Object]
   744   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "]iodo-EGF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   923   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   923   C1323367:epidermal growth factor [Molecular Function]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0014520:Epidermal [Tissue]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C0221920:Epidermal [Spatial Concept]
   812   C1521761:Factor [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]

Phrase: "and ["

Phrase: "125I"

Phrase: "]iodoglucagon to endosomal cathepsin B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0063780:iodoglucagon [Amino Acid, Peptide, or Protein]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "BS3 as the cross-linker"

Phrase: "(8,"

Phrase: "22"

Phrase: ")."
Processing 00000000.tx.305: We found that both disuccinimidyl suberate and BS3 were ineffective at cross-linking [125I]iodoglucagon to endosomal neutral glucagonase or to glucagon receptor at pH 7 (results not shown). 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "both disuccinimidyl suberate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0058479:disuccinimidyl suberate [Organic Chemical,Pharmacologic Substance]
   861   C0947344:Suberate [Organic Chemical]

Phrase: "and"

Phrase: "BS3"

Phrase: "were"

Phrase: "ineffective at"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C3242229:ineffective [Idea or Concept]

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "[125I"

Phrase: "]iodoglucagon to endosomal neutral glucagonase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0063780:iodoglucagon [Amino Acid, Peptide, or Protein]

Phrase: "or to glucagon receptor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0061352:Glucagon Receptor [Amino Acid, Peptide, or Protein,Receptor]
   833   C1415011:GLUCAGON RECEPTOR [Gene or Genome]
   770   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   770   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   770   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "at pH 7"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:pH 7 [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "(results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.306: However, we did detect a 170-kDa endosomal glucagon-binding protein using the zero-length water-soluble cross-linker EDC, which catalyzes the formation of peptide bonds between amino and carboxyl groups. 

Phrase: "However,"

Phrase: "we"

Phrase: "did"

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "a 170-kDa endosomal glucagon-binding protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0243122:binding [Functional Concept]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the zero-length water-soluble cross-linker EDC,"

Phrase: "which"

Phrase: "catalyzes"

Phrase: "the formation of peptide bonds"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0678616:peptide bond formation [Natural Phenomenon or Process]
   797   C1327133:peptide formation [Molecular Function]
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "between amino"

Phrase: "and"

Phrase: "carboxyl groups."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0596260:Carboxyl Group [Organic Chemical]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
Processing 00000000.tx.307: This chemical cross-linker has been used extensively to identify polypeptides that are in close proximity such as skeletal essential light chain-1 and F-actin (46) or profilin and /-actin (47). 

Phrase: "This chemical cross-linker"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828360:Cross [Conceptual Entity]

Phrase: "has"

Phrase: "been"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "extensively to"

Phrase: "identify"

Phrase: "polypeptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1305923:Polypeptides [Amino Acid, Peptide, or Protein]

Phrase: "that"

Phrase: "are in close proximity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0587267:Close [Functional Concept]
   770   C1514583:Proximity [Spatial Concept]
   770   C1551058:Are [Quantitative Concept]

Phrase: "such as skeletal essential light chain-1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   804   C0023693:Light [Natural Phenomenon or Process]
   804   C0037253:skeletal [Body System]
   804   C0205224:Essential [Qualitative Concept]
   804   C0337112:Chain [Manufactured Object]
   804   C0521324:Skeletal [Spatial Concept]
   804   C1306462:Light [Functional Concept]
   804   C1524075:Chain [Idea or Concept]
   804   C1881376:Light [Qualitative Concept]

Phrase: "and"

Phrase: "F-actin"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C1180307:F-Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1622186:F-actin [Cell Component]
   861   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
   789 E C0439681:Actinic [Qualitative Concept]

Phrase: "(46"

Phrase: ")"

Phrase: "or"

Phrase: "profilin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0072074:Profilin [Amino Acid, Peptide, or Protein]

Phrase: "and /-"

Phrase: "actin"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   928 E C0439681:Actinic [Qualitative Concept]

Phrase: "(47"

Phrase: ")."
Processing 00000000.tx.308: The 170-kDa affinity-labeled protein we have identified in this present study is likely to be the endosomal neutral glucagonase, because 1) [125I]iodoglucagon bound to the protein with a high affinity (IC50 5 x 10-7 M) and specificity, and 2) the binding of [125I]iodoglucagon to the protein was completely abolished by a low concentration of bacitracin, a known inhibitor of endosomal neutral glucagonase. 

Phrase: "The 170-kDa affinity-labeled protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "we"

Phrase: "have"

Phrase: "identified in this present study"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0150312:Present [Quantitative Concept]
   760   C0205396:Identified [Qualitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   760   C2603343:Study [Research Activity]

Phrase: "is"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "the endosomal neutral glucagonase,"

Phrase: "because"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "[125I"

Phrase: "]iodoglucagon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0063780:iodoglucagon [Amino Acid, Peptide, or Protein]

Phrase: "bound to the protein"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   819   C0522527:Protein bound [Qualitative Concept]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0332297:bound [Spatial Concept]
   770   C1145667:Bound [Activity]
   770   C1167622:Bound [Molecular Function]
   770   C1689898:% bound [Quantitative Concept]
   770   C2349209:Bound [Conceptual Entity]

Phrase: "with a high affinity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205250:High [Qualitative Concept]
   861   C1299351:High [Qualitative Concept]
   861   C1510827:Affinity [Natural Phenomenon or Process]
   861   C2700149:HIGH [Intellectual Product]

Phrase: "(IC50 5 x 10-7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0600495:IC50 [Quantitative Concept]

Phrase: "M)"

Phrase: "and"

Phrase: "specificity,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0037791:Specificity [Quantitative Concept]
  1000   C1511884:Specificity [Quantitative Concept]
   928 E C0205369:Specific [Qualitative Concept]
   928 E C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "the binding of [125I"

Phrase: "]iodoglucagon to the protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0063780:iodoglucagon [Amino Acid, Peptide, or Protein]

Phrase: "was"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "abolished by a low concentration of bacitracin,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   748   C0086045:Concentration [Mental Process]
   748   C0205251:low [Qualitative Concept]
   748   C1299352:Low [Qualitative Concept]
   748   C1446561:Concentration [Quantitative Concept]
   748   C1550472:low [Idea or Concept]

Phrase: "a known inhibitor of endosomal neutral glucagonase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.309: Other characteristics of the 170-kDa glucagon-binding protein include the following: 1) lack of sensitivity to GTP, 2) sensitivity to N-glycanase, 3) capacity to specifically bind the radiolabeled [Tyr12]-miniglucagon derivate, and 4) inability to be linked covalently to radiolabeled glucagon using DFDNB as the cross-linker. 

Phrase: "Other characteristics of the 170-kDa glucagon-binding protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1521970:Characteristics [Qualitative Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "the following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "lack of sensitivity"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C0036667:Sensitivity [Quantitative Concept]
   790   C0312418:Sensitivity [Mental Process]
   790   C0332268:lack [Qualitative Concept]
   790   C0427965:Sensitivity [Finding]
   790   C1511883:Sensitivity [Quantitative Concept]
   790   C1522640:Sensitivity [Qualitative Concept]
   790   C2346484:SENSITIVITY [Phenomenon or Process]
   790   C2349185:Sensitivity [Qualitative Concept]
   718 E C0332324:Sensitive [Functional Concept]
   718 E C1550474:sensitive [Idea or Concept]

Phrase: "to GTP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018353:GTP [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "sensitivity to N-glycanase,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   797   C0332324:Sensitive to [Functional Concept]
   770   C0036667:Sensitivity [Quantitative Concept]
   770   C0312418:Sensitivity [Mental Process]
   770   C0427965:Sensitivity [Finding]
   770   C1511883:Sensitivity [Quantitative Concept]
   770   C1522640:Sensitivity [Qualitative Concept]
   770   C2346484:SENSITIVITY [Phenomenon or Process]
   770   C2349185:Sensitivity [Qualitative Concept]

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "capacity to specifically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1516240:Capacity [Quantitative Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "the radiolabeled"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527121:Radiolabeled [Qualitative Concept]
   966 E C0597354:radiolabel [Indicator, Reagent, or Diagnostic Aid]

Phrase: "[Tyr12"

Phrase: "]-miniglucagon derivate,"

Phrase: "and"

Phrase: "4"

Phrase: ")"

Phrase: "inability to"

Phrase: "be"

Phrase: "linked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: "covalently to radiolabeled glucagon"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   770   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1527121:Radiolabeled [Qualitative Concept]
   737 E C0597354:radiolabel [Indicator, Reagent, or Diagnostic Aid]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "DFDNB as the cross-linker."
Processing 00000000.tx.310: With the exception of N-glycosylation, all of these characteristics clearly distinguish the 170-kDa glucagon-binding protein from the glucagon receptor. 

Phrase: "With the exception"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1554961:exception [Idea or Concept]
  1000   C1705847:Exception [Conceptual Entity]

Phrase: "of N-glycosylation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017982:glycosylation [Natural Phenomenon or Process]
   861   C0376322:Glycosylation [Molecular Function]

Phrase: "all of these characteristics clearly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0444868:All [Quantitative Concept]
   760   C1521970:Characteristics [Qualitative Concept]
   760   C3539085:All [Idea or Concept]

Phrase: "distinguish"

Phrase: "the 170-kDa glucagon-binding protein from the glucagon receptor."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   775   C1512202:Glucagon Receptor Binding [Molecular Function]
   760   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757 E C0033618:Protein Binding [Molecular Function]
   757   C0597357:Receptor Protein [Amino Acid, Peptide, or Protein,Receptor]
   757   C0597358:Receptor Binding [Molecular Function]
   739   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0243122:binding [Functional Concept]
   739   C1145667:Binding [Activity]
   739   C1167622:Binding [Molecular Function]
Processing 00000000.tx.311: In agreement with our demonstration of the presence of a neutral basic processing activity within hepatic endosomes, the dibasic substrate human proinsulin and the monobasic substrate chicken proalbumin were shown to be processed, respectively, at the Arg-Arg and Arg-Phe-Ala-Arg sites in Triton X-100-solubilized liver endosomal extracts at pH 6 (34). 

Phrase: "In agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680240:Agreement [Social Behavior]

Phrase: "with our demonstration"

Phrase: "of the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of a neutral basic processing activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "within hepatic endosomes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034850:Endosomes [Cell Component]

Phrase: "the dibasic substrate human proinsulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0086418:Human [Human]

Phrase: "and"

Phrase: "the monobasic substrate chicken proalbumin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0032923:Proalbumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "processed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522240:Processed [Phenomenon or Process]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: ","

Phrase: "respectively,"

Phrase: "at the Arg-Arg"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0653858:Arg-Arg [Amino Acid, Peptide, or Protein]

Phrase: "and"

Phrase: "Arg-Phe-Ala-Arg sites"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   804   C0205145:Sites [Spatial Concept]
   771 E C1515974:Site [Body Location or Region]
   771 E C2825164:Site [Spatial Concept]
   708   C0653858:Arg-Arg [Amino Acid, Peptide, or Protein]

Phrase: "in Triton X-100-solubilized liver endosomal extracts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   829   C0023899:Liver Extracts [Organic Chemical,Pharmacologic Substance]
   762   C2828366:Extract [Substance]

Phrase: "at pH 6"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.312: In these studies, proinsulin and proalbumin processing was attributed to Ca2+-dependent furin, a subtilisin-like endoprotease that processes a number of proteins in liver with a preference for dibasic residues preceded by an additional basic residue at the -4 position (48). 

Phrase: "In these studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033362:Proinsulin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "proalbumin processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709694:Processing [Activity]

Phrase: "was"

Phrase: "attributed to Ca2+-dependent furin,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0851827:Dependent [Qualitative Concept]
   760   C0919550:FURIN [Gene or Genome]
   760   C1701901:Dependent [Qualitative Concept]
   760   C3244310:dependent [Functional Concept]
   726   C0449234:Attribute [Idea or Concept]
   726   C1704772:Attribute [Conceptual Entity]
   726   C1882133:Attribute [Qualitative Concept]

Phrase: "a subtilisin-like endoprotease"

Phrase: "that processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1184743:Process [Body Part, Organ, or Organ Component]
   966   C1522240:Process [Phenomenon or Process]

Phrase: "a number of proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "in liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "with a preference"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0558295:preference [Idea or Concept]
  1000   C1549513:Preference [Idea or Concept]

Phrase: "for dibasic residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "preceded by an additional basic residue"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0332152:preceded [Temporal Concept]
   753   C1524062:Additional [Functional Concept]
   753   C1527178:Basic [Functional Concept]
   753   C1709915:Residue [Conceptual Entity]
   753   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "at the -4 position"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0733755:Position [Spatial Concept]
   789 E C0240795:POSITIONAL [Finding]

Phrase: "(48"

Phrase: ")."
Processing 00000000.tx.313: In intracellular vesicles, the same transmembrane serine protease was shown to cleave internalized Pseudomonas exotoxin A after Arg279, generating the active 37-kDa carboxyl-terminal fragment that translocates from endocytic vesicles to the cytosol (49). 

Phrase: "In intracellular vesicles,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333262:VESICLES [Acquired Abnormality]
   827 E C1622418:vesicle [Cell Component]
   777 E C0205378:Vesicular [Qualitative Concept]

Phrase: "the same transmembrane serine protease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0036734:serine protease [Amino Acid, Peptide, or Protein,Enzyme]
   861   C2717971:Serine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C1947941:Protease [Enzyme]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "cleave"

Phrase: "internalized Pseudomonas exotoxin A after Arg279,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0015309:Exotoxin [Hazardous or Poisonous Substance]
   753   C0033808:Pseudomonas [Bacterium]
   753   C0314768:Exotoxin [Biologically Active Substance,Hazardous or Poisonous Substance]

Phrase: "generating"

Phrase: "the active 37-kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1532717:kDa [Quantitative Concept]

Phrase: "carboxyl-terminal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205088:Terminal [Temporal Concept]
   861   C0596260:Carboxyl [Organic Chemical]
   861   C1705314:Terminal [Manufactured Object]
   861   C1705315:Terminal [Spatial Concept]

Phrase: "fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "that"

Phrase: "translocates from endocytic vesicles"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0887883:Endocytic Vesicles [Cell Component]
   770   C0333262:VESICLES [Acquired Abnormality]
   737 E C1622418:vesicle [Cell Component]

Phrase: "to the cytosol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosol [Cell Component]

Phrase: "(49"

Phrase: ")."
Processing 00000000.tx.314: A role for furin in the intracellular processing of endocytosed Diphtheria toxin at Arg190-Val191-Arg192-Arg193 and anthrax toxin at Arg164-Lys165-Lys166-Arg167 has also been demonstrated (50). 

Phrase: "A role for furin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in the intracellular processing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1709694:Processing [Activity]

Phrase: "of endocytosed Diphtheria toxin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0012550:Diphtheria Toxin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Hazardous or Poisonous Substance]
   827   C0012546:DIPHTERIA [Disease or Syndrome]
   827   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]

Phrase: "at Arg190-Val191-Arg192-Arg193"

Phrase: "and"

Phrase: "anthrax toxin at Arg164-Lys165-Lys166-Arg167"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0051962:anthrax toxin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Hazardous or Poisonous Substance]
   748   C0003175:Anthrax [Disease or Syndrome]
   748   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]
   748   C1254288:Anthrax [Eukaryote]

Phrase: "has"

Phrase: "also"

Phrase: "been"

Phrase: "demonstrated"

Phrase: "(50"

Phrase: ")."
Processing 00000000.tx.315: Finally, immunoblotting has detected furin in rat liver Golgi-ENs (this study; Ref. 35), and endogenous furin has been found within early endosomes of various cells (51). 

Phrase: "Finally,"

Phrase: "immunoblotting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "has"

Phrase: "detected furin in rat liver Golgi-ENs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0919550:FURIN [Gene or Genome]

Phrase: "("

Phrase: "this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "; Ref. 35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "endogenous furin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0919550:FURIN [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "found within early endosomes of various cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   762   C0887883:Early endosome [Cell Component]
   748   C0007634:Cells [Cell]
   748   C0034850:Endosomes [Cell Component]
   748   C0150312:Found [Quantitative Concept]
   748   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   748   C1279919:Early [Temporal Concept]
   748   C3282337:Cells [Cell]
   714 E C0243095:Find [Finding]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "(51"

Phrase: ")."
Processing 00000000.tx.316: These data are consistent with the endocytosis of cell surface furin to early endosomes (52). 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "consistent with the endocytosis of cell surface furin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "to early endosomes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0887883:Early endosome [Cell Component]
   861   C0034850:Endosomes [Cell Component]

Phrase: "(52"

Phrase: ")."
Processing 00000000.tx.317: The endosomal glucagon-degrading enzyme described here differs from furin proteolytic activity in several respects: 1) the endosomal neutral glucagonase activity was not inhibited by metal-chelating reagents such as EDTA and EGTA, whereas Ca2+ was strictly required for furin activity; 

Phrase: "The endosomal glucagon-degrading enzyme"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   923   C0298190:glucagon-degrading enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "here"

Phrase: "differs from furin proteolytic activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   797   C1150256:furin activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C0597304:Proteolytic [Molecular Function]
   760   C0919550:FURIN [Gene or Genome]
   760   C1561536:*Activity [Idea or Concept]
   760   C1947941:proteolytic [Enzyme]

Phrase: "in several respects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0679133:respects [Social Behavior]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "the endosomal neutral glucagonase activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "inhibited by metal-chelating reagents"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0025552:Metal [Inorganic Chemical]
   760   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]
   760   C0311403:Inhibited [Qualitative Concept]
   760   C3537131:Chelating [Molecular Function]

Phrase: "such as EDTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "whereas"

Phrase: "Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "was"

Phrase: "strictly"

Phrase: "required for furin activity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C1150256:furin activity [Molecular Function]
   770   C0205177:Activity [Functional Concept]
   770   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C0919550:FURIN [Gene or Genome]
   770   C1514873:Required [Functional Concept]
   770   C1561536:*Activity [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.318: 2) quantitative immunodepletion of endosomal furin failed to reduce neutral glucagonase activity; 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "quantitative immunodepletion of endosomal furin"

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reduce"

Phrase: "neutral glucagonase activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.319: 3) no degradation products were observed when pure active furin was incubated with glucagon under conditions for which cleavage of various furin substrates were reported (53); 

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "no degradation products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "when"

Phrase: "pure active furin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0919550:FURIN [Gene or Genome]

Phrase: "was"

Phrase: "incubated with glucagon"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   790   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "under conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "for which cleavage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0010813:cleavage [Cell Function]
  1000   C0596311:Cleavage [Phenomenon or Process]
  1000   C1330957:cleavage [Cell Function]

Phrase: "of various furin substrates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1710236:Substrate [Manufactured Object]

Phrase: "were"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(53"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.320: 4) furin recognition sequences (-Arg-X-Lys/Arg-Arg- or -Lys/Arg-X-X-X-Lys/Arg-Arg-) are not present in the glucagon molecule, especially a basic residue at the -4 or -6 positions (54); 

Phrase: "4"

Phrase: ")"

Phrase: "furin recognition sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0162326:Sequences [Nucleotide Sequence]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]

Phrase: "(-Arg-X-Lys/Arg-Arg- or -Lys/Arg-X-X-X-Lys/Arg-Arg-)"

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "present in the glucagon molecule,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0567416:Molecule [Substance]
   760   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "especially"

Phrase: "a basic residue at the -4 or -6 positions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1709915:Residue [Conceptual Entity]
   742   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "(54"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.321: and 5) with the exception of the Arg18-Ala19 cleavage site, the other five major cleavages do not occur at a dibasic peptide bond. 

Phrase: "and"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "with the exception"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1554961:exception [Idea or Concept]
  1000   C1705847:Exception [Conceptual Entity]

Phrase: "of the Arg18-Ala19 cleavage site,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205145:Site [Spatial Concept]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]

Phrase: "the"

Phrase: "other five major cleavages"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0010813:cleavage [Cell Function]
   793   C0596311:Cleavage [Phenomenon or Process]
   793   C1330957:cleavage [Cell Function]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "occur at a dibasic peptide bond."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0678595:peptide bond [Natural Phenomenon or Process]
   753   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   753   C1709305:Occur [Activity]
   753   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.322: In addition, the possibility that the 170-kDa glycoprotein that was linked covalently to [125I]iodoglucagon represented furin was ruled out by the following: 1) its molecular mass (170 kDa) being distinct from that of furin, which is reported to be approximately 8590 kDa by SDS-PAGE as shown by ourselves in the present study and others (53); 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "the possibility"

Phrase: "that"

Phrase: "the 170-kDa glycoprotein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017968:Glycoprotein [Amino Acid, Peptide, or Protein,Carbohydrate]

Phrase: "that"

Phrase: "was"

Phrase: "linked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: "covalently to [125I"

Phrase: "]iodoglucagon represented furin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0919550:FURIN [Gene or Genome]

Phrase: "was"

Phrase: "ruled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1446409:ruled [Qualitative Concept]
   966 E C0805874:Rule [Idea or Concept]
   966 E C0870077:Rule [Intellectual Product]

Phrase: "out by the following"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439787:Out [Spatial Concept]
   770   C0849355:Out [Qualitative Concept]
   737   C0332283:follow [Temporal Concept]
   737   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "its molecular mass"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   861   C0577559:Mass [Finding]
   861   C1306372:*Mass [Quantitative Concept]

Phrase: "(170 kDa)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1532717:kDa [Quantitative Concept]

Phrase: "being"

Phrase: "distinct from that of furin,"

Phrase: "which"

Phrase: "is"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "approximately 8590 kDa by SDS-PAGE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1532717:kDa [Quantitative Concept]

Phrase: "as"

Phrase: "shown by ourselves"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]

Phrase: "in the present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "and"

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "(53"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.323: 2) the absence of an effect with EGTA-treated endosomes on the 125I labeling of the 170-kDa complex when compared with experiments omitting this furin inhibitor; 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "the absence of an effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:absence [Quantitative Concept]
   760   C1689985:Absence [Anatomical Abnormality]

Phrase: "with EGTA-treated endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034850:Endosomes [Cell Component]

Phrase: "on the 125I labeling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1167624:Labeling [Mental Process]
   861   C1947902:Labeling [Manufactured Object]
   861   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "of the 170-kDa complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439855:Complex [Qualitative Concept]
   827   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "when"

Phrase: "compared with experiments"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0681814:Experiments [Research Activity]
   790   C1707455:Compared [Activity]
   756 E C1706386:Experiment [Conceptual Entity]
   706 E C1517586:Experimental [Qualitative Concept]

Phrase: "omitting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750563:omitting [Idea or Concept]

Phrase: "this furin inhibitor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1999216:Inhibitor [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.324: and 3) the failure to immunoprecipitate the 170-kDa glycoprotein using anti-furin antibody. 

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "the failure to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0231174:Failure [Functional Concept]
   861   C0680095:failure [Individual Behavior]

Phrase: "immunoprecipitate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0301871:Immunoprecipitate [Immunologic Factor]

Phrase: "the 170-kDa glycoprotein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017968:Glycoprotein [Amino Acid, Peptide, or Protein,Carbohydrate]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-furin antibody."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.325: Using similar criteria, other glucagon-degrading enzymes previously proposed as being physiologically relevant to the mechanism of glucagon clearance from liver and plasma serum differ from the neutral glucagonase described here. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "similar criteria,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0243161:criteria [Intellectual Product]

Phrase: "other glucagon-degrading enzymes previously"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   912   C0298190:glucagon-degrading enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0014442:Enzymes [Enzyme,Organic Chemical]
   812   C0014445:enzymes [Functional Concept]

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "as"

Phrase: "being"

Phrase: "physiologically relevant to the mechanism of glucagon clearance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C2347946:Relevant [Qualitative Concept]

Phrase: "from liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "and"

Phrase: "plasma serum"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0487953:plasma serum [Clinical Attribute]
   861   C0229671:Serum [Body Substance]
   861   C1546774:Serum [Intellectual Product]
   861   C1550100:Serum [Body Substance]

Phrase: "differ from the neutral glucagonase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1882074:Neutral [Qualitative Concept]
   760   C2825492:Neutral [Phenomenon or Process]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "here."
Processing 00000000.tx.326: Thus, the neutral glucagon-processing enzyme differs from the following: 1) IDE, a metalloendopeptidase of 110 kDa that generates glucagon degradation products that are structurally different from those described in the present study (9) and 2) the serine protease dipeptidyl peptidase IV, which is relatively insensitive to PMSF (55), displays a molecular mass of 105 kDa in rat hepatocytes (56), and removes the N-terminal dipeptides His1-Ser2 and Gln3-Gly4 from native glucagon (14). 

Phrase: "Thus,"

Phrase: "the neutral glucagon-processing enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0014442:Enzyme [Enzyme,Organic Chemical]
   729 E C0014445:enzymes [Functional Concept]

Phrase: "differs from the following"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0332283:follow [Temporal Concept]
   737   C1719822:Follow [Intellectual Product]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "IDE,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "a metalloendopeptidase of 110 kDa"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1442934:Metalloendopeptidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "that"

Phrase: "generates"

Phrase: "glucagon degradation products"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   896   C0017687:Glucagon product [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]

Phrase: "that"

Phrase: "are"

Phrase: "structurally different from those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1705242:Different [Qualitative Concept]

Phrase: "described in the present study"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C1552738:described [Idea or Concept]
   760   C2603343:Study [Research Activity]

Phrase: "(9"

Phrase: ")"

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "the serine protease dipeptidyl peptidase IV,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0081937:Dipeptidyl-Peptidase IV [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   884   C1414141:DIPEPTIDYL PEPTIDASE IV [Gene or Genome]
   875   C0072327:protease IV [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0022709:dipeptidyl peptidase [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   804   C0030940:Peptidase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1947941:Peptidase [Enzyme]

Phrase: "which"

Phrase: "is"

Phrase: "relatively insensitive to PMSF"

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "displays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0870432:displays [Functional Concept]
  1000   C1705417:Display [Manufactured Object]

Phrase: "a molecular mass of 105 kDa"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   783   C0577559:A mass [Finding]
           Mass
   753   C1306372:*Mass [Quantitative Concept]

Phrase: "in rat hepatocytes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0227525:Hepatocytes [Cell]
   827 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(56"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "removes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "the N-terminal dipeptides His1-Ser2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1416526:SER2 [Gene or Genome]
   804   C2827379:SER2 [Gene or Genome]

Phrase: "and"

Phrase: "Gln3-Gly4 from native glucagon"

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.327: However, other members of the subtilisin-like proprotein convertase (PCs) (i.e. PC1, PC2, paired basic amino acid converting enzyme 4, PC4, PC5, and PC7) may be putative candidates, but their presence in the endosomal compartment of hepatic parenchyma and their catalytic activity toward the mature glucagon hormone have not been investigated (57, 58). 

Phrase: "However,"

Phrase: "other members of the subtilisin-like proprotein convertase (PCs)"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0680022:members [Population Group]
   711 E C2698041:Member [Professional or Occupational Group]

Phrase: "(i.e. PC1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0683454:I-E [Diagnostic Procedure,Intellectual Product]

Phrase: "PC2,"

Phrase: "paired"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709450:Paired [Qualitative Concept]

Phrase: "basic amino acid converting enzyme 4,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   861   C0301714:Basic Amino Acid [Amino Acid, Peptide, or Protein]
   827   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C2917660:Amino Acid [Pharmacologic Substance]
   799   C0001128:Acid [Chemical]
   799   C0014442:Enzyme [Enzyme,Organic Chemical]
   799   C0202406:Acid [Laboratory Procedure]
   799   C1527178:Basic [Functional Concept]
   727 E C0920750:basicity [Quantitative Concept]
   716 E C0014445:enzymes [Functional Concept]

Phrase: "PC4,"

Phrase: "PC5,"

Phrase: "and"

Phrase: "PC7"

Phrase: ")"

Phrase: "may"

Phrase: "be"

Phrase: "putative candidates,"

Phrase: "but"

Phrase: "their presence in the endosomal compartment of hepatic parenchyma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "their catalytic activity toward the mature glucagon hormone"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0243102:catalytic activity [Molecular Function]
   770   C1264638:Catalytic activity [Functional Concept]
   770   C1547012:*Catalytic Activity [Quantitative Concept]
   767   C1149475:hormone activity [Molecular Function]
   744   C0205177:Activity [Functional Concept]
   744   C0439167:% activity [Quantitative Concept]
   744   C0441655:Activity [Activity]
   744   C1561536:*Activity [Idea or Concept]

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "(57,"

Phrase: "58"

Phrase: ")."
Processing 00000000.tx.328: Cathepsin B (Enzyme Commission no. 3.4.22.1), a rat liver endosomal/lysosomal cysteine protease that processes at acidic pH internalized glucagon (8), EGF (22), and presumably IGF-I (59), is active in early endosomes between pH 4 and 7 (38). 

Phrase: "Cathepsin B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0699919:Cathepsin B [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332804:CATHEPSIN B [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Enzyme Commission"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1709239:Enzyme Commission [Organization]
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "no. 3.4.22.1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442757:3 4 [Finding]
   812   C0439086:<3 [Quantitative Concept]
   812   C2827736:3+ [Quantitative Concept]
   812   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "a rat liver endosomal/lysosomal cysteine protease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0758959:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0769345:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   827   C2717970:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   799   C1947941:Protease [Enzyme]

Phrase: "that processes at acidic pH"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C1184743:Process [Body Part, Organ, or Organ Component]
   726   C1522240:Process [Phenomenon or Process]

Phrase: "internalized"

Phrase: "glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(8"

Phrase: ")"

Phrase: ","

Phrase: "EGF"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1323367:epidermal growth factor [Molecular Function]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0014520:Epidermal [Tissue]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C0221920:Epidermal [Spatial Concept]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]
   711 E C3496194:Epidermis [Cell]

Phrase: "(22"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "presumably IGF-I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0021665:IGF-I [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1334089:IGF I [Gene or Genome]
   827   C0021966:I- [Inorganic Chemical]
   827   C0037657:IGF [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(59"

Phrase: ")"

Phrase: ","

Phrase: "is"

Phrase: "active in early endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205177:Active [Functional Concept]

Phrase: "between pH 4"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2678549:PH-4 [Gene or Genome]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "and"

Phrase: "7"

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.329: It has both endo- and exopeptidase activity, with the exopeptidase activity optimal at pH 5 or less, and the endopeptidase activity maximal at pH 7 (36). 

Phrase: "It"

Phrase: "has"

Phrase: "both endo-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0014175:Endo [Disease or Syndrome]
  1000   C1427293:ENDO [Gene or Genome]

Phrase: "and"

Phrase: "exopeptidase activity,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150209:exopeptidase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "with the exopeptidase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150209:exopeptidase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "optimal at pH 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2698651:Optimal [Qualitative Concept]

Phrase: "or"

Phrase: "less,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "and"

Phrase: "the endopeptidase activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1150171:endopeptidase activity [Molecular Function]
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "maximal at pH 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205289:Maximal [Qualitative Concept]
   770   C0806909:Maximal [Quantitative Concept]

Phrase: "(36"

Phrase: ")."
Processing 00000000.tx.330: Although this protease was responsible for proteolytic cleavage of ricin A chain in macrophage endosomes at both neutral and acidic pH (38), our results indicate that its proteolytic activity toward the glucagon molecule was restricted to acidic pH as indicated by the following observations: 1) lack of inhibition of endosomal neutral glucagonase by the cysteine protease inhibitor E64, a characteristic inhibitor of cathepsin B (22); 

Phrase: "Although"

Phrase: "this protease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
  1000   C1947941:Protease [Enzyme]

Phrase: "was"

Phrase: "responsible for proteolytic cleavage of ricin A chain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1273518:Responsible [Finding]

Phrase: "in macrophage endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034850:Endosomes [Cell Component]

Phrase: "at both neutral"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1882074:Neutral [Qualitative Concept]
  1000   C2825492:Neutral [Phenomenon or Process]

Phrase: "and"

Phrase: "acidic pH (38"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0001128:Acidic [Chemical]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
   755 E C0202406:Acid [Laboratory Procedure]

Phrase: ")"

Phrase: ","

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "its proteolytic activity toward the glucagon molecule"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C0597304:Proteolytic [Molecular Function]
   748   C1561536:*Activity [Idea or Concept]
   748   C1947941:proteolytic [Enzyme]

Phrase: "was"

Phrase: "restricted to acidic pH"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0001128:Acidic [Chemical]
   770   C0020283:[pH] [Quantitative Concept]
   770   C0443288:Restricted [Functional Concept]
   770   C0450407:ph+ [Finding]
   770   C0450408:ph++ [Finding]
   770   C0450409:ph+++ [Finding]

Phrase: "as"

Phrase: "indicated by the following observations"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0302523:observations [Research Activity]
   760   C0700325:observations [Health Care Activity]
   760   C1444656:Indicated [Finding]
   760   C3244290:observations [Functional Concept]
   726   C0332283:follow [Temporal Concept]
   726   C1719822:Follow [Intellectual Product]
   726 E C1964257:Observation [Diagnostic Procedure]

Phrase: ":"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "lack of inhibition of endosomal neutral glucagonase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C0332268:lack [Qualitative Concept]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C1882074:Neutral [Qualitative Concept]
   748   C2825492:Neutral [Phenomenon or Process]
   748   C3463820:Inhibition [Activity]

Phrase: "by the cysteine protease inhibitor E64,"

Phrase: "a characteristic inhibitor of cathepsin B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1999216:Inhibitor [Qualitative Concept]

Phrase: "(22"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.331: and 2) lack of cross-reactivity of endosomal neutral glucagonase toward a specific cathepsin B antibody (22). 

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "lack of cross-reactivity of endosomal neutral glucagonase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0010357:Cross Reactivity [Molecular Function]
   770   C0872139:cross reactivity [Molecular Function]
   770   C1880190:CROSS REACTIVITY [Event]
   744   C0332268:lack [Qualitative Concept]
   744   C1882074:Neutral [Qualitative Concept]
   744   C2825492:Neutral [Phenomenon or Process]
   744   C2828360:Cross [Conceptual Entity]

Phrase: "toward a specific cathepsin B antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(22"

Phrase: ")."
Processing 00000000.tx.332: A rat liver membrane protease that cleaves glucagon and produces glucagon-(1929) has been previously isolated from plasma membrane fractions (16). 

Phrase: "A rat liver membrane protease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C1947941:Protease [Enzyme]

Phrase: "that"

Phrase: "cleaves"

Phrase: "glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "produces"

Phrase: "glucagon-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(1929"

Phrase: ")"

Phrase: "has"

Phrase: "been"

Phrase: "previously"

Phrase: "isolated from plasma membrane fractions"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   806   C0007603:Plasma membrane [Cell Component]
   760   C0025255:Membrane [Tissue]
   760   C0032105:Plasma [Body Substance]
   760   C0205409:Isolated [Functional Concept]
   760   C0596901:Membrane [Cell Component]
   760   C1264633:Fractions [Quantitative Concept]
   760   C1548221:Isolated [Idea or Concept]
   760   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   760   C1706182:Membrane [Manufactured Object]
   726 E C0370215:Isolate [Substance]
   726 E C1554103:Fraction [Idea or Concept]
   726 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.333: The purified enzyme displayed a molecular mass of 100 kDa, was inhibited by both sulfhydryl-modifying reagents and chelating agents, and was present at highest levels in the liver (15, 16). 

Phrase: "The purified enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014442:Enzyme [Enzyme,Organic Chemical]
   777 E C0014445:enzymes [Functional Concept]

Phrase: "displayed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0870432:displayed [Functional Concept]
   966 E C1705417:Display [Manufactured Object]

Phrase: "a molecular mass of 100 kDa,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   783   C0577559:A mass [Finding]
           Mass
   753   C1306372:*Mass [Quantitative Concept]

Phrase: "was"

Phrase: "inhibited by both sulfhydryl-modifying reagents"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0038738:Sulfhydryl Reagents [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]
   753   C0038734:sulfhydryl [Organic Chemical]
   753   C0311403:Inhibited [Qualitative Concept]
   719   C0392747:MODIFY [Functional Concept]

Phrase: "and"

Phrase: "chelating agents,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0007974:Chelating Agents [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C3537131:Chelating [Molecular Function]
   827   C0450442:Agent [Chemical Viewed Functionally]
   827   C1254351:Agent [Pharmacologic Substance]
   827   C1521826:Agent [Intellectual Product]

Phrase: "and"

Phrase: "was"

Phrase: "present at highest levels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "in the liver"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "(15,"

Phrase: "16"

Phrase: ")."
Processing 00000000.tx.334: The N-terminal sequence of the purified protein was shown to be distinct from that of IDE (16). 

Phrase: "The N-terminal sequence of the purified protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   767   C0002518:Protein Sequence [Amino Acid Sequence]
   744   C0004793:Sequence [Nucleotide Sequence]
   744   C0162326:Sequence [Nucleotide Sequence]
   744   C0162327:Sequence [Nucleotide Sequence]
   744   C1519249:Sequence [Functional Concept]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "distinct from that of IDE"

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.335: Using a rabbit antiserum directed against the N-terminal sequence of rat liver MGE (see Materials and Methods and Ref. 16), we show in the present study that MGE is absent from hepatic plasma membranes using immunoblot analysis, but present in the low-speed particulate N and ML fractions and in highly purified mitochondria. 

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a rabbit antiserum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "directed against the N-terminal sequence of rat liver MGE"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   756   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   738   C0004793:Sequence [Nucleotide Sequence]
   738   C0023884:Liver [Body Part, Organ, or Organ Component]
   738   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   738   C0034693:Rat, NOS [Mammal]
   738   C0034721:Rat [Mammal]
   738   C0082712:miniglucagon [Amino Acid, Peptide, or Protein]
   738   C0162326:Sequence [Nucleotide Sequence]
   738   C0162327:Sequence [Nucleotide Sequence]
   738   C0205088:Terminal [Temporal Concept]
   738   C0521447:Nuclear [Spatial Concept]
   738   C0736268:LIVER [Body Part, Organ, or Organ Component]
   738   C1278929:Liver [Body Part, Organ, or Organ Component]
   738   C1519249:Sequence [Functional Concept]
   738   C1705314:Terminal [Manufactured Object]
   738   C1705315:Terminal [Spatial Concept]
   738   C2346688:LIVER [Food]
   704   C0439851:Direct [Qualitative Concept]
   704   C1947931:Direct [Qualitative Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "Ref. 16"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "show in the present study"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C1547282:Show [Intellectual Product]
   760   C2603343:Study [Research Activity]

Phrase: "that MGE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "is"

Phrase: "absent from hepatic plasma membranes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:Absent [Quantitative Concept]
   760   C2699517:ABSENT [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "immunoblot analysis,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "but"

Phrase: "present in the low-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "speed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678536:Speed [Quantitative Concept]

Phrase: "particulate N"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0521447:Nuclear [Spatial Concept]

Phrase: "and"

Phrase: "ML fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "and in highly purified mitochondria."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0026237:Mitochondria [Cell Component]
   760   C0205250:Highly [Qualitative Concept]
   760   C1515981:And [Idea or Concept]
   760   C1998793:Purified [Functional Concept]
Processing 00000000.tx.336: Thus, in contrast to the report of Blache et al. 

Phrase: "Thus,"

Phrase: "in contrast to the report"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "of Blache et al."
Processing 00000000.tx.337: (16), we were unable to confirm the presence of MGE in hepatic plasma membranes. 

Phrase: "(16"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "were"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the presence of MGE"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in hepatic plasma membranes."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0007603:Plasma Membranes [Cell Component]
   827   C0025255:Membranes [Tissue]
   827   C0032105:Plasma [Body Substance]
   827   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   793 E C0596901:Membrane [Cell Component]
   793 E C1706182:Membrane [Manufactured Object]
   743 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.338: In the study of Blache et al. 

Phrase: "In the study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "of Blache et al."
Processing 00000000.tx.339: (16), no comparison was made with MGE present in other liver subcellular fractions suggesting that the plasma membrane-MGE association may have derived from organelle contamination. 

Phrase: "(16"

Phrase: ")"

Phrase: ","

Phrase: "no comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "was"

Phrase: "made with MGE present"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C0082712:miniglucagon [Amino Acid, Peptide, or Protein]
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   726   C1881534:Make [Functional Concept]

Phrase: "in other liver subcellular fractions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0038528:Subcellular Fractions [Cell Component]
   896   C0982262:LIVER FRACTION [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the plasma membrane-MGE association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0004083:Association [Mental Process]
   804   C0439849:Association [Qualitative Concept]
   804   C0596306:Association [Phenomenon or Process]
   804   C0699792:association [Social Behavior]

Phrase: "may"

Phrase: "have"

Phrase: "derived from organelle contamination."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0029219:Organelle [Cell Component]
   770   C0259846:contamination [Human-caused Phenomenon or Process]
   770   C1441547:Derived [Qualitative Concept]
   770   C1881659:CONTAMINATION [Event]
   770   C2349974:Contamination [Idea or Concept]
   770   C3245521:derived [Idea or Concept]
Processing 00000000.tx.340: Moreover, Blache et al. 

Phrase: "Moreover,"

Phrase: "Blache et al."
Processing 00000000.tx.341: (16) did not demonstrate that the N-terminal sequence obtained from the purified protein and used to raise the rabbit antiserum did in fact come from the protease, because the antibody to this peptide could not precipitate the proteolytic activity. 

Phrase: "(16"

Phrase: ")"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the N-terminal sequence"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0004793:Sequence [Nucleotide Sequence]
   827   C0162326:Sequence [Nucleotide Sequence]
   827   C0162327:Sequence [Nucleotide Sequence]
   827   C1519249:Sequence [Functional Concept]
   755 E C1548958:Sequential [Idea or Concept]
   755 E C1705294:Sequential [Qualitative Concept]

Phrase: "obtained from the purified protein"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1301820:Obtained [Functional Concept]
   760   C1998793:Purified [Functional Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "and"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "raise"

Phrase: "the rabbit antiserum"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020960:Antiserum [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "did in fact"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1707660:DID [Machine Activity]
   790   C2828361:Did [Activity]

Phrase: "come from the protease,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   770   C1947941:Protease [Enzyme]

Phrase: "because"

Phrase: "the antibody to this peptide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "precipitate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "the proteolytic activity."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C0597304:Proteolytic [Molecular Function]
   861   C1561536:*Activity [Idea or Concept]
   861   C1947941:proteolytic [Enzyme]
Processing 00000000.tx.342: Studies investigating the fate of iodinated and colloidal gold-labeled glucagon in hepatocytes using quantitative electron microscope autoradiography (3, 4) have never reported endocytosed glucagon in mitochondria, whereas an endosomal location for internalized glucagon has been clearly established using both morphological (3, 4) and biochemical approaches (5). 

Phrase: "Studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "investigating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigating [Functional Concept]

Phrase: "the fate of iodinated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1539479:FATE [Gene or Genome]

Phrase: "and"

Phrase: "colloidal gold-labeled glucagon in hepatocytes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   753   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "quantitative electron microscope autoradiography"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   902   C1510991:Quantitative Autoradiography [Diagnostic Procedure]
   812   C0004400:Autoradiography [Laboratory Procedure]
   712 E C2986957:Autoradiograph [Manufactured Object]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4"

Phrase: ")"

Phrase: "have"

Phrase: "never"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2003901:Never [Temporal Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "endocytosed glucagon in mitochondria,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   770   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "whereas"

Phrase: "an endosomal location for internalized glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0450429:Location [Spatial Concept]
   753   C1515974:Location [Body Location or Region]

Phrase: "has"

Phrase: "been"

Phrase: "clearly"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "both morphological"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0543482:morphological [Spatial Concept]
   928 E C0332437:Morphology [Qualitative Concept]
   928 E C0700329:Morphology, NOS [Finding]
   928 E C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "4"

Phrase: ")"

Phrase: "and"

Phrase: "biochemical approaches"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0449445:Approaches [Spatial Concept]
   861   C1292724:Approaches [Functional Concept]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.343: Whatever the nature of the 100-kDa protein recognized by both the antisera used in our study and that of Blache et al. 

Phrase: "Whatever"

Phrase: "the nature of the 100-kDa protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0349590:Nature [Idea or Concept]
   748   C1262865:Nature [Functional Concept]

Phrase: "recognized by both"

Phrase: "the antisera"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020960:Antisera [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "used in our study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "that of Blache et al."
Processing 00000000.tx.344: (16), our demonstration of the mitochondrial location of the antigenic protein suggests a function related to mitochondrial physiology that is clearly distinct from that of degrading polypeptide hormones such as glucagon. 

Phrase: "(16"

Phrase: ")"

Phrase: ","

Phrase: "our demonstration of the mitochondrial location of the antigenic protein"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "related to mitochondrial physiology"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0026237:Mitochondrial [Cell Component]
   770   C0031842:Physiology [Biomedical Occupation or Discipline]
   770   C0031843:physiology [Physiologic Function]
   770   C0439849:Related [Qualitative Concept]
   770   C0445223:Related [Finding]
   770   C0521451:Mitochondrial [Functional Concept]
   737 E C0163712:Relate [Organic Chemical]

Phrase: "that"

Phrase: "is"

Phrase: "clearly distinct from that of degrading polypeptide hormones"

Phrase: "such as glucagon."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.345: In summary, we have identified an endosomal membrane serine glucagonase that binds specifically to glucagon and bacitracin, and transforms glucagon to glucagon-(1929) at neutral pH. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "we"

Phrase: "have"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "an endosomal membrane serine glucagonase"

Phrase: "that"

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "specifically to glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   790   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "bacitracin,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0004599:Bacitracin [Amino Acid, Peptide, or Protein,Antibiotic]
   944 E C0718794:Baciguent [Amino Acid, Peptide, or Protein,Antibiotic]

Phrase: "and"

Phrase: "transforms glucagon to glucagon-"

Phrase: "(1929"

Phrase: ")"

Phrase: "at neutral pH."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1882074:Neutral pH [Qualitative Concept]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]
Processing 00000000.tx.346: In various studies, the purification and subsequent characterization of bacitracin-sensitive proteases have successfully been made using affinity chromatography of proteolytic activities on bacitracin-agarose (60). 

Phrase: "In various studies,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "the purification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243114:purification [Functional Concept]
  1000   C1998793:Purification [Functional Concept]

Phrase: "and"

Phrase: "subsequent characterization of bacitracin-sensitive proteases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1880022:Characterization [Activity]

Phrase: "have"

Phrase: "successfully"

Phrase: "been"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "affinity chromatography of proteolytic activities"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0008551:Chromatography, Affinity [Laboratory Procedure]
   760   C0008550:Chromatography [Laboratory Procedure]
   760   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "on bacitracin-agarose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036681:Agarose [Carbohydrate]

Phrase: "(60"

Phrase: ")."
Processing 00000000.tx.347: Remarkably, bacitracin-agarose has been extensively used for affinity chromatography of serine proteinases, such as homologs of eubacterial subtilisins from Halobacterium mediterranei (61). 

Phrase: "Remarkably,"

Phrase: "bacitracin-agarose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036681:Agarose [Carbohydrate]

Phrase: "has"

Phrase: "been"

Phrase: "extensively"

Phrase: "used for affinity chromatography of serine proteinases,"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   778   C0008551:Chromatography, Affinity [Laboratory Procedure]
   778   C2717971:Serine Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   757   C1524063:Use of [Functional Concept]
   748   C0008550:Chromatography [Laboratory Procedure]
   748   C0030940:Proteinases [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0030946:proteinases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   748   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   748   C1273517:used [Finding]
   748   C1510827:Affinity [Natural Phenomenon or Process]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1622131:proteinase [Molecular Function]
   714 E C1947941:Proteinase [Enzyme]
   714 E C1947944:Use [Intellectual Product]

Phrase: "such as homologs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   966   C1334043:Homolog [Gene or Genome]
   893 E C2697616:Homology [Qualitative Concept]

Phrase: "of eubacterial subtilisins"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0038601:Subtilisins [Amino Acid, Peptide, or Protein,Enzyme]
   827 E C0752243:Subtilisin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "from Halobacterium mediterranei"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0524842:Halobacterium mediterranei [Archaeon]
   861   C0018540:Halobacterium [Archaeon]

Phrase: "(61"

Phrase: ")."
Processing 00000000.tx.348: Development of such purification protocols should enable us to address the physiological significance of the bacitracin-sensitive endosomal serine glucagonase in the intracellular metabolism of glucagon. 

Phrase: "Development of such purification protocols"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C0872253:protocol development [Research Activity]
   760   C0243107:development [Physiologic Function]
   760   C0678723:Development [Organism Function]
   760   C1527148:Development [Functional Concept]

Phrase: "should"

Phrase: "enable"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562342:enable [Mental Process]
  1000   C1171285:enable [Mental Process]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "the physiological significance of the bacitracin-sensitive endosomal serine glucagonase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0237881:Significance [Quantitative Concept]
   739   C0750502:Significance [Idea or Concept]

Phrase: "in the intracellular metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "of glucagon."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.349: Moreover, the presence of glycosylated side chains predicts that immobilized lectins will also be a useful tool in the purification of the 170-kDa endosomal glucagon-binding protein.  

Phrase: "Moreover,"

Phrase: "the presence of glycosylated side chains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "predicts"

Phrase: "that immobilized lectins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023206:Lectins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "will"

Phrase: "also"

Phrase: "be"

Phrase: "a useful tool in the purification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0336791:Tool [Manufactured Object]
   753   C2827396:Tool [Manufactured Object]
   748   C0871532:tool use [Finding]

Phrase: "of the 170-kDa endosomal glucagon-binding protein."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0242210:Binding Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   799   C0243122:binding [Functional Concept]
   799   C1145667:Binding [Activity]
   799   C1167622:Binding [Molecular Function]
Processing 00000000.tx.350: Footnotes  Abbreviations: BS3, Bis(sulfosuccinimidyl) suberate; 

Phrase: "Footnotes  Abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0000723:Abbreviations [Intellectual Product]

Phrase: ":"

Phrase: "BS3,"

Phrase: "Bis("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0556985:BIS [Temporal Concept]
  1000   C2247301:BIS [Molecular Function]
  1000   C3540495:BIS [Intellectual Product]

Phrase: "sulfosuccinimidyl"

Phrase: ")"

Phrase: "suberate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0947344:Suberate [Organic Chemical]

Phrase: ";"
Processing 00000000.tx.351: CoA, coenzyme A; 

Phrase: "CoA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009226:Coenzyme A [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0009235:Coenzyme [Biologically Active Substance,Organic Chemical]

Phrase: "coenzyme A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0009226:Coenzyme A [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0009235:Coenzyme [Biologically Active Substance,Organic Chemical]

Phrase: ";"
Processing 00000000.tx.352: DFDNB, 1,4-difluoro-2,5-dinitrobenzene; 

Phrase: "DFDNB,"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "4-difluoro-2,"

Phrase: "5-dinitrobenzene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012459:Dinitrobenzene [Organic Chemical]

Phrase: ";"
Processing 00000000.tx.353: E64, L-3-carboxy-2,3-trans-epoxypropionyl-leucylamido(4-guanidino)butane; 

Phrase: "E64,"

Phrase: "L-3-carboxy-2,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0604267:L-3 [Carbohydrate]
   812   C0439394:l's [Quantitative Concept]
   812   C0596260:Carboxy [Organic Chemical]
   812   C1706495:L- [Intellectual Product]
   812   C3642217:/L [Quantitative Concept]

Phrase: "3-trans-epoxypropionyl-leucylamido"

Phrase: "(4-guanidino"

Phrase: ")"

Phrase: "butane"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006474:Butane [Organic Chemical,Pharmacologic Substance]
  1000   C0006476:butane [Organic Chemical]

Phrase: ";"
Processing 00000000.tx.354: EDC, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide; 

Phrase: "EDC,"

Phrase: "1-ethyl-3-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]

Phrase: "(3-dimethylaminopropyl"

Phrase: ")"

Phrase: "carbodiimide"

Phrase: ";"
Processing 00000000.tx.355: EGF, epidermal growth factor; 

Phrase: "EGF,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1323367:epidermal growth factor [Molecular Function]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0014520:Epidermal [Tissue]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C0221920:Epidermal [Spatial Concept]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]
   711 E C3496194:Epidermis [Cell]

Phrase: "epidermal growth factor"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C0242275:Epidermal Growth Factor [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1323367:epidermal growth factor [Molecular Function]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0014520:Epidermal [Tissue]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0220844:growth [Physiologic Function]
   827   C0221920:Epidermal [Spatial Concept]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]
   711 E C3496194:Epidermis [Cell]

Phrase: ";"
Processing 00000000.tx.356: EN, endosomal fraction; 

Phrase: "EN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosomes [Cell Component]

Phrase: "endosomal fraction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1264633:Fraction [Quantitative Concept]
   861   C1554103:Fraction [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.357: IDE, insulin-degrading enzyme; 

Phrase: "IDE,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.358: MGE, miniglucagon endopeptidase; 

Phrase: "MGE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "miniglucagon endopeptidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.359: PC, proprotein convertase; 

Phrase: "PC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3540812:PC [Gene or Genome]

Phrase: "proprotein convertase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1100660:Proprotein Convertase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0379214:pro protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1709708:Proprotein [Amino Acid, Peptide, or Protein]

Phrase: ";"
Processing 00000000.tx.360: PMSF, phenylmethylsulfonyl fluoride; 

Phrase: "PMSF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   861   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "phenylmethylsulfonyl fluoride"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   861   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.361: RP-HPLC, reversed phase-HPLC; 

Phrase: "RP-HPLC,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0008562:HPLC [Laboratory Procedure]

Phrase: "reversed phase-HPLC"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0008562:HPLC [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.362: TFA, trifluoroacetic acid. 

Phrase: "TFA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040982:Trifluoroacetic Acid [Organic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "trifluoroacetic acid."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0040982:Trifluoroacetic Acid [Organic Chemical]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.363: Received April 30, 2003. 

Phrase: "Received April 30,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1514756:Received [Qualitative Concept]

Phrase: "2003."
Processing 00000000.tx.364: Accepted for publication August 22, 2003.  

Phrase: "Accepted for publication August 22,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1272684:Accepted [Qualitative Concept]
   760   C1548435:Accepted [Idea or Concept]
   760   C1704324:Publication [Intellectual Product]
   726 E C1548601:Accept [Idea or Concept]

Phrase: "2003."
Processing 00000000.tx.365: References Top Abstract Introduction Materials and Methods Results Discussion References  Jelinek LJ, Lok S, Rosenberg GB, Smith RA, Grant FJ, Biggs S, Bensch PA, Kuijper JL, Sheppard PO, Sprecher CA, OHara PJ, Foster D, Walker KM, Chen LHJ, McKernan PA, Kindsvogel W 1993 Expression cloning and signaling properties of the rat glucagon receptor. 

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Jelinek LJ,"

Phrase: "Lok S,"

Phrase: "Rosenberg GB,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041700:GB [Geographic Area]
   861   C1551090:Gb [Quantitative Concept]

Phrase: "Smith RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Grant FJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016080:FJ [Geographic Area]

Phrase: "Biggs S,"

Phrase: "Bensch PA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]

Phrase: "Kuijper JL,"

Phrase: "Sheppard PO,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442027:PO [Spatial Concept]

Phrase: "Sprecher CA,"

Phrase: "OHara PJ,"

Phrase: "Foster D,"

Phrase: "Walker KM,"

Phrase: "Chen LHJ,"

Phrase: "McKernan PA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]

Phrase: "Kindsvogel W 1993 Expression cloning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0599958:expression cloning [Molecular Biology Research Technique]
   804   C0009015:Cloning [Research Activity]

Phrase: "and"

Phrase: "signaling properties of the rat glucagon receptor."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   748   C0871161:properties [Qualitative Concept]
   748   C1292721:properties [Functional Concept]
   714 E C1882134:Property [Conceptual Entity]
   714 E C2347695:Property [Entity]
Processing 00000000.tx.366: Science 259:16141616[Medline] Exton JH 1988 Mechanisms of action of glucagon. 

Phrase: "Science 259"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "16141616"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Exton JH 1988 Mechanisms of action of glucagon."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   789   C0031327:mechanism of action [Physiologic Function]
   789   C1524059:mechanism of action [Functional Concept]
   744   C0441712:Mechanisms [Functional Concept]
   711 E C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.367: In: Cooke BA, King RJB, van Der Molen HJ, eds. 

Phrase: "In"

Phrase: ":"

Phrase: "Cooke BA,"

Phrase: "King"

Phrase: "RJB,"

Phrase: "van Der Molen HJ,"

Phrase: "eds."
Processing 00000000.tx.368: Hormones and their actions. 

Phrase: "Hormones"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0019932:Hormones [Hormone]
   916 E C0458083:Hormonal [Qualitative Concept]

Phrase: "and"

Phrase: "their actions."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441472:actions [Functional Concept]
   966 E C3266814:Action [Activity]
Processing 00000000.tx.369: Part II. 

Phrase: "Part II."
Processing 00000000.tx.370: Berlin: Springer Verlag; 

Phrase: "Berlin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005125:Berlin [Geographic Area]

Phrase: ":"

Phrase: "Springer Verlag"

Phrase: ";"
Processing 00000000.tx.371: 231264 Watanabe J, Kanai K, Kanamura S 1988 Glucagon receptors in endothelial and Kupffer cells of mouse liver. 

Phrase: "231264 Watanabe J,"

Phrase: "Kanai K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Kanamura S 1988 Glucagon receptors in endothelial"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   778   C0061352:Receptors, Glucagon [Amino Acid, Peptide, or Protein,Receptor]
   748   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   748   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   748   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   745 E C1415011:GLUCAGON RECEPTOR [Gene or Genome]

Phrase: "and"

Phrase: "Kupffer cells of mouse liver."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C1522062:Mouse Liver Cell [Tissue]
   806   C0022801:Kupffer Cells [Cell]
   797   C0227525:liver cells [Cell]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.372: J Histochem Cytochem 36:10811089[Abstract] Barazzone P, Gorden P, Carpentier JL, Orci L, Freychet P, Canivet B 1980 Binding, internalization, and lysosomal association of 125I-glucagon in isolated rat hepatocytes. 

Phrase: "J Histochem Cytochem 36"

Phrase: ":"

Phrase: "10811089"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Barazzone P,"

Phrase: "Gorden P,"

Phrase: "Carpentier JL,"

Phrase: "Orci L,"

Phrase: "Freychet P,"

Phrase: "Canivet B 1980 Binding,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0243122:binding [Functional Concept]
   812   C1145667:Binding [Activity]
   812   C1167622:Binding [Molecular Function]

Phrase: "internalization,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0871786:internalization [Mental Process]

Phrase: "and"

Phrase: "lysosomal association of 125I-glucagon"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "in isolated rat hepatocytes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0227525:Hepatocytes [Cell]
   793 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.373: A quantitative electron microscope autoradiographic study. 

Phrase: "A quantitative electron microscope autoradiographic study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0557651:Study [Manufactured Object]
   804   C2603343:Study [Research Activity]
Processing 00000000.tx.374: J Clin Invest 66:10811093[Medline] Authier F, Janicot M, Lederer F, Desbuquois B 1990 Fate of injected glucagon taken up by rat liver in vivo. 

Phrase: "J"

Phrase: "Clin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]

Phrase: "Invest"

Phrase: "66"

Phrase: ":"

Phrase: "10811093"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Authier F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Janicot M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lederer F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Desbuquois B 1990 Fate of injected glucagon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1539479:FATE [Gene or Genome]

Phrase: "taken up"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C1883727:Taken [Conceptual Entity]
   799 E C1515187:Take [Health Care Activity]

Phrase: "by rat liver"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   861   C0023884:Liver [Body Part, Organ, or Organ Component]
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]
   861   C0736268:LIVER [Body Part, Organ, or Organ Component]
   861   C1278929:Liver [Body Part, Organ, or Organ Component]
   861   C2346688:LIVER [Food]
   805 E C0205054:Hepatic [Body Location or Region]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.375: Biochem J 272:703712[Medline] Buggy JJ, Heurich RO, MacDougall M, Kelley KA, Livingston JN, Yoo-Warren H, Rossomando AJ 1997 Role of the glucagon receptor COOH-terminal domain in glucagon-mediated signaling and receptor internalization. 

Phrase: "Biochem J 272"

Phrase: ":"

Phrase: "703712"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Buggy JJ,"

Phrase: "Heurich RO,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0035826:RO [Geographic Area]
   861   C1413096:RO [Gene or Genome]
   861   C2987048:RO [Gene or Genome]

Phrase: "MacDougall M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kelley KA,"

Phrase: "Livingston JN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1428813:JN [Gene or Genome]

Phrase: "Yoo-Warren H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "Rossomando AJ 1997 Role of the glucagon receptor COOH-terminal domain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0035820:Role [Social Behavior]
   738   C1705810:Role [Conceptual Entity]

Phrase: "in glucagon-mediated signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037083:Signaling [Cell Function]
   827   C3537152:signaling [Biologic Function]

Phrase: "and"

Phrase: "receptor internalization."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0599281:receptor internalization [Phenomenon or Process]
   861   C0871786:internalization [Mental Process]
Processing 00000000.tx.376: Diabetes 46:14001405[Abstract] Authier F, Desbuquois B 1991 Degradation of glucagon in isolated liver endosomes. 

Phrase: "Diabetes 46"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "14001405"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Authier F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Desbuquois B 1991 Degradation of glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "in isolated liver endosomes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034850:Endosomes [Cell Component]
Processing 00000000.tx.377: Biochem J 280:211218[Medline] Authier F, Mort JS, Bell AW, Posner BI, Bergeron JJM 1995 Proteolysis of glucagon within hepatic endosomes by membrane-associated cathepsins B and D. 

Phrase: "Biochem J 280"

Phrase: ":"

Phrase: "211218"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Authier F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Mort JS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]

Phrase: "Bell AW,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0282379:AW [Geographic Area]
   861   C0332281:AW [Qualitative Concept]

Phrase: "Posner BI,"

Phrase: "Bergeron JJM 1995 Proteolysis of glucagon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0597304:Proteolysis [Molecular Function]

Phrase: "within hepatic endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034850:Endosomes [Cell Component]

Phrase: "by membrane-associated cathepsins B"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0699919:Cathepsins B [Amino Acid, Peptide, or Protein,Enzyme]
   844 E C1332804:CATHEPSIN B [Gene or Genome]

Phrase: "and"

Phrase: "D."
Processing 00000000.tx.378: J Biol Chem 270:1579815807[Abstract/Free FullText] Rose K, Savoy LA, Muir AV, Davies JG, Offord RE, Turcatti G 1988 Insulin proteinase liberates from glucagon a fragment known to have enhanced activity against Ca2+ + Mg2+-dependent ATPase. 

Phrase: "J Biol Chem 270"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1579815807"

Phrase: "[Abstract/Free FullText"

Phrase: "]"

Phrase: "Rose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035853:Rose [Plant]
  1000   C0995005:ROSE [Pharmacologic Substance]

Phrase: "K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Savoy LA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023031:La [Element, Ion, or Isotope]

Phrase: "Muir AV,"

Phrase: "Davies JG,"

Phrase: "Offord RE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986904:RE [Idea or Concept]

Phrase: "Turcatti G 1988 Insulin proteinase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0021669:Insulin Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   804   C1622131:proteinase [Molecular Function]
   804   C1947941:Proteinase [Enzyme]

Phrase: "liberates from glucagon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   790   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "a fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332255:fragment [Functional Concept]
  1000   C1708096:Fragment [Qualitative Concept]

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "enhanced activity against Ca2+ + Mg2+-dependent ATPase."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   800   C1148651:Mg2+-ATPase activity [Molecular Function]
   778   C1707919:Enhanced Activity [Quantitative Concept]
   774   C1148926:ATPase activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.379: Biochem J 256:847851[Medline] Hamel FG, Mahoney MJ, Duckworth WC 1991 Degradation of intraendosomal insulin by insulin-degrading enzyme without acidification. 

Phrase: "Biochem J 256"

Phrase: ":"

Phrase: "847851"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hamel FG,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439214:fg [Quantitative Concept]
   861   C2348814:FG [Quantitative Concept]

Phrase: "Mahoney MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Duckworth WC 1991 Degradation of intraendosomal insulin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C3547574:insulin degradation [Molecular Function]
   748   C0243125:degradation [Functional Concept]
   748   C0699900:Degradation [Organism Function]

Phrase: "by insulin-degrading enzyme"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0021669:Insulin-Degrading Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415875:INSULIN-DEGRADING ENZYME [Gene or Genome]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C0014445:enzymes [Functional Concept]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "without acidification."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1522821:acidification [Cell Function]
  1000   C2987513:Acidification [Phenomenon or Process]
Processing 00000000.tx.380: Diabetes 40:436443[Abstract] Authier F, Posner BI, Bergeron JJM 1994 Hepatic endosomes are a major physiological locus of insulin and glucagon degradation in vivo. 

Phrase: "Diabetes 40"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]
   861   C0439509:/40 [Temporal Concept]

Phrase: ":"

Phrase: "436443"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Authier F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Posner BI,"

Phrase: "Bergeron JJM 1994 Hepatic endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0034850:Endosomes [Cell Component]

Phrase: "are"

Phrase: "a major physiological locus of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1708726:Locus [Gene or Genome]

Phrase: "and"

Phrase: "glucagon degradation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.381: In: Ciechanover A, Schwartz AL, eds. 

Phrase: "In"

Phrase: ":"

Phrase: "Ciechanover A,"

Phrase: "Schwartz AL,"

Phrase: "eds."
Processing 00000000.tx.382: Cellular proteolytic systems. 

Phrase: "Cellular proteolytic systems."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   793   C0449913:System [Functional Concept]
   793   C1553451:System [Manufactured Object]
   793   C1704459:System [Medical Device]
   743 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.383: Vol 15. 

Phrase: "Vol 15."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0449468:VOL [Quantitative Concept]
   861   C0560268:vol% [Quantitative Concept]
   861   C1690016:% vol [Qualitative Concept]
Processing 00000000.tx.384: New York: Wiley-Liss; 

Phrase: "New York"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]

Phrase: ":"

Phrase: "Wiley-Liss"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1508741:LISS [Laboratory Procedure]
   861   C2247545:LIS [Molecular Function]

Phrase: ";"
Processing 00000000.tx.385: 89113 Hagopian WA, Tager HS 1984 Receptor binding and cell-mediated metabolism of [125I]monoiodoglucagon by isolated canine hepatocytes. 

Phrase: "89113 Hagopian WA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0043038:WA [Geographic Area]

Phrase: "Tager HS 1984 Receptor binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0597358:Receptor Binding [Molecular Function]
   804   C0243122:binding [Functional Concept]
   804   C1145667:Binding [Activity]
   804   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "cell-mediated metabolism of [125I"

Phrase: "]monoiodoglucagon by isolated canine hepatocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0128936:monoiodoglucagon [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.386: J Biol Chem 259:89868993[Abstract/Free FullText] Sheetz MJ, Tager HS 1988 Characterization of a glucagon receptor-linked protease from canine hepatic plasma membranes. 

Phrase: "J Biol Chem 259"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "89868993"

Phrase: "[Abstract/Free FullText"

Phrase: "] Sheetz MJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439254:MJ [Medical Device]

Phrase: "Tager HS 1988 Characterization of a glucagon receptor-linked protease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1880022:Characterization [Activity]

Phrase: "from canine hepatic plasma membranes."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   861   C0007603:Plasma Membranes [Cell Component]
   812   C0025255:Membranes [Tissue]
   812   C0032105:Plasma [Body Substance]
   812   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   779 E C0596901:Membrane [Cell Component]
   779 E C1706182:Membrane [Manufactured Object]
   729 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.387: J Biol Chem 263:1921019217[Abstract/Free FullText] Hinke SA, Pospisilik JA, Demuth HU, Mannhart S, Khn-Wache K, Hoffmann T, Nishimura E, Pederson RA, McIntosh CHS 2000 Dipeptidyl peptidase IV (DPIV/CD26) degradation of glucagon. 

Phrase: "J Biol Chem 263"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1921019217"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hinke SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Pospisilik JA,"

Phrase: "Demuth HU,"

Phrase: "Mannhart S,"

Phrase: "Khn-Wache K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]

Phrase: "Hoffmann T,"

Phrase: "Nishimura E,"

Phrase: "Pederson RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "McIntosh CHS 2000 Dipeptidyl peptidase IV"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0081937:Dipeptidyl-Peptidase IV [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   861   C1414141:DIPEPTIDYL PEPTIDASE IV [Gene or Genome]
   827   C0022709:dipeptidyl peptidase [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   799   C0030940:Peptidase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C1947941:Peptidase [Enzyme]

Phrase: "(DPIV/CD26"

Phrase: ")"

Phrase: "degradation of glucagon."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0243125:degradation [Functional Concept]
   790   C0699900:Degradation [Organism Function]
Processing 00000000.tx.388: Characterization of glucagon degradation products and DPIV-resistant analogs. 

Phrase: "Characterization of glucagon degradation products"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterization [Activity]

Phrase: "and"

Phrase: "DPIV-resistant analogs."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0243071:analogs [Chemical Viewed Structurally]
   721 E C0679213:analogies [Idea or Concept]
Processing 00000000.tx.389: J Biol Chem 275:38273834[Abstract/Free FullText] Blache P, Kervran A, Dufour M, Martinez J, Le-Nguyen D, Lotersztajn S, Pavoine C, Pecker F, Bataille D 1990 Glucagon-(1929), a Ca2+ pump inhibitory peptide, is processed from glucagon in the rat liver plasma membrane by a thiol endopeptidase. 

Phrase: "J Biol Chem 275"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "38273834"

Phrase: "[Abstract/Free FullText"

Phrase: "] Blache P,"

Phrase: "Kervran A,"

Phrase: "Dufour M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Martinez J,"

Phrase: "Le-Nguyen D,"

Phrase: "Lotersztajn S,"

Phrase: "Pavoine C,"

Phrase: "Pecker F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Bataille D 1990 Glucagon-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   812   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(1929"

Phrase: ")"

Phrase: ","

Phrase: "a Ca2+ pump inhibitory peptide,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "is"

Phrase: "processed from glucagon"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   790   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1522240:Processed [Phenomenon or Process]
   756 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "in the rat liver plasma membrane"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0007603:Plasma membrane [Cell Component]
   812   C0025255:Membrane [Tissue]
   812   C0032105:Plasma [Body Substance]
   812   C0596901:Membrane [Cell Component]
   812   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]
   812   C1706182:Membrane [Manufactured Object]
   741 E C0205287:Membranous [Qualitative Concept]

Phrase: "by a thiol endopeptidase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
Processing 00000000.tx.390: J Biol Chem 265:2151421519[Abstract/Free FullText] Blache P, Kervran A, Le-Nguyen D, Dufour M, Cohen-Solal A, Duckworth W, Bataille D 1993 Endopeptidase from rat liver membranes, which generates miniglucagon from glucagon. 

Phrase: "J Biol Chem 265"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "2151421519"

Phrase: "[Abstract/Free FullText"

Phrase: "] Blache P,"

Phrase: "Kervran A,"

Phrase: "Le-Nguyen D,"

Phrase: "Dufour M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Cohen-Solal A,"

Phrase: "Duckworth W,"

Phrase: "Bataille D 1993 Endopeptidase from rat liver membranes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0030946:Endopeptidase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "which"

Phrase: "generates"

Phrase: "miniglucagon from glucagon."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0082712:miniglucagon [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.391: J Biol Chem 268:2174821753[Abstract/Free FullText] Mallat A, Pavoine C, Dufour M, Lotersztajn S, Bataille D, Pecker F 1987 A glucagon fragment is responsible for the inhibition of the liver Ca2+ pump by glucagon. 

Phrase: "J Biol Chem 268"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "2174821753"

Phrase: "[Abstract/Free FullText"

Phrase: "] Mallat A,"

Phrase: "Pavoine C,"

Phrase: "Dufour M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lotersztajn S,"

Phrase: "Bataille D,"

Phrase: "Pecker F 1987"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   827   C0439133:(f) [Intellectual Product]
   827   C1553038:[f] [Quantitative Concept]

Phrase: "A glucagon fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332255:fragment [Functional Concept]
   861   C1708096:Fragment [Qualitative Concept]

Phrase: "is"

Phrase: "responsible for the inhibition of the liver Ca2+ pump"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1273518:Responsible [Finding]

Phrase: "by glucagon."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.392: Nature 325:620622[CrossRef][Medline] Pavoine C, Brechler V, Kervran A, Blache P, Le-Nguyen D, Laurent S, Bataille D, Pecker F 1991 Miniglucagon [glucagon-(1929)] is a component of the positive inotropic effect of glucagon. 

Phrase: "Nature 325"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "620622"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pavoine C,"

Phrase: "Brechler V,"

Phrase: "Kervran A,"

Phrase: "Blache P,"

Phrase: "Le-Nguyen D,"

Phrase: "Laurent S,"

Phrase: "Bataille D,"

Phrase: "Pecker F 1991 Miniglucagon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0082712:miniglucagon [Amino Acid, Peptide, or Protein]

Phrase: "[glucagon-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "(1929"

Phrase: ")"

Phrase: "]"

Phrase: "is"

Phrase: "a component of the positive inotropic effect of glucagon."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0449432:Component [Manufactured Object]
   742   C1705248:Component [Conceptual Entity]
Processing 00000000.tx.393: Am J Physiol 260:C993C999 Dalle S, Smith P, Blache P, Le-Nguyen D, Le Brigand L, Bergeron F, Ashcroft FM, Bataille D 1999 Miniglucagon (glucagon 1929), a potent and efficient inhibitor of secretagogue-induced insulin release through a Ca2+ pathway. 

Phrase: "Am"

Phrase: "J Physiol 260"

Phrase: ":"

Phrase: "C993C999 Dalle S,"

Phrase: "Smith P,"

Phrase: "Blache P,"

Phrase: "Le-Nguyen D,"

Phrase: "Le Brigand L,"

Phrase: "Bergeron F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Ashcroft FM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540627:FM [Gene or Genome]

Phrase: "Bataille D 1999 Miniglucagon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0082712:miniglucagon [Amino Acid, Peptide, or Protein]

Phrase: "(glucagon 1929"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   861   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "a potent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   900   C3245505:Potential [Qualitative Concept]

Phrase: "and"

Phrase: "efficient inhibitor of secretagogue-induced insulin release"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0021643:insulin inhibitor [Pharmacologic Substance]
   748   C1999216:Inhibitor [Qualitative Concept]

Phrase: "through a Ca2+ pathway."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.394: J Biol Chem 274:1086910876[Abstract/Free FullText] Dalle S, Fonts G, Lajoix AD, Le Brigand L, Gross R, Ribes G, Dufour M, Barry L, Le-Nguyen D, Bataille D 2002 Miniglucagon (glucagon 1929). 

Phrase: "J Biol Chem 274"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1086910876"

Phrase: "[Abstract/Free FullText"

Phrase: "] Dalle S,"

Phrase: "Fonts G,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   861   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "Lajoix AD,"

Phrase: "Le Brigand L,"

Phrase: "Gross R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Ribes G,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   861   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "Dufour M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Barry L,"

Phrase: "Le-Nguyen D,"

Phrase: "Bataille D 2002 Miniglucagon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0082712:miniglucagon [Amino Acid, Peptide, or Protein]

Phrase: "(glucagon 1929"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   861   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.395: A novel regulator of the pancreatic islet physiology. 

Phrase: "A novel regulator of the pancreatic islet physiology."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0182953:REGULATOR [Medical Device]
   744   C1704734:Regulator [Medical Device]
   744   C1704735:Regulator [Conceptual Entity]
Processing 00000000.tx.396: Diabetes 51:406412[Abstract/Free FullText] Authier F, Mtioui M, Fabrega S, Kouach M, Briand G 2002 Endosomal proteolysis of internalized insulin at the C-terminal region of the B chain by cathepsin D. 

Phrase: "Diabetes 51"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "406412"

Phrase: "[Abstract/Free FullText"

Phrase: "] Authier F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Mtioui M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Fabrega S,"

Phrase: "Kouach M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Briand G 2002 Endosomal proteolysis of internalized insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0597304:Proteolysis [Molecular Function]

Phrase: "at the C-terminal region"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C1707271:C-Terminal [Amino Acid Sequence]
   827   C0017446:Region [Geographic Area]
   827   C0205088:Terminal [Temporal Concept]
   827   C0205147:Region [Spatial Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
   755 E C0205276:Regional [Spatial Concept]
   755 E C1947913:Regional [Spatial Concept]

Phrase: "of the B chain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0337112:Chain [Manufactured Object]
   861   C1524075:Chain [Idea or Concept]

Phrase: "by cathepsin D."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007427:CATHEPSIN D [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1332805:CATHEPSIN D [Gene or Genome]
   861   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.397: J Biol Chem 277:94379446[Abstract/Free FullText] Authier F, Mtioui M, Bell AW, Mort JS 1999 Negative regulation of epidermal growth factor signaling by selective proteolytic mechanisms in the endosome mediated by cathepsin B. 

Phrase: "J Biol Chem 277"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "94379446"

Phrase: "[Abstract/Free FullText"

Phrase: "] Authier F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Mtioui M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Bell AW,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0282379:AW [Geographic Area]
   861   C0332281:AW [Qualitative Concept]

Phrase: "Mort JS 1999 Negative regulation of epidermal growth factor signaling"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   799   C1160192:negative regulation of growth [Organism Function]
   799   C3158357:negative regulation of signaling [Biologic Function]
   777   C1160191:regulation of growth [Organism Function]
           growth regulation
   777   C2756011:regulation of signaling [Biologic Function]
   739   C0205160:Negative [Qualitative Concept]
   739   C0851285:Regulation [Governmental or Regulatory Activity]
   739   C1327622:Regulation [Biologic Function]
   739   C1513916:Negative [Finding]
   739   C2825415:Negative [Conceptual Entity]
   739   C2825491:Negative [Qualitative Concept]

Phrase: "by selective proteolytic mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0441712:Mechanisms [Functional Concept]
   793 E C1706376:Mechanism [Manufactured Object]

Phrase: "in the endosome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034850:Endosome [Cell Component]

Phrase: "mediated by cathepsin B."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0699919:Cathepsin B [Amino Acid, Peptide, or Protein,Enzyme]
   833   C1332804:CATHEPSIN B [Gene or Genome]
   770   C0007428:Cathepsin [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.398: J Biol Chem 274:3372333731[Abstract/Free FullText] Shii K, Roth RA 1986 Inhibition of insulin degradation by hepatoma cells after microinjection of monoclonal antibodies to a specific cytosolic protease. 

Phrase: "J Biol Chem 274"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "3372333731"

Phrase: "[Abstract/Free FullText"

Phrase: "] Shii K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Roth RA 1986 Inhibition of insulin degradation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "by hepatoma cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   966   C0677626:hepatoma cell [Cell]
   861   C0007634:Cells [Cell]
   861   C0023903:Hepatoma [Neoplastic Process]
   861   C2239176:Hepatoma [Neoplastic Process]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "after microinjection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025991:Microinjection [Therapeutic or Preventive Procedure]

Phrase: "of monoclonal antibodies"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0746619:monoclonal [Finding]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "to a specific cytosolic protease."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C1947941:Protease [Enzyme]
Processing 00000000.tx.399: Proc Natl Acad Sci USA 83:41474151[Abstract] Lowry OH, Rosebrough NJ, Farr AL, Randall RJ 1951 Protein measurement with the folin phenol reagent. 

Phrase: "Proc Natl Acad Sci USA 83"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0041703:USA [Geographic Area]
   799   C0268596:ACAD [Disease or Syndrome]
   799   C1418943:PROC [Gene or Genome]
   799   C2700624:ACAD [Cell Function]
   799   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "41474151"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Lowry OH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0220853:OH- [Element, Ion, or Isotope]

Phrase: "Rosebrough NJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027971:NJ [Geographic Area]

Phrase: "Farr AL,"

Phrase: "Randall RJ 1951 Protein measurement with the folin phenol reagent."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0202202:Protein measurement [Laboratory Procedure]
   757   C0202446:Phenol measurement [Laboratory Procedure]
   739   C0242485:Measurement [Functional Concept]
Processing 00000000.tx.400: J Biol Chem 193:265275[Free FullText] Authier F, Rachubinski RA, Posner BI, Bergeron JJM 1994 Endosomal proteolysis of insulin by an acidic thiol metalloprotease unrelated to insulin degrading enzyme. 

Phrase: "J Biol Chem 193"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "265275"

Phrase: "[Free FullText"

Phrase: "] Authier F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Rachubinski RA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3538806:Ra [Spatial Concept]

Phrase: "Posner BI,"

Phrase: "Bergeron JJM 1994 Endosomal proteolysis of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0597304:Proteolysis [Molecular Function]

Phrase: "by an acidic thiol metalloprotease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0025543:METALLOPROTEASE [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "unrelated to insulin degrading enzyme."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0445356:Unrelated [Finding]
   760   C1704623:Unrelated [Qualitative Concept]
Processing 00000000.tx.401: J Biol Chem 269:30103016[Abstract/Free FullText] Neville DM 1968 Isolation of an organ specific protein antigen from cell surface membrane of rat liver. 

Phrase: "J Biol Chem 269"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "30103016"

Phrase: "[Abstract/Free FullText"

Phrase: "] Neville DM 1968 Isolation of an organ specific protein antigen"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0204727:Isolation [Therapeutic or Preventive Procedure]
   739   C0205409:Isolation [Functional Concept]
   739   C0220862:isolation [Laboratory Procedure]

Phrase: "from cell surface membrane"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   913   C0007603:Cell Membrane [Cell Component]
   913   C3161472:Cell Membrane [Cell Component]
   901   C0699040:Cell surface [Cell Component]
   827   C0007634:Cell [Cell]
   827   C0025255:Membrane [Tissue]
   827   C0205148:Surface [Spatial Concept]
   827   C0596901:Membrane [Cell Component]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1706182:Membrane [Manufactured Object]
   827   C1948049:Cell [Spatial Concept]
   755 E C0205287:Membranous [Qualitative Concept]

Phrase: "of rat liver."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
  1000   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   861   C0023884:Liver [Body Part, Organ, or Organ Component]
   861   C0034693:Rat, NOS [Mammal]
   861   C0034721:Rat [Mammal]
   861   C0736268:LIVER [Body Part, Organ, or Organ Component]
   861   C1278929:Liver [Body Part, Organ, or Organ Component]
   861   C2346688:LIVER [Food]
   805 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.402: Biochim Biophys Acta 154:540552[Medline] Authier F, Desbuquois B, de Galle B 1992 Ligand-mediated internalization of glucagon receptors in intact rat liver. 

Phrase: "Biochim Biophys Acta 154"

Phrase: ":"

Phrase: "540552"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Authier F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Desbuquois B,"

Phrase: "de Galle B 1992 Ligand-mediated internalization of glucagon receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   741   C0599281:receptor internalization [Phenomenon or Process]
   739   C0871786:internalization [Mental Process]

Phrase: "in intact rat liver."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   901   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   827   C0023884:Liver [Body Part, Organ, or Organ Component]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C0736268:LIVER [Body Part, Organ, or Organ Component]
   827   C1278929:Liver [Body Part, Organ, or Organ Component]
   827   C2346688:LIVER [Food]
   771 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.403: Endocrinology 131:447457[Abstract] Walter P, Blobel G 1983 Preparation of microsomal membranes for cotranslational protein translocation. 

Phrase: "Endocrinology 131"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "447457"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Walter P,"

Phrase: "Blobel G 1983 Preparation of microsomal membranes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   774   C0017687:Glucagon preparation [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   748   C0455052:Preparation [Health Care Activity]
   748   C1521827:Preparation [Functional Concept]

Phrase: "for cotranslational protein translocation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0599893:Protein translocation [Cell Function]
   827   C0040715:Translocation [Cell or Molecular Dysfunction]
   827   C2987521:Translocation [Activity]
Processing 00000000.tx.404: Methods Enzymol 96:8493[Medline] Bodnar AG, Rachubinski RA 1991 Characterization of the integral membrane polypeptides of rat liver peroxisomes isolated from untreated and clofibrate-treated rats. 

Phrase: "Methods Enzymol 96"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0025663:Methods [Intellectual Product]
   827   C0025664:methods [Intellectual Product]
   827   C0449851:Methods [Functional Concept]
   793 E C0871511:METHOD [Intellectual Product]

Phrase: ":"

Phrase: "8493"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bodnar AG,"

Phrase: "Rachubinski RA 1991 Characterization of the integral membrane polypeptides of rat liver peroxisomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   735   C1880022:Characterization [Activity]

Phrase: "isolated from untreated"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0205409:Isolated [Functional Concept]
   790   C0332155:untreated [Finding]
   790   C1548221:Isolated [Idea or Concept]
   756 E C0370215:Isolate [Substance]
   756 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "clofibrate-treated rats."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034693:rats [Mammal]
   827   C0034721:Rats [Mammal]
Processing 00000000.tx.405: Biochem Cell Biol 69:499508[Medline] Wattiaux R, Wattiaux-De Coninck S, Ronveaux-Dupal MF, Dubois F 1978 Isolation of rat liver lysosomes by isopycnic centrifugation in a metrizamide gradient. 

Phrase: "Biochem Cell Biol 69"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0007634:Cell [Cell]
   812   C0450388:69 [Intellectual Product]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "499508"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Wattiaux R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Wattiaux-De Coninck S,"

Phrase: "Ronveaux-Dupal MF,"

Phrase: "Dubois F 1978 Isolation of rat liver lysosomes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0204727:Isolation [Therapeutic or Preventive Procedure]
   744   C0205409:Isolation [Functional Concept]
   744   C0220862:isolation [Laboratory Procedure]

Phrase: "by isopycnic centrifugation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0007705:Centrifugation, Isopycnic [Laboratory Procedure]
   861   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "in a metrizamide gradient."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439182:% gradient [Quantitative Concept]
   861   C0812409:Gradient [Quantitative Concept]
Processing 00000000.tx.406: J Cell Biol 78:349368[Abstract] Bordier C 1981 Phase separation of integral membrane proteins in Triton X-114 solution. 

Phrase: "J Cell Biol 78"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "349368"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Bordier C 1981 Phase separation of integral membrane proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0036679:Separation [Pathologic Function]
   742   C0237868:Separation [Social Behavior]
   742   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "in Triton X-114 solution."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0037633:Solution [Substance]
   812   C0525069:Solution [Biomedical or Dental Material]
   756   C0146953:Triton X-114 [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.407: J Biol Chem 256:16041607[Abstract/Free FullText] Laemmli UK 1970 Cleavage of structural proteins during the assembly of the head of bacteriophage T4. 

Phrase: "J Biol Chem 256"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "16041607"

Phrase: "[Abstract/Free FullText"

Phrase: "] Laemmli UK 1970 Cleavage of structural proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C0597304:Protein Cleavage [Molecular Function]
   748   C0010813:cleavage [Cell Function]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1330957:cleavage [Cell Function]

Phrase: "during the assembly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1706853:Assembly [Activity]
  1000   C1879748:Assembly [Manufactured Object]

Phrase: "of the head"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0018670:Head [Body Location or Region]
  1000   C1281590:Head [Body Part, Organ, or Organ Component]
  1000   C1706305:Head [Manufactured Object]
   944 E C0205096:Cephalic [Spatial Concept]

Phrase: "of bacteriophage T4."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162570:Bacteriophage T4 [Virus]
Processing 00000000.tx.408: Nature 227:680685[Medline] Authier F, Danielsen GM, Kouach M, Briand G, Chauvet G 2001 Identification of insulin domains important for binding to and degradation by endosomal acidic insulinase. 

Phrase: "Nature 227"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "680685"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Authier F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Danielsen GM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0546866:GM [Antibiotic,Carbohydrate]

Phrase: "Kouach M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Briand G,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   861   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "Chauvet G 2001 Identification of insulin domains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0020792:Identification [Mental Process]
   748   C0205396:Identification [Qualitative Concept]

Phrase: "important for binding"

Phrase: "to"

Phrase: "and"

Phrase: "degradation by endosomal acidic insulinase."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243125:degradation [Functional Concept]
   760   C0699900:Degradation [Organism Function]
Processing 00000000.tx.409: Endocrinology 142:276289[Abstract/Free FullText] Brennan SO, Peach RJ 1991 The processing of human proinsulin and chicken proalbumin by rat hepatic vesicles suggests a convertase specific for X-Y-Arg-Arg or Arg-X-Y-Arg sequences. 

Phrase: "Endocrinology 142"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "276289"

Phrase: "[Abstract/Free FullText"

Phrase: "] Brennan SO,"

Phrase: "Peach RJ 1991"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0330659:Peach [Plant]
   827   C0949824:Peach [Food]
   827   C0972391:PEACH [Pharmacologic Substance]
   827   C1337216:PEACH [Food]

Phrase: "The processing of human proinsulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1709694:Processing [Activity]

Phrase: "and"

Phrase: "chicken proalbumin by rat hepatic vesicles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0032923:Proalbumin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "a convertase"

Phrase: "specific for X-Y-Arg-Arg"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205369:Specific [Qualitative Concept]
   753   C1552740:specific [Intellectual Product]

Phrase: "or"

Phrase: "Arg-X-Y-Arg sequences."
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   804   C0162326:Sequences [Nucleotide Sequence]
   771 E C0004793:Sequence [Nucleotide Sequence]
   771 E C0162327:Sequence [Nucleotide Sequence]
   771 E C1519249:Sequence [Functional Concept]
   721 E C1548958:Sequential [Idea or Concept]
   721 E C1705294:Sequential [Qualitative Concept]
   708   C0653858:Arg-Arg [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.410: J Biol Chem 266:2150421508[Abstract/Free FullText] Alarcon C, Cheatham B, Lincoln B, Kahn CR, Siddle K, Rhodes CJ 1994 A Kex2-related endopeptidase activity present in rat liver specifically processes the insulin proreceptor. 

Phrase: "J Biol Chem 266"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "2150421508"

Phrase: "[Abstract/Free FullText"

Phrase: "] Alarcon C,"

Phrase: "Cheatham B,"

Phrase: "Lincoln B,"

Phrase: "Kahn CR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0201975:Cr [Laboratory Procedure]
   861   C3539604:CR [Gene or Genome]

Phrase: "Siddle K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Rhodes CJ 1994"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0454812:Rhodes [Geographic Area]

Phrase: "A Kex2-related endopeptidase activity present in rat liver specifically processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0150312:Present [Quantitative Concept]
   738   C0449450:Present [Idea or Concept]

Phrase: "the insulin proreceptor."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0063612:insulin proreceptor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.411: Biochem J 301:257265[Medline] Berg T, Gjen T, Bakke O 1995 Physiological functions of endosomal proteolysis. 

Phrase: "Biochem J 301"

Phrase: ":"

Phrase: "257265"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Berg T,"

Phrase: "Gjen T,"

Phrase: "Bakke O 1995 Physiological functions of endosomal proteolysis."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0542341:Functions [Functional Concept]
   711 E C0031843:function [Physiologic Function]
   711 E C0700205:FUNCTION [Classification]
   711 E C1705273:Function [Intellectual Product]
Processing 00000000.tx.412: Biochem J 307:313326[Medline] Renfrew CA, Hubbard AL 1991 Sequential processing of epidermal growth factor in early and late endosomes of rat liver. 

Phrase: "Biochem J 307"

Phrase: ":"

Phrase: "313326"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Renfrew CA,"

Phrase: "Hubbard AL 1991 Sequential processing of epidermal growth factor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1709694:Processing [Activity]

Phrase: "in early"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1279919:Early [Temporal Concept]

Phrase: "and"

Phrase: "late endosomes of rat liver."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1166848:late endosome [Cell Component]
   760   C0034850:Endosomes [Cell Component]
Processing 00000000.tx.413: J Biol Chem 266:43484356[Abstract/Free FullText] Blum JS, Fiani ML, Stahl PD 1991 Proteolytic cleavage of ricin A chain in endosomal vesicles. 

Phrase: "J Biol Chem 266"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "43484356"

Phrase: "[Abstract/Free FullText"

Phrase: "] Blum JS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552154:Js [Body Part, Organ, or Organ Component]

Phrase: "Fiani ML, Stahl PD 1991 Proteolytic cleavage of ricin A chain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   736   C0010813:cleavage [Cell Function]
   736   C0596311:Cleavage [Phenomenon or Process]
   736   C1330957:cleavage [Cell Function]

Phrase: "in endosomal vesicles."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0333262:VESICLES [Acquired Abnormality]
   827 E C1622418:vesicle [Cell Component]
   777 E C0205378:Vesicular [Qualitative Concept]
Processing 00000000.tx.414: Evidence for the action of endosomal proteases at both neutral and acidic pH. 

Phrase: "Evidence for the action of endosomal proteases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "at both neutral"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1882074:Neutral [Qualitative Concept]
  1000   C2825492:Neutral [Phenomenon or Process]

Phrase: "and"

Phrase: "acidic pH."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]
Processing 00000000.tx.415: J Biol Chem 266:2209122095[Abstract/Free FullText] Diment S, Martin KJ, Stahl PD 1989 Cleavage of parathyroid hormone in macrophage endosomes illustrates a novel pathway for intracellular processing of proteins. 

Phrase: "J Biol Chem 266"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "2209122095"

Phrase: "[Abstract/Free FullText"

Phrase: "] Diment S,"

Phrase: "Martin KJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439255:kJ [Quantitative Concept]

Phrase: "Stahl PD 1989 Cleavage of parathyroid hormone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0010813:cleavage [Cell Function]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1330957:cleavage [Cell Function]

Phrase: "in macrophage endosomes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034850:Endosomes [Cell Component]

Phrase: "illustrates"

Phrase: "a novel pathway for intracellular processing of proteins."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1704259:Pathway [Molecular Function]
   744   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.416: J Biol Chem 264:1340313406[Abstract/Free FullText] Chapman HA 1998 Endosomal proteolysis and MHC class II function. 

Phrase: "J Biol Chem 264"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1340313406"

Phrase: "[Abstract/Free FullText"

Phrase: "] Chapman HA 1998 Endosomal proteolysis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0597304:Proteolysis [Molecular Function]
   733 E C1947941:proteolytic [Enzyme]

Phrase: "and"

Phrase: "MHC class II function."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   812   C0031843:function [Physiologic Function]
   812   C0542341:Function [Functional Concept]
   812   C0700205:FUNCTION [Classification]
   812   C1705273:Function [Intellectual Product]
   756   C0017349:MHC Class II [Gene or Genome]
   741 E C0205245:Functional [Functional Concept]
   741 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.417: Curr Opin Immunol 10:93102[CrossRef][Medline] McKenzie R, Lotersztajn S, Pavoine C, Pecker F, Epand RM, Orlowski RC 1990 Inhibition of the calcium pump by human parathyroid hormone-(134) and human calcitonin in liver plasma membranes. 

Phrase: "Curr Opin Immunol 10"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "93102"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] McKenzie R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Lotersztajn S,"

Phrase: "Pavoine C,"

Phrase: "Pecker F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Epand RM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2951520:RM [Body Location or Region]

Phrase: "Orlowski RC 1990 Inhibition of the calcium pump"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C3544583:inhibition of calcium pump [Molecular Function]
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C3463820:Inhibition [Activity]

Phrase: "by human parathyroid hormone-"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0020063:parathyroid hormone, human [Amino Acid, Peptide, or Protein,Hormone]
   901   C0030520:Parathyroid Hormone [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C1882913:PARATHYROID HORMONE [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   901   C3536885:Parathyroid Hormone [Pharmacologic Substance]
   827   C0019932:Hormone [Hormone]
   827   C0030518:Parathyroid, NOS [Body Part, Organ, or Organ Component]
   755 E C0458083:Hormonal [Qualitative Concept]

Phrase: "(134"

Phrase: ")"

Phrase: "and"

Phrase: "human calcitonin in liver plasma membranes."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0770558:Human calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
           Calcitonin
   783   C0544357:Human plasma [Pharmacologic Substance]
   753   C0006668:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0086418:Human [Human]
   753   C1704385:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C2825090:Calcitonin [Pharmacologic Substance]
   753   C3536753:Calcitonin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.418: Biochem J 266:817822[Medline] Duckworth WC, Bennett RG, Hamel FG 1998 Insulin degradation: progress and potential. 

Phrase: "Biochem J 266"

Phrase: ":"

Phrase: "817822"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Duckworth WC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0013123:WC [Organism Function]
   861   C2825512:WC [Quantitative Concept]

Phrase: "Bennett RG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412999:RG [Gene or Genome]

Phrase: "Hamel FG 1998 Insulin degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C3547574:insulin degradation [Molecular Function]
   804   C0243125:degradation [Functional Concept]
   804   C0699900:Degradation [Organism Function]

Phrase: ":"

Phrase: "progress"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1272688:progress [Functional Concept]
  1000   C1280477:Progress [Functional Concept]

Phrase: "and"

Phrase: "potential."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3245505:Potential [Qualitative Concept]
Processing 00000000.tx.419: Endocr Rev 19:608624[Abstract/Free FullText] Mayorga LS, Diaz R, Stahl PD 1988 Plasma membrane-derived vesicles containing receptor-ligand complexes are fusogenic with early endosomes in a cell-free system. 

Phrase: "Endocr Rev 19"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "608624"

Phrase: "[Abstract/Free FullText"

Phrase: "] Mayorga LS,"

Phrase: "Diaz R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Stahl PD 1988 Plasma membrane-derived vesicles"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   795   C0333262:VESICLES [Acquired Abnormality]
   762 E C1622418:vesicle [Cell Component]
   712 E C0205378:Vesicular [Qualitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "receptor-ligand complexes"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C1621296:receptor ligand [Molecular Function]
   896   C1523873:receptor complex [Cell Component]
   827   C0023688:Ligand [Chemical]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C1704241:Complexes [Chemical Viewed Structurally]
   793 E C0439855:Complex [Qualitative Concept]

Phrase: "are"

Phrase: "fusogenic with early endosomes"

Phrase: "in a cell-free system."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   923   C0007625:Cell-Free System [Cell Component]
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   741 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.420: J Biol Chem 263:1721317216[Abstract/Free FullText] Brimble KS, Ananthanarayanan VS 1993 Calcium binding and translocation properties of glucagon and its fragments. 

Phrase: "J Biol Chem 263"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1721317216"

Phrase: "[Abstract/Free FullText"

Phrase: "] Brimble KS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541894:ks [Quantitative Concept]

Phrase: "Ananthanarayanan"

Phrase: "VS"

Phrase: "1993 Calcium binding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1516144:Calcium Binding [Molecular Function]
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]

Phrase: "and"

Phrase: "translocation properties of glucagon"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0871161:properties [Qualitative Concept]
   770   C1292721:properties [Functional Concept]
   737 E C1882134:Property [Conceptual Entity]
   737 E C2347695:Property [Entity]

Phrase: "and"

Phrase: "its fragments."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332255:fragments [Functional Concept]
  1000   C0486805:Fragments [Body Substance]
   966 E C1708096:Fragment [Qualitative Concept]
Processing 00000000.tx.421: Biochemistry 32:16321640[Medline] Falnes PO, Sandvig K 2000 Penetration of protein toxins into cells. 

Phrase: "Biochemistry 32"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: ":"

Phrase: "16321640"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Falnes PO,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442027:PO [Spatial Concept]

Phrase: "Sandvig K 2000 Penetration of protein toxins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205321:Penetration [Functional Concept]

Phrase: "into cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.422: Curr Opin Cell Biol 12:407413[CrossRef][Medline] Andreev OA, Saraswat LD, Lowey S, Slaughter C, Borejdo J 1999 Interaction of the N-terminus of chicken skeletal essential light chain 1 with F-actin. 

Phrase: "Curr Opin Cell Biol 12"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0007634:Cell [Cell]
   804   C1269647:Cell [Cell]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "407413"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Andreev OA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0029408:OA [Disease or Syndrome]
   861   C2985270:OA [Finding]

Phrase: "Saraswat LD,"

Phrase: "Lowey S,"

Phrase: "Slaughter C,"

Phrase: "Borejdo J 1999 Interaction of the N-terminus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1704675:Interaction [Functional Concept]

Phrase: "of chicken skeletal essential light chain 1"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   799   C0008051:Chicken [Bird]
   799   C0023693:Light [Natural Phenomenon or Process]
   799   C0037253:skeletal [Body System]
   799   C0205224:Essential [Qualitative Concept]
   799   C0337112:Chain [Manufactured Object]
   799   C0521324:Skeletal [Spatial Concept]
   799   C0677521:Chicken [Food]
   799   C1306462:Light [Functional Concept]
   799   C1365945:CHICKEN [Food]
   799   C1524075:Chain [Idea or Concept]
   799   C1881376:Light [Qualitative Concept]

Phrase: "with F-actin."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C1180307:F-Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1622186:F-actin [Cell Component]
   861   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
   789 E C0439681:Actinic [Qualitative Concept]
Processing 00000000.tx.423: Biochemistry 38:24802485[CrossRef][Medline] Nyman T, Page R, Schutt CE, Karlsson R, Lindberg U 2002 A cross-linked profilin-actin heterodimer interferes with elongation at the fast-growing end of F-actin. 

Phrase: "Biochemistry 38"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: ":"

Phrase: "24802485"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nyman T,"

Phrase: "Page R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Schutt CE,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827664:CE [Idea or Concept]

Phrase: "Karlsson R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Lindberg U 2002"

Phrase: "A"

Phrase: "cross-linked"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178576:Cross Linked [Natural Phenomenon or Process]
  1000   C0332220:cross linked [Functional Concept]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "profilin-actin heterodimer"

Phrase: "interferes with elongation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   882   C0521102:Interferes with [Qualitative Concept]
           Interfere

Phrase: "at the fast-growing end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0444930:End [Spatial Concept]
   827   C2746065:End [Temporal Concept]
   771 E C0205088:Terminal [Temporal Concept]
   771 E C1705314:Terminal [Manufactured Object]
   771 E C1705315:Terminal [Spatial Concept]

Phrase: "of F-actin."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C1180307:F-Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1622186:F-actin [Cell Component]
   861   C0001271:Actin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]
   789 E C0439681:Actinic [Qualitative Concept]
Processing 00000000.tx.424: J Biol Chem 277:1582815833[Abstract/Free FullText] Nakayama K 1997 Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins. 

Phrase: "J Biol Chem 277"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1582815833"

Phrase: "[Abstract/Free FullText"

Phrase: "] Nakayama K 1997 Furin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0919550:FURIN [Gene or Genome]

Phrase: ":"

Phrase: "a mammalian subtilisin/Kex2p-"

Phrase: "like endoprotease"

Phrase: "involved in processing of a wide variety of precursor proteins."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   743   C0033665:precursor protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   741   C0033666:protein processing [Molecular Function]
   741   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   739   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0332464:Wide [Spatial Concept]
   739   C1314939:Involved [Functional Concept]
   739   C1709634:Precursor [Idea or Concept]
   739   C1709694:Processing [Activity]
   739   C1883525:Variety [Conceptual Entity]
   739   C2346866:Variety [Conceptual Entity]
Processing 00000000.tx.425: Biochem J 327:625635[Medline] Ogata M, Fryling CM, Pastan I, FitzGerald DJ 1992 Cell-mediated cleavage of Pseudomonas exotoxin between Arg279 and Gly280 generates the enzymatically active fragment which translocates to the cytosol. 

Phrase: "Biochem J 327"

Phrase: ":"

Phrase: "625635"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ogata M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Fryling CM,"

Phrase: "Pastan I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "FitzGerald DJ 1992 Cell-mediated cleavage of Pseudomonas exotoxin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0010813:cleavage [Cell Function]
   742   C0596311:Cleavage [Phenomenon or Process]
   742   C1330957:cleavage [Cell Function]

Phrase: "between Arg279"

Phrase: "and"

Phrase: "Gly280"

Phrase: "generates"

Phrase: "the enzymatically active fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332255:fragment [Functional Concept]
   827   C1708096:Fragment [Qualitative Concept]

Phrase: "which"

Phrase: "translocates to the cytosol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1383501:Cytosol [Cell Component]
Processing 00000000.tx.426: J Biol Chem 267:2539625401[Abstract/Free FullText] Gordon VM, Klimpel KR, Arora N, Henderson MA, Leppla SH 1995 Proteolytic activation of bacterial toxins by eukaryotic cells is performed by furin and by additional cellular proteases. 

Phrase: "J Biol Chem 267"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "2539625401"

Phrase: "[Abstract/Free FullText"

Phrase: "] Gordon VM,"

Phrase: "Klimpel KR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022773:KR [Geographic Area]

Phrase: "Arora N, Henderson MA,"

Phrase: "Leppla SH 1995 Proteolytic activation of bacterial toxins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   769   C2249699:activation of proteolysis [Molecular Function]
   744   C1879547:Activation [Activity]

Phrase: "by eukaryotic cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0015161:Eukaryotic Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "performed by furin"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C1550369:Performed By [Qualitative Concept]
   790   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0884358:Performed [Functional Concept]
   790   C0919550:FURIN [Gene or Genome]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and by additional cellular proteases."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0007634:Cellular [Cell]
   760   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C0178539:Cellular [Functional Concept]
   760   C1515981:And [Idea or Concept]
   760   C1524062:Additional [Functional Concept]
   760   C1947941:Proteases [Enzyme]
Processing 00000000.tx.427: Infect Immun 63:8287[Abstract] Molloy SS, Thomas L, Kamibayashi C, Mumby MC, Thomas G 1998 Regulation of endosome sorting by a specific PP2A isoform. 

Phrase: "Infect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439663:infect [Functional Concept]

Phrase: "Immun 63"

Phrase: ":"

Phrase: "8287"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Molloy SS,"

Phrase: "Thomas L,"

Phrase: "Kamibayashi C,"

Phrase: "Mumby MC,"

Phrase: "Thomas G 1998 Regulation of endosome sorting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "by a specific PP2A isoform."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597298:Isoform [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.428: J Cell Biol 142:13991411[Abstract/Free FullText] Schafer W, Stroh A, Berghofer S, Seiler J, Vey M, Kruse ML, Kern HF, Klenk HD, Garten W 1995 Two independent targeting signals in the cytoplasmic domain determine trans-Golgi network localization and endosomal trafficking of the proprotein convertase furin. 

Phrase: "J Cell Biol 142"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "13991411"

Phrase: "[Abstract/Free FullText"

Phrase: "] Schafer W,"

Phrase: "Stroh A,"

Phrase: "Berghofer S,"

Phrase: "Seiler J,"

Phrase: "Vey M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kruse ML, Kern HF,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0018488:Hf [Element, Ion, or Isotope]
   804   C1538440:HF [Gene or Genome]
   804   C3273279:HF [Gene or Genome]

Phrase: "Klenk HD,"

Phrase: "Garten W 1995 Two independent targeting signals in the cytoplasmic domain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   704   C1710082:Signal [Phenomenon or Process]

Phrase: "determine"

Phrase: "trans-Golgi network localization"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C1660008:Golgi localisation [Cell Function]
   812   C0475264:Localisation [Functional Concept]
   812   C1744691:localisation [Biologic Function]
   756   C0887838:trans-Golgi Network [Cell Component]

Phrase: "and"

Phrase: "endosomal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0034850:Endosome [Cell Component]

Phrase: "trafficking of the proprotein convertase furin."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1100660:Proprotein Convertase [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0287990:Furin [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0379214:pro protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0599896:trafficking [Cell Function]
   753   C0919550:FURIN [Gene or Genome]
   753   C1709708:Proprotein [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.429: EMBO J 14:24242435[Abstract] Chiron MF, Fryling CM, FitzGerald DJ 1994 Cleavage of pseudomonas exotoxin and diphtheria toxin by a furin-like enzyme prepared from beef liver. 

Phrase: "EMBO J 14"

Phrase: ":"

Phrase: "24242435"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Chiron MF,"

Phrase: "Fryling CM,"

Phrase: "FitzGerald DJ 1994 Cleavage of pseudomonas exotoxin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0010813:cleavage [Cell Function]
   748   C0596311:Cleavage [Phenomenon or Process]
   748   C1330957:cleavage [Cell Function]

Phrase: "and"

Phrase: "diphtheria toxin by a furin-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0012550:Diphtheria Toxin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Hazardous or Poisonous Substance]
   760   C0012546:DIPHTERIA [Disease or Syndrome]
   760   C0040549:Toxin [Biologically Active Substance,Hazardous or Poisonous Substance]

Phrase: "like enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "prepared from beef liver."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C1440926:Beef Liver [Food]
   833   C3484530:BEEF LIVER [Immunologic Factor,Pharmacologic Substance]
   770   C0023884:Liver [Body Part, Organ, or Organ Component]
   770   C0452849:Beef [Food]
   770   C0736268:LIVER [Body Part, Organ, or Organ Component]
   770   C1278929:Liver [Body Part, Organ, or Organ Component]
   770   C2346688:LIVER [Food]
   770   C2362309:BEEF [Pharmacologic Substance]
   737   C1521827:Prepare [Functional Concept]
   715 E C0205054:Hepatic [Body Location or Region]
Processing 00000000.tx.430: J Biol Chem 269:1816718176[Abstract/Free FullText] Nakayama K, Watanabe T, Nakagawa T, Kim WS, Nagahama M, Hosaka M, Hatsuzawa K, Kondoh-Hashiba K, Murakami K 1992 Consensus sequence for precursor processing at mono-arginyl sites. 

Phrase: "J Biol Chem 269"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1816718176"

Phrase: "[Abstract/Free FullText"

Phrase: "] Nakayama K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Watanabe T,"

Phrase: "Nakagawa T,"

Phrase: "Kim WS,"

Phrase: "Nagahama M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hosaka M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hatsuzawa K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Kondoh-Hashiba K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]

Phrase: "Murakami K 1992 Consensus sequence for precursor processing"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0079160:Consensus Sequence [Nucleotide Sequence]
   744   C0004793:Sequence [Nucleotide Sequence]
   744   C0162326:Sequence [Nucleotide Sequence]
   744   C0162327:Sequence [Nucleotide Sequence]
   744   C0376298:Consensus [Social Behavior]
   744   C1519249:Sequence [Functional Concept]

Phrase: "at mono-arginyl sites."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.431: Evidence for the involvement of a Kex2-like endoprotease in precursor cleavages at both dibasic and mono-arginyl sites. 

Phrase: "Evidence for the involvement of a Kex2-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "like endoprotease"

Phrase: "in precursor cleavages"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0010813:cleavage [Cell Function]
   827   C0596311:Cleavage [Phenomenon or Process]
   827   C1330957:cleavage [Cell Function]

Phrase: "at both dibasic"

Phrase: "and"

Phrase: "mono-arginyl sites."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205145:Sites [Spatial Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.432: J Biol Chem 267:1633516340[Abstract/Free FullText] Mentlein R 1999 Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides. 

Phrase: "J Biol Chem 267"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1633516340"

Phrase: "[Abstract/Free FullText"

Phrase: "] Mentlein R 1999 Dipeptidyl-peptidase IV"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0081937:Dipeptidyl-Peptidase IV [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   861   C1414141:DIPEPTIDYL PEPTIDASE IV [Gene or Genome]
   827   C0022709:dipeptidyl peptidase [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   799   C0030940:Peptidase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C1947941:Peptidase [Enzyme]

Phrase: "(CD26"

Phrase: ")-"

Phrase: "role in the inactivation of regulatory peptides."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.433: Regul Pept 85:924[CrossRef][Medline] Loch N, Tauber R, Becker A, Hartel-Schenk S, Reutter W 1992 Biosynthesis and metabolism of dipeptidylpeptidase IV in primary cultured rat hepatocytes and Morris hepatoma 7777 cells. 

Phrase: "Regul Pept 85"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0080384:PEPT [Organic Chemical,Pharmacologic Substance]

Phrase: ":"

Phrase: "924"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Loch N, Tauber R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205090:R- [Spatial Concept]
   812   C0684010:R. [Professional or Occupational Group]
   812   C2603358:R' [Clinical Attribute]

Phrase: "Becker A,"

Phrase: "Hartel-Schenk S,"

Phrase: "Reutter W 1992 Biosynthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0005572:biosynthesis [Functional Concept]
   812   C0220781:Biosynthesis [Biologic Function]

Phrase: "and"

Phrase: "metabolism of dipeptidylpeptidase IV"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0025519:Metabolism [Organism Function]
   770   C0025520:metabolism [Functional Concept]

Phrase: "in primary cultured rat hepatocytes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0227525:Hepatocytes [Cell]
   779 E C0669372:Hepatocyte NOS [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "Morris hepatoma 7777 cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   858   C0677626:hepatoma cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.434: Eur J Biochem 210:161168[Abstract] Steiner DF 1998 The proprotein convertases. 

Phrase: "Eur J Biochem 210"

Phrase: ":"

Phrase: "161168"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Steiner DF 1998"

Phrase: "The proprotein convertases."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1100660:Proprotein Convertases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0379214:pro protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1709708:Proprotein [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.435: Curr Opin Chem Biol 2:3139[CrossRef][Medline] Seidah NG, Prat A 2002 Precursor convertases in the secretory pathway, cytosol and extracellular milieu. 

Phrase: "Curr Opin Chem Biol 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "3139"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Seidah NG,"

Phrase: "Prat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418780:PRAT [Gene or Genome]

Phrase: "A 2002 Precursor convertases in the secretory pathway,"

Phrase: "cytosol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosol [Cell Component]

Phrase: "and"

Phrase: "extracellular milieu."
Processing 00000000.tx.436: Essays Biochem 38:7994[Medline] Navab R, Chevet E, Authier F, Di Guglielmo GM, Bergeron JJ, Brodt P 2001 Inhibition of endosomal insulin-like growth factor-I processing by cysteine proteinase inhibitors blocks receptor-mediated functions. 

Phrase: "Essays Biochem 38"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0600647:Essays [Intellectual Product]

Phrase: ":"

Phrase: "7994"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Navab R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Chevet E,"

Phrase: "Authier F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Di Guglielmo GM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0546866:GM [Antibiotic,Carbohydrate]

Phrase: "Bergeron JJ,"

Phrase: "Brodt P 2001 Inhibition of endosomal insulin-like growth factor-I processing"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C1512280:Growth Factor Inhibition [Physiologic Function]
   767   C2249823:inhibition of growth [Organism Function]
   736   C0021467:Inhibition [Mental Process]
   736   C0021469:Inhibition [Molecular Function]
   736   C1628982:% inhibition [Quantitative Concept]
   736   C3463820:Inhibition [Activity]

Phrase: "by cysteine proteinase inhibitors"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
  1000   C0010658:Cysteine Proteinase Inhibitors [Biologically Active Substance,Pharmacologic Substance]
  1000   C2756981:Cysteine Proteinase Inhibitors [Molecular Function]
   901   C2717970:Cysteine Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
   867   C0033607:proteinase inhibitor [Biologically Active Substance,Pharmacologic Substance]
   867   C1961133:Proteinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   867   C2673177:proteinase inhibitor [Molecular Function]
   827   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   827   C0243077:inhibitors [Chemical Viewed Functionally]
   827   C1622131:proteinase [Molecular Function]
   827   C1947941:Proteinase [Enzyme]
   793 E C1999216:Inhibitor [Qualitative Concept]

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "receptor-mediated functions."
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   896   C0920644:receptor function [Molecular Function]
   827   C0542341:Functions [Functional Concept]
   793 E C0031843:function [Physiologic Function]
   793 E C0700205:FUNCTION [Classification]
   793 E C1705273:Function [Intellectual Product]
   743 E C0205245:Functional [Functional Concept]
   743 E C2700217:Functional [Conceptual Entity]
Processing 00000000.tx.437: J Biol Chem 276:1364413649[Abstract/Free FullText] Stepanov VM, Rudenskaya GN 1983 Proteinase affinity chromatography on bacitracin-Sepharose. 

Phrase: "J Biol Chem 276"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1364413649"

Phrase: "[Abstract/Free FullText"

Phrase: "] Stepanov VM,"

Phrase: "Rudenskaya GN 1983 Proteinase affinity chromatography on bacitracin-Sepharose."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   764   C0008551:Chromatography, Affinity [Laboratory Procedure]
   762   C0008552:Chromatography, Sepharose [Laboratory Procedure,Research Activity]
   742   C0008550:Chromatography [Laboratory Procedure]
   742   C1510827:Affinity [Natural Phenomenon or Process]
Processing 00000000.tx.438: J Appl Biochem 5:420428[Medline] Stepanov VM, Rudenskaya GN, Revina LP, Gryaznova YB, Lysogorskaya EN, Filippova IY, Ivanova II 1992 A serine proteinase of an archaebacterium, Halobacterium mediterranei. 

Phrase: "J Appl Biochem 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1858559:APPL [Gene or Genome]

Phrase: ":"

Phrase: "420428"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Stepanov VM,"

Phrase: "Rudenskaya GN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0018381:GN [Geographic Area]

Phrase: "Revina LP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0037943:LP [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C0228341:LP [Body Part, Organ, or Organ Component]
   861   C2239920:LP [Gene or Genome]

Phrase: "Gryaznova YB,"

Phrase: "Lysogorskaya EN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034850:Endosomes [Cell Component]

Phrase: "Filippova IY,"

Phrase: "Ivanova II 1992"

Phrase: "A serine proteinase of an archaebacterium,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C2717971:Serine Proteinase [Amino Acid, Peptide, or Protein,Enzyme]
   783   C0377149:proteinase a [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0030946:Proteinase [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   753   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C1622131:proteinase [Molecular Function]
   753   C1947941:Proteinase [Enzyme]

Phrase: "Halobacterium mediterranei."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0524842:Halobacterium mediterranei [Archaeon]
   861   C0018540:Halobacterium [Archaeon]
Processing 00000000.tx.439: A homologue of eubacterial subtilisins. 

Phrase: "A homologue of eubacterial subtilisins."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1334043:Homologue [Gene or Genome]
Processing 00000000.tx.440: Biochem J 285:281286[Medline]

Phrase: "Biochem J 285"

Phrase: ":"

Phrase: "281286"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

